molecule,virus,reference,type,pubchem_smiles,obabel_smiles,pubchem_id,similarity_calculated,release
Remdesivir,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4,CCC(COC(=O)C(NP(=O)(Oc1ccccc1)OCC1OC(C(C1O)O)(C#N)c1ccc2n1ncnc2N)C)CC,121304016,1,0.3
Chloroquine,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,2719,1,0.3
Nitazoxanide,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],CC(=O)Oc1ccccc1C(=O)Nc1ncc(s1)[N+](=O)[O-],41684,1,0.3
Nafamostat,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N,NC(=Nc1ccc(cc1)C(=O)Oc1ccc2c(c1)ccc(c2)C(=N)N)N,4413,1,0.3
penciclovir,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,C1=NC2=C(N1CCC(CO)CO)N=C(NC2=O)N,OCC(CCn1cnc2c1nc(N)[nH]c2=O)CO,135398748,1,0.3
nafamostat,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N,NC(=Nc1ccc(cc1)C(=O)Oc1ccc2c(c1)ccc(c2)C(=N)N)N,4413,1,0.3
favipiravir,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,C1=C(N=C(C(=O)N1)C(=O)N)F,Fc1c[nH]c(=O)c(n1)C(=O)N,492405,1,0.3
Loratadine,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,CCOC(=O)N1CCC(=C2c3ccc(cc3CCc3c2nccc3)Cl)CC1,3957,1,0.3
Daunorubicin,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,COc1cccc2c1C(=O)c1c(C2=O)c(O)c2c(c1O)C(OC1CC(N)C(C(O1)C)O)CC(C2)(O)C(=O)C,30323,1,0.3
Midostaurin,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,COC1C(CC2OC1(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O)N(C(=O)c1ccccc1)C,9829523,1,0.3
Ponatinib,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,CN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)c1ccc(c(c1)C#Cc1cnc2n1nccc2)C,24826799,1,0.3
Silmitasertib,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,C1=CC(=CC(=C1)Cl)NC2=NC3=C(C=CC(=C3)C(=O)O)C4=C2C=CN=C4,Clc1cccc(c1)Nc1nc2cc(ccc2c2c1ccnc2)C(=O)O,24748573,1,0.3
Valproic Acid,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CCCC(CCC)C(=O)O,CCCC(C(=O)O)CCC,3121,1,0.3
Haloperidol,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,3559,1,0.3
Metformin,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CN(C)C(=N)N=C(N)N,CN(C(=N)N=C(N)N)C,4091,1,0.3
Migalastat,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,C1C(C(C(C(N1)CO)O)O)O,OCC1NCC(C(C1O)O)O,176077,1,0.3
S-verapamil,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,COc1ccc(cc1OC)CCN(CCCC(c1ccc(c(c1)OC)OC)(C(C)C)C#N)C,92305,1,0.3
Indomethacin,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,COc1ccc2c(c1)c(CC(=O)O)c(n2C(=O)c1ccc(cc1)Cl)C,3715,1,0.3
Ruxolitinib,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,N#CCC(n1ncc(c1)c1ncnc2c1cc[nH]2)C1CCCC1,25126798,1,0.3
Mycophenolic acid,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O,COc1c(CC=C(CCC(=O)O)C)c(O)c2c(c1C)COC2=O,446541,1,0.3
Entacapone,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N,CCN(C(=O)C(=Cc1cc(O)c(c(c1)[N+](=O)[O-])O)C#N)CC,5281081,1,0.3
Ribavirin,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542,1,0.3
E-52862,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4,Cc1cc(nn1c1ccc2c(c1)cccc2)OCCN1CCOCC1,44247568,1,0.3
Merimepodib,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COC1=C(C=CC(=C1)NC(=O)NC2=CC=CC(=C2)CNC(=O)OC3CCOC3)C4=CN=CO4,COc1cc(ccc1c1cnco1)NC(=O)Nc1cccc(c1)CNC(=O)OC1COCC1,153241,1,0.3
RVX-208,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC1=CC(=CC(=C1OCCO)C)C2=NC3=C(C(=CC(=C3)OC)OC)C(=O)N2,OCCOc1c(C)cc(cc1C)c1nc2cc(OC)cc(c2c(=O)[nH]1)OC,135564749,1,0.3
XL413,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,C1CC(NC1)C2=NC3=C(C(=O)N2)OC4=C3C=C(C=C4)Cl,Clc1ccc2c(c1)c1nc([nH]c(=O)c1o2)C1CCCN1,135564632,1,0.3
AC-55541,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC(=NNC(=O)C(C1=NNC(=O)C2=CC=CC=C21)NC(=O)C3=CC=CC=C3)C4=CC(=CC=C4)Br,Brc1cccc(c1)C(=NNC(=O)C(c1n[nH]c(=O)c2c1cccc2)NC(=O)c1ccccc1)C,9589606,1,0.3
Apicidin,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CCC(C)C1C(=O)N2CCCCC2C(=O)NC(C(=O)NC(C(=O)N1)CC3=CN(C4=CC=CC=C43)OC)CCCCCC(=O)CC,CCC(=O)CCCCCC1NC(=O)C2CCCCN2C(=O)C(NC(=O)C(NC1=O)Cc1cn(c2c1cccc2)OC)C(CC)C,6918328,1,0.3
AZ3451,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC(C1CCCCC1)N2C3=C(C=C(C=C3)C(=O)NC4=CC=C(C=C4)C#N)N=C2C5=CC6=C(C=C5Br)OCO6,N#Cc1ccc(cc1)NC(=O)c1ccc2c(c1)nc(n2C(C1CCCCC1)C)c1cc2OCOc2cc1Br,126961335,1,0.3
AZ8838,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CCCC1=C(C=CC(=C1)F)C(C2=NC=CN2)O,CCCc1cc(F)ccc1C(c1ncc[nH]1)O,126961334,1,0.3
Bafilomycin A1,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC1CC(=CC=CC(C(OC(=O)C(=CC(=CC(C1O)C)C)OC)C(C)C(C(C)C2(CC(C(C(O2)C(C)C)C)O)O)O)OC)C,COC1C=CC=C(C)CC(C)C(O)C(C=C(C=C(C(=O)OC1C(C(C(C1(O)CC(O)C(C(O1)C(C)C)C)C)O)C)OC)C)C,6436223,1,0.3
CCT 365623,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,NCc1ccc(s1)S(=O)(=O)c1cc(cc(c1)S(=O)(=O)C)c1ccccc1,NCc1ccc(s1)S(=O)(=O)c1cc(cc(c1)S(=O)(=O)C)c1ccccc1,,1,0.3
GB110,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CCC(C)C(C(=O)NCC1=CC(=CC=C1)C(=O)N2CCC(CC2)CN)NC(=O)C(CC3CCCCC3)NC(=O)C4=CC=NO4,NCC1CCN(CC1)C(=O)c1cccc(c1)CNC(=O)C(C(CC)C)NC(=O)C(NC(=O)c1ccno1)CC1CCCCC1,49843508,1,0.3
H-89,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,C1=CC2=C(C=CN=C2)C(=C1)S(=O)(=O)NCCNCC=CC3=CC=C(C=C3)Br,Brc1ccc(cc1)C=CCNCCNS(=O)(=O)c1cccc2c1ccnc2,449241,1,0.3
JQ1,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C,O=C(OC(C)(C)C)CC1N=C(c2ccc(cc2)Cl)c2c(-n3c1nnc3C)sc(c2C)C,46907787,1,0.3
PB28,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)C4CCCCC4,COc1cccc2c1CCCC2CCCN1CCN(CC1)C1CCCCC1,10474335,1,0.3
PD-144418,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CCCN1CCC=C(C1)C2=CC(=NO2)C3=CC=C(C=C3)C,CCCN1CCC=C(C1)c1onc(c1)c1ccc(cc1)C,9817231,1,0.3
RS-PPCC,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COC(=O)C1(CC1CN1CCC(CC1)(O)c1ccccc1)c1ccc(cc1)C,COC(=O)C1(CC1CN1CCC(CC1)(O)c1ccccc1)c1ccc(cc1)C,,1,0.3
TMCB,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CN(C)C1=NC2=C(N1CC(=O)O)C(=C(C(=C2Br)Br)Br)Br,OC(=O)Cn1c(nc2c1c(Br)c(Br)c(c2Br)Br)N(C)C,46943415,1,0.3
UCPH-101,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COC1=CC=C(C=C1)C2C(=C(OC3=C2C(=O)CC(C3)C4=CC=CC5=CC=CC=C54)N)C#N,COc1ccc(cc1)C1C2=C(OC(=C1C#N)N)CC(CC2=O)c1cccc2c1cccc2,25223366,1,0.3
ZINC1775962367,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,O=C1C[N+]2([B-](O1)(OC(=O)C2)c1ccc(cc1)Cn1c(C)nc2c1cc(Cl)c(c2[N+](=O)[O-])Cl)C,O=C1C[N+]2([B-](O1)(OC(=O)C2)c1ccc(cc1)Cn1c(C)nc2c1cc(Cl)c(c2[N+](=O)[O-])Cl)C,,1,0.3
ZINC4326719,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COC1=C(C=C(C=C1)C2=NN3C(=NN=C3S2)C4=CC=CO4)OC,COc1cc(ccc1OC)c1nn2c(s1)nnc2c1ccco1,661498,1,0.3
ZINC4511851,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COC1=C(C=C(C=C1)C2=NN3C(=NN=C3S2)C4=CC=CS4)OC,COc1cc(ccc1OC)c1nn2c(s1)nnc2c1cccs1,3163969,1,0.3
ZINC95559591,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,C1CC(C1)C(=O)NCCCNC2=NC(=NC=C2C3CC3)NC4=CC=C(C=C4)N5CCOCC5,O=C(C1CCC1)NCCCNc1nc(ncc1C1CC1)Nc1ccc(cc1)N1CCOCC1,44465558,1,0.3
4E2RCat,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,C1=CC=C(C=C1)CN2C(=O)C(=CC3=CC=C(O3)C4=CC(=C(C=C4)Cl)C(=O)O)SC2=S,S=C1SC(=Cc2ccc(o2)c2ccc(c(c2)C(=O)O)Cl)C(=O)N1Cc1ccccc1,2287236,1,0.3
ABBV-744,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CCNC(=O)C1=CC2=C(N1)C(=O)N(C=C2C3=C(C=CC(=C3)C(C)(C)O)OC4=C(C=C(C=C4C)F)C)C,CCNC(=O)c1cc2c([nH]1)c(=O)n(cc2c1cc(ccc1Oc1c(C)cc(cc1C)F)C(O)(C)C)C,132010322,1,0.3
Camostat,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CN(C)C(=O)COC(=O)CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N,CN(C(=O)COC(=O)Cc1ccc(cc1)OC(=O)c1ccc(cc1)N=C(N)N)C,2536,1,0.3
Captopril,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC(CS)C(=O)N1CCCC1C(=O)O,SCC(C(=O)N1CCCC1C(=O)O)C,44093,1,0.3
CB5083,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC1=CC2=C(C=CC=C2N1C3=NC4=C(COCC4)C(=N3)NCC5=CC=CC=C5)C(=O)N,NC(=O)c1cccc2c1cc(n2c1nc(NCc2ccccc2)c2c(n1)CCOC2)C,73051434,1,0.3
Chloramphenicol,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],OCC(C(c1ccc(cc1)[N+](=O)[O-])O)NC(=O)C(Cl)Cl,5959,1,0.3
Chloroquine,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,2719,1,0.3
Compound 10,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,C1=CC(=CC=C1C=C2C(=O)NC(=O)S2)OCC(=O)O,OC(=O)COc1ccc(cc1)C=C1SC(=O)NC1=O,139595720,1,0.3
Compound 2,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CO[C@@H]1CC/C=C/c2cccc(c2)[C@@H](CCNC(=O)OC(C)(C)C)OC(=O)[C@H]2NN(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1C)C(C)C)C)CCC2,CO[C@@H]1CC/C=C/c2cccc(c2)[C@@H](CCNC(=O)OC(C)(C)C)OC(=O)[C@H]2NN(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1C)C(C)C)C)CCC2,,1,0.3
CPI-0610,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC1=NOC2=C1C3=CC=CC=C3C(=NC2CC(=O)N)C4=CC=C(C=C4)Cl,NC(=O)CC1N=C(c2ccc(cc2)Cl)c2c(-c3c1onc3C)cccc2,57389999,1,0.3
Dabrafenib,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,Nc1nccc(n1)c1sc(nc1c1cccc(c1F)NS(=O)(=O)c1c(F)cccc1F)C(C)(C)C,44462760,1,0.3
DBeQ,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,C1=CC=C(C=C1)CNC2=NC(=NC3=CC=CC=C32)NCC4=CC=CC=C4,c1ccc(cc1)CNc1nc(NCc2ccccc2)c2c(n1)cccc2,676352,1,0.3
dBET6,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)NCCCCCCCCNC(=O)COC4=CC=CC5=C4C(=O)N(C5=O)C6CCC(=O)NC6=O)C7=CC=C(C=C7)Cl)C,O=C(COc1cccc2c1C(=O)N(C2=O)C1CCC(=O)NC1=O)NCCCCCCCCNC(=O)CC1N=C(c2ccc(cc2)Cl)c2c(-n3c1nnc3C)sc(c2C)C,121427831,1,0.3
IHVR-19029,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,OC[C@H]1N(CCCCCCN(C(=O)NC(C)(C)C)C2CCCCC2)C[C@@H]([C@H]([C@@H]1O)O)O,OC[C@H]1N(CCCCCCN(C(=O)NC(C)(C)C)C2CCCCC2)C[C@@H]([C@H]([C@@H]1O)O)O,,1,0.3
Linezolid,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,CC(=O)NCC1OC(=O)N(C1)c1ccc(c(c1)F)N1CCOCC1,441401,1,0.3
Lisinopril,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,NCCCCC(C(=O)N1CCCC1C(=O)O)NC(C(=O)O)CCc1ccccc1,5362119,1,0.3
Minoxidil,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,Nc1cc(nc(=N)n1O)N1CCCCC1,4201,1,0.3
ML240,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COC1=CC=CC2=C1N=C(N=C2NCC3=CC=CC=C3)N4C5=CC=CC=C5N=C4N,COc1cccc2c1nc(nc2NCc1ccccc1)n1c(N)nc2c1cccc2,49830258,1,0.3
MZ1,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,O[C@@H]1C[C@H](N(C1)C(=O)[C@H](C(C)(C)C)NC(=O)COCCOCCOCCNC(=O)C[C@@H]1N=C(c2ccc(cc2)Cl)c2c(n3c1nnc3C)sc(c2C)C)C(=O)NCc1ccc(cc1)c1scnc1C,O[C@@H]1C[C@H](N(C1)C(=O)[C@H](C(C)(C)C)NC(=O)COCCOCCOCCNC(=O)C[C@@H]1N=C(c2ccc(cc2)Cl)c2c(n3c1nnc3C)sc(c2C)C)C(=O)NCc1ccc(cc1)c1scnc1C,,1,0.3
Nafamostat,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N,NC(=Nc1ccc(cc1)C(=O)Oc1ccc2c(c1)ccc(c2)C(=N)N)N,4413,1,0.3
Pevonedistat,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,C1CC2=CC=CC=C2C1NC3=C4C=CN(C4=NC=N3)C5CC(C(C5)O)COS(=O)(=O)N,OC1CC(CC1COS(=O)(=O)N)n1ccc2c1ncnc2NC1CCc2c1cccc2,16720766,1,0.3
PS3061,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,N#CCC[C@H]1OC(=O)[C@H](C)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2cn(c3c2cccc3)Cc2ccc(cc2)Br)N(C(=O)[C@@H](NC(=O)[C@@H](N(C(=O)[C@@H](NC1=O)CC(C)C)C)CC(C)C)CC(C)C)C,N#CCC[C@H]1OC(=O)[C@H](C)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2cn(c3c2cccc3)Cc2ccc(cc2)Br)N(C(=O)[C@@H](NC(=O)[C@@H](N(C(=O)[C@@H](NC1=O)CC(C)C)C)CC(C)C)CC(C)C)C,,1,0.3
Rapamycin (Sirolimus),SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,COC1CC(CCC1O)CC(C1OC(=O)C2CCCCN2C(=O)C(=O)C2(O)OC(CCC2C)CC(OC)C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)C1)C)C)O)OC)C)C)C)C,5284616,1,0.3
Sanglifehrin A,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CCC1CC(C2(C(C(C(C(O2)CC(C(C)CCC=CC=C(C)C3CC=CC=CC(C(C(C(C(=O)NC(C(=O)NC(C(=O)N4CCCC(N4)C(=O)O3)CC5=CC(=CC=C5)O)C(C)C)CCC(=O)C)O)C)O)O)C)O)C)NC1=O)C,CCC1CC(C)C2(NC1=O)OC(CC(C(CCC=CC=C(C1CC=CC=CC(O)C(C)C(O)C(CCC(=O)C)C(=O)NC(C(=O)NC(C(=O)N3NC(C(=O)O1)CCC3)Cc1cccc(c1)O)C(C)C)C)C)O)C(C(C2C)O)C,5388925,1,0.3
Sapanisertib (INK128/MlN128),SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,Nc1oc2c(n1)cc(cc2)c1nn(c2c1c(N)ncn2)C(C)C,Nc1oc2c(n1)cc(cc2)c1nn(c2c1c(N)ncn2)C(C)C,,1,0.3
FK-506 (Tacrolimus),SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,C=CCC1C=C(C)CC(C)CC(OC)C2OC(O)(C(CC2OC)C)C(=O)C(=O)N2C(C(=O)OC(C(C(CC1=O)O)C)C(=CC1CCC(C(C1)OC)O)C)CCCC2,445643,1,0.3
Ternatin 4 (DA3),SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,C=C[C@@H](C[C@@H]1NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H]2N(C(=O)[C@@H](N(C1=O)C)C)CCCC2)[C@@H](C(C)C)O)[C@H](CC)C)C,C=C[C@@H](C[C@@H]1NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H]2N(C(=O)[C@@H](N(C1=O)C)C)CCCC2)[C@@H](C(C)C)O)[C@H](CC)C)C,,1,0.3
Tigecycline,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C,O=C(Nc1cc(N(C)C)c2c(c1O)C(=C1C(C2)CC2C(C1=O)(O)C(=C(C(=O)C2N(C)C)C(=O)N)O)O)CNC(C)(C)C,54686904,1,0.3
Tomivosertib (eFT-508),SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,Nc1ncnc(c1)Nc1cc(C)c2n(c1=O)C1(CCCCC1)NC2=O,Nc1ncnc(c1)Nc1cc(C)c2n(c1=O)C1(CCCCC1)NC2=O,,1,0.3
Verdinexor,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,C1=CC=NC(=C1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,O=C(C=Cn1cnc(n1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)NNc1ccccn1,71492799,1,0.3
WDB002,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC[C@@H]([C@@H]1/C=C/C/C=C/C[C@@H](C)[C@H](O)[C@H]([C@H]2O[C@](C(=O)C(=O)N3[C@H](C(=O)O1)CCCC3)(O)[C@H](C)CC2)C)Cc1ccccc1,CC[C@@H]([C@@H]1/C=C/C/C=C/C[C@@H](C)[C@H](O)[C@H]([C@H]2O[C@](C(=O)C(=O)N3[C@H](C(=O)O1)CCCC3)(O)[C@H](C)CC2)C)Cc1ccccc1,,1,0.3
Zotatifin (eFT226),SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COc1nc(OC)cc2c1[C@]1(O)[C@H](O)[C@@H]([C@H]([C@@]1(O2)c1ccc(cc1)C#N)c1ccccc1)CN(C)C,COc1nc(OC)cc2c1[C@]1(O)[C@H](O)[C@@H]([C@H]([C@@]1(O2)c1ccc(cc1)C#N)c1ccccc1)CN(C)C,,1,0.3
Camostat,MERS,10.3390/v10120721,experimental,CN(C)C(=O)COC(=O)CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N,CN(C(=O)COC(=O)Cc1ccc(cc1)OC(=O)c1ccc(cc1)N=C(N)N)C,2536,1,0.3
Chloroquine,MERS,10.3390/v10120721,experimental,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,2719,1,0.3
Chlorpromazine,MERS,10.3390/v10120721,experimental,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,2726,1,0.3
Ouabain,MERS,10.3390/v10120721,experimental,CC1C(C(C(C(O1)OC2CC(C3(C4C(CCC3(C2)O)C5(CCC(C5(CC4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O,OCC12C(O)CC(CC2(O)CCC2C1C(O)CC1(C2(O)CCC1C1=CC(=O)OC1)C)OC1OC(C)C(C(C1O)O)O,439501,1,0.3
bufalin,MERS,10.3390/v10120721,experimental,CC12CCC(CC1CCC3C2CCC4(C3(CCC4C5=COC(=O)C=C5)O)C)O,OC1CCC2(C(C1)CCC1C2CCC2(C1(O)CCC2c1ccc(=O)oc1)C)C,9547215,1,0.3
Dihydrotanshinone,MERS,10.3390/v10120721,experimental,CC1COC2=C1C(=O)C(=O)C3=C2C=CC4=C(C=CC=C43)C,CC1COC2=C1C(=O)C(=O)c1c2ccc2c1cccc2C,5316743,1,0.3
Disulfiram,MERS,10.3390/v10120721,experimental,CCN(CC)C(=S)SSC(=S)N(CC)CC,CCN(C(=S)SSC(=S)N(CC)CC)CC,3117,1,0.3
6-thioguanine,MERS,10.3390/v10120721,experimental,C1=NC2=C(N1)C(=S)N=C(N2)N,Nc1nc(=S)c2c([nH]1)nc[nH]2,,1,0.3
mycophenolic acid,MERS,10.3390/v10120721,experimental,CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O,COc1c(CC=C(CCC(=O)O)C)c(O)c2c(c1C)COC2=O,,1,0.3
Promethazine,MERS,10.3390/v10120721,experimental,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,CN(C(CN1c2ccccc2Sc2c1cccc2)C)C,4927,1,0.3
fluphenazine,MERS,10.3390/v10120721,experimental,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F,3372,1,0.3
Ribavirin,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542,1,0.3
Lopinavir,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727,1,0.3
ritonavir,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622,1,0.3
Penciclovir,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,C1=NC2=C(N1CCC(CO)CO)N=C(NC2=O)N,OCC(CCn1cnc2c1nc(N)[nH]c2=O)CO,135398748,1,0.3
Nitazoxanide,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],CC(=O)Oc1ccccc1C(=O)Nc1ncc(s1)[N+](=O)[O-],41684,1,0.3
Chloroquine,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,2719,1,0.3
Remdesivir,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4,CCC(COC(=O)C(NP(=O)(Oc1ccccc1)OCC1OC(C(C1O)O)(C#N)c1ccc2n1ncnc2N)C)CC,,1,0.3
Favipiravir,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,C1=C(N=C(C(=O)N1)C(=O)N)F,Fc1c[nH]c(=O)c(n1)C(=O)N,492405,1,0.3
Ribavirin,SARS,10.3201/eid1004.030458,experimental,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542,1,0.3
Oseltamivir,SARS,10.3201/eid1004.030458,experimental,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,CCOC(=O)C1=CC(C(C(C1)N)NC(=O)C)OC(CC)CC,65028,1,0.3
Foscarnet,SARS,10.3201/eid1004.030458,experimental,C(=O)(O)P(=O)(O)O,OC(=O)P(=O)(O)O,3415,1,0.3
EGCG Palmitate,SARS,10.2174/1871528114666151022150122,experimental,Oc1cc(O)c2c(c1)O[C@@H]([C@@H](C2)OC(=O)c1cc(O)c(c(c1)O)O)c1cc(O)c(c(c1)O)O,Oc1cc(O)c2c(c1)O[C@@H]([C@@H](C2)OC(=O)c1cc(O)c(c(c1)O)O)c1cc(O)c(c(c1)O)O,,1,0.3
glycyrrhizin,SARS,10.1021/jm0493008,experimental,CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C,OC1C(OC2OC(C(=O)O)C(C(C2O)O)O)C(OC(C1O)C(=O)O)OC1CCC2(C(C1(C)C)CCC1(C2C(=O)C=C2C1(C)CCC1(C2CC(C)(CC1)C(=O)O)C)C)C,,1,0.3
zanamivir,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N,OCC(C(C1OC(=CC(C1NC(=O)C)N=C(N)N)C(=O)O)O)O,60855,1,0.3
oseltamivir,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,CCOC(=O)C1=CC(C(C(C1)N)NC(=O)C)OC(CC)CC,65028,1,0.3
arbidol,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3,CCOC(=O)c1c(CSc2ccccc2)n(c2c1c(CN(C)C)c(O)c(c2)Br)C,131411,1,0.3
Lamivudine,SARS-CoV-2,10.5582/bst.2020.01020,experimental,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,Nc1ccn(c(=O)n1)C1CSC(O1)CO,60825,1,0.3
lopinavir,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727,1,0.3
ritonavir,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622,1,0.3
Umifenovir,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3,CCOC(=O)c1c(CSc2ccccc2)n(c2c1c(CN(C)C)c(O)c(c2)Br)C,131411,1,0.3
hydroxychloroquine,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,OCCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,3652,1,0.3
chloroquine,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,2719,1,0.3
remdesivir,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4,CCC(COC(=O)C(NP(=O)(Oc1ccccc1)OCC1OC(C(C1O)O)(C#N)c1ccc2n1ncnc2N)C)CC,121304016,1,0.3
arbidol,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3,CCOC(=O)c1c(CSc2ccccc2)n(c2c1c(CN(C)C)c(O)c(c2)Br)C,131411,1,0.3
lopinavir,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727,1,0.3
ritonavir,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622,1,0.3
darunavir,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,CC(CN(S(=O)(=O)c1ccc(cc1)N)CC(C(Cc1ccccc1)NC(=O)OC1COC2C1CCO2)O)C,213039,1,0.3
cobicistat,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5,O=C(NC(Cc1ccccc1)CCC(Cc1ccccc1)NC(=O)C(NC(=O)N(Cc1csc(n1)C(C)C)C)CCN1CCOCC1)OCc1cncs1,25151504,1,0.3
favipiravir,SARS-CoV-2,10.5582/bst.2020.01020,experimental,C1=C(N=C(C(=O)N1)C(=O)N)F,Fc1c[nH]c(=O)c(n1)C(=O)N,492405,1,0.3
thalidomide,SARS-CoV-2,10.5582/bst.2020.01020,experimental,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,O=C1CCC(C(=O)N1)N1C(=O)c2c(C1=O)cccc2,5426,1,0.3
vitamin C,SARS-CoV-2,10.5582/bst.2020.01020,experimental,C(C(C1C(=C(C(=O)O1)O)O)O)O,OCC(C1OC(=O)C(=C1O)O)O,54670067,1,0.3
methylpredinsone,SARS-CoV-2,10.5582/bst.2020.01020,experimental,OCC(=O)[C@@]1(O)CC[C@@H]2[C@]1(C)CC(=O)[C@H]1[C@H]2C[C@@H](C2=CC(=O)C=C[C@]12C)C,OCC(=O)[C@@]1(O)CC[C@@H]2[C@]1(C)CC(=O)[C@H]1[C@H]2C[C@@H](C2=CC(=O)C=C[C@]12C)C,,1,0.3
pirfenidone,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CC1=CN(C(=O)C=C1)C2=CC=CC=C2,Cc1ccc(=O)n(c1)c1ccccc1,40632,1,0.3
bromhexine hydrochloride,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CN(CC1=C(C(=CC(=C1)Br)Br)N)C2CCCCC2.Cl,Brc1cc(CN(C2CCCCC2)C)c(c(c1)Br)N.Cl,5702220,1,0.3
Fingolimod,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N,CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N,107970,1,0.3
INSC-1,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CCC(=O)N1CCN(CC1)Cc1cc(F)ccc1CN1CCC2(CC1)NC(=O)c1n2ccc1[C@H](NS(=O)(=O)c1ccccc1)C,CCC(=O)N1CCN(CC1)Cc1cc(F)ccc1CN1CCC2(CC1)NC(=O)c1n2ccc1[C@H](NS(=O)(=O)c1ccccc1)C,,1,0.3
INSC-2,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Fc1cccc(c1)[C@@H](CN1CCC(CC1)NC(=O)[C@@H](C(C)C)NC(=O)c1nn(c2c1CCC2)c1cccc(c1)F)C,Fc1cccc(c1)[C@@H](CN1CCC(CC1)NC(=O)[C@@H](C(C)C)NC(=O)c1nn(c2c1CCC2)c1cccc(c1)F)C,,1,0.3
INSC-3,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(C[C@@]1(CCOc2c1cccc2)NC(=O)Nc1cccc(c1)C1(N)CC1)NC[C@H](C(C)C)NC(=O)c1csc(c1)C,O=C(C[C@@]1(CCOc2c1cccc2)NC(=O)Nc1cccc(c1)C1(N)CC1)NC[C@H](C(C)C)NC(=O)c1csc(c1)C,,1,0.3
INSC-4,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C1Nc2c(cccc2[C@@H]2N1CCN(C2)C(=O)c1c(C)cccc1F)NC(=O)C(N)(C)C,O=C1Nc2c(cccc2[C@@H]2N1CCN(C2)C(=O)c1c(C)cccc1F)NC(=O)C(N)(C)C,,1,0.3
INSC-5,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1cccc(c1)[C@@H]1CC2(NS1(=O)=O)CN(C2)c1ccc(c(c1)C)C(=O)N1CCN(C(=O)C1)c1ccc(cc1)F,COc1cccc(c1)[C@@H]1CC2(NS1(=O)=O)CN(C2)c1ccc(c(c1)C)C(=O)N1CCN(C(=O)C1)c1ccc(cc1)F,,1,0.3
INSC-6,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Fc1ccc(cc1)S(=O)(=O)N[C@H](c1ccccc1)C(=O)Nc1ccc(cc1)c1c(cc[nH]c1=O)CN1CCC(CC1)(F)F,Fc1ccc(cc1)S(=O)(=O)N[C@H](c1ccccc1)C(=O)Nc1ccc(cc1)c1c(cc[nH]c1=O)CN1CCC(CC1)(F)F,,1,0.3
INSC-7,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CNCS(=O)(=O)Nc1cccc(c1)NC(=O)c1cn(c2c1cccc2)C[C@H](c1ccc(cc1)C(F)(F)F)O,CNCS(=O)(=O)Nc1cccc(c1)NC(=O)c1cn(c2c1cccc2)C[C@H](c1ccc(cc1)C(F)(F)F)O,,1,0.3
INSC-8,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(c1ccc(cc1)[C@]1(C)NC(=O)N(C1=O)Cc1ccc(c(c1)F)C)N1CCC2(CC1)C[C@H](C(=O)N2)c1ccc(c(c1)C)O,O=C(c1ccc(cc1)[C@]1(C)NC(=O)N(C1=O)Cc1ccc(c(c1)F)C)N1CCC2(CC1)C[C@H](C(=O)N2)c1ccc(c(c1)C)O,,1,0.3
INSC-9,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Oc1ccc(cc1)[C@@H]1CC2(NC1=O)CCN(CC2)C(=O)c1ccc(cc1C)[C@]1(C)NC(=O)N(C1=O)Cc1cccc(c1)O,Oc1ccc(cc1)[C@@H]1CC2(NC1=O)CCN(CC2)C(=O)c1ccc(cc1C)[C@]1(C)NC(=O)N(C1=O)Cc1cccc(c1)O,,1,0.3
INSC-10,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Fc1cccc(c1)c1n[nH]c2c1CN(C2=O)c1ccn2c1NC(=O)[C@@]12CCN1CCC(=O)c1ccc(s1)C,Fc1cccc(c1)c1n[nH]c2c1CN(C2=O)c1ccn2c1NC(=O)[C@@]12CCN1CCC(=O)c1ccc(s1)C,,1,0.3
INSC-11,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CN1CCC2(CC1)[C@H](NC(=O)N2C[C@H](c1cccc2c1cco2)C)c1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)C,CN1CCC2(CC1)[C@H](NC(=O)N2C[C@H](c1cccc2c1cco2)C)c1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)C,,1,0.3
INSC-12,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Fc1ccc(cc1)S(=O)(=O)N[C@H](c1ccccc1F)C(=O)Nc1ccc(cc1)c1c(cc[nH]c1=O)CN1CCCCC1,Fc1ccc(cc1)S(=O)(=O)N[C@H](c1ccccc1F)C(=O)Nc1ccc(cc1)c1c(cc[nH]c1=O)CN1CCCCC1,,1,0.3
INSC-13,SARS-CoV-2,10.1101/2020.03.03.972133,computational,NCC[C@@H](c1ccc(cc1)F)C(=O)Nc1ccc(c(c1)c1ccnc(c1)C)CN1C(=O)CCC1=O,NCC[C@@H](c1ccc(cc1)F)C(=O)Nc1ccc(c(c1)c1ccnc(c1)C)CN1C(=O)CCC1=O,,1,0.3
INSC-14,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C([C@@H](N)C)Nc1cccc2c1NC(=O)C1N2CCN(C1)C(=O)c1ccc(s1)c1ccc(cc1)F,O=C([C@@H](N)C)Nc1cccc2c1NC(=O)C1N2CCN(C1)C(=O)c1ccc(s1)c1ccc(cc1)F,,1,0.3
INSC-15,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COCc1cccc(c1O)c1n[nH]c2c1CN(C2=O)C(=O)N[C@H](C[C@@H](c1scnc1C(C)C)N)C,COCc1cccc(c1O)c1n[nH]c2c1CN(C2=O)C(=O)N[C@H](C[C@@H](c1scnc1C(C)C)N)C,,1,0.3
INSC-16,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Cc1ccc(cc1)C1=NS(=O)(=O)C2=C(N1)CC[C@]2(C)C1CCN(CC1)C[C@@H]1CCCN(C1)c1nc2c([nH]1)cccc2,Cc1ccc(cc1)C1=NS(=O)(=O)C2=C(N1)CC[C@]2(C)C1CCN(CC1)C[C@@H]1CCCN(C1)c1nc2c([nH]1)cccc2,,1,0.3
INSC-17,SARS-CoV-2,10.1101/2020.03.03.972133,computational,NCCOC(=O)[C@H]1CC[C@@H]1c1nc2c([nH]1)CCN(C2)c1ccc(cc1NS(=O)(=O)c1ccc(nc1)C)C(F)(F)F,NCCOC(=O)[C@H]1CC[C@@H]1c1nc2c([nH]1)CCN(C2)c1ccc(cc1NS(=O)(=O)c1ccc(nc1)C)C(F)(F)F,,1,0.3
INSC-18,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Oc1cccc(c1)NC(=O)c1ccc(c2c1[nH]c(c2)[C@@H](N1CCC2(CC1)NC(=O)c1c(O2)cccc1)C(=O)N)O,Oc1cccc(c1)NC(=O)c1ccc(c2c1[nH]c(c2)[C@@H](N1CCC2(CC1)NC(=O)c1c(O2)cccc1)C(=O)N)O,,1,0.3
INSC-19,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1ccsc1C(=O)CCN1CC[C@@H]2[C@@H](C1=O)c1[nH]nc(c1C2)c1cc(O)cc(c1)F,COc1ccsc1C(=O)CCN1CC[C@@H]2[C@@H](C1=O)c1[nH]nc(c1C2)c1cc(O)cc(c1)F,,1,0.3
INSC-20,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(C(C)C)NC1CCN(CC1)[C@@]1(CC[C@H]1C[C@H]1Nc2ccccc2S(=O)(=O)N1C)Cc1cc(F)ccc1O,O=C(C(C)C)NC1CCN(CC1)[C@@]1(CC[C@H]1C[C@H]1Nc2ccccc2S(=O)(=O)N1C)Cc1cc(F)ccc1O,,1,0.3
INSC-21,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CCS(=O)(=O)Nc1ccc2c(c1)NC(=O)[C@@]1(C2)CN(C[C@H](c2cc(C)cc(c2)O)O)C(=O)c2c1cccc2,CCS(=O)(=O)Nc1ccc2c(c1)NC(=O)[C@@]1(C2)CN(C[C@H](c2cc(C)cc(c2)O)O)C(=O)c2c1cccc2,,1,0.3
INSC-22,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1cc(F)cc(c1)c1n[nH]c2c1CC(C)(C)N(C2=O)C(=O)NCCCC(=O)c1cnc(s1)C,COc1cc(F)cc(c1)c1n[nH]c2c1CC(C)(C)N(C2=O)C(=O)NCCCC(=O)c1cnc(s1)C,,1,0.3
INSC-23,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Fc1ccc(cc1)CCC[C@@H]1OC2=C(C(=O)N)N(CN2C1=O)C(=O)c1cc2c(s1)cccc2,Fc1ccc(cc1)CCC[C@@H]1OC2=C(C(=O)N)N(CN2C1=O)C(=O)c1cc2c(s1)cccc2,,1,0.3
INSC-24,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CCC(=O)Nc1ccc(cc1)n1c(C)nc2c1C(=O)N[C@H](N2C)C1=COC[C@H](C1)c1cccc(c1)F,CCC(=O)Nc1ccc(cc1)n1c(C)nc2c1C(=O)N[C@H](N2C)C1=COC[C@H](C1)c1cccc(c1)F,,1,0.3
INSC-25,SARS-CoV-2,10.1101/2020.03.03.972133,computational,OC[C@@H](S(=O)(=O)NCC1CCC(CC1)c1[nH]c(c(n1)c1cccc(c1C)O)C)c1cccnc1,OC[C@@H](S(=O)(=O)NCC1CCC(CC1)c1[nH]c(c(n1)c1cccc(c1C)O)C)c1cccnc1,,1,0.3
INSC-26,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Oc1ccc(c(c1)NC(=O)c1cc(C)cc2c1[nH]c(c2)C(=O)N1CC[C@]2(C1)NC(=O)c1c(O2)cccc1)Cl,Oc1ccc(c(c1)NC(=O)c1cc(C)cc2c1[nH]c(c2)C(=O)N1CC[C@]2(C1)NC(=O)c1c(O2)cccc1)Cl,,1,0.3
INSC-27,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1cc2c(n1CC(=O)OCC(=O)NC[C@@H]1[C@H](O)C[C@@H]1NC(=O)Nc1cccc(c1)F)cccc2,COc1cc2c(n1CC(=O)OCC(=O)NC[C@@H]1[C@H](O)C[C@@H]1NC(=O)Nc1cccc(c1)F)cccc2,,1,0.3
INSC-28,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C([C@H]1[C@@H](Cc2c(C31CCN(CC3)C(=O)Nc1ccc(c(c1)C)F)cc([nH]2)C)C(=O)N)Oc1c[nH]ccc1=O,O=C([C@H]1[C@@H](Cc2c(C31CCN(CC3)C(=O)Nc1ccc(c(c1)C)F)cc([nH]2)C)C(=O)N)Oc1c[nH]ccc1=O,,1,0.3
INSC-29,SARS-CoV-2,10.1101/2020.03.03.972133,computational,NCc1c(C)ncc2c1cc(C(=O)N[C@H](C(=O)N[C@@]1(CCCOC1)/C=C/C(=O)NCc1ccccc1O)C1CCC1)c(c2)[C@H](O)C,NCc1c(C)ncc2c1cc(C(=O)N[C@H](C(=O)N[C@@]1(CCCOC1)/C=C/C(=O)NCc1ccccc1O)C1CCC1)c(c2)[C@H](O)C,,1,0.3
INSC-30,SARS-CoV-2,10.1101/2020.03.03.972133,computational,NCCc1nc2ccccc2c(c1CO)C(=O)N[C@H](C(=O)N[C@@H](c1ccc(cc1)O)/C=C/C(=O)NCc1cccc(c1)F)CC(C)C,NCCc1nc2ccccc2c(c1CO)C(=O)N[C@H](C(=O)N[C@@H](c1ccc(cc1)O)/C=C/C(=O)NCc1cccc(c1)F)CC(C)C,,1,0.3
INSC-31,SARS-CoV-2,10.1101/2020.03.03.972133,computational,NCc1cnn2c1c(CO)c(cc2C)C(=O)N[C@@H]([C@H]1CC1(C)C)C(=O)N[C@@H](c1ccc(cc1)O)/C=C/C(=O)NCc1ccccc1,NCc1cnn2c1c(CO)c(cc2C)C(=O)N[C@@H]([C@H]1CC1(C)C)C(=O)N[C@@H](c1ccc(cc1)O)/C=C/C(=O)NCc1ccccc1,,1,0.3
INSC-32,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1ccc(c(c1)F)S(=O)(=O)N[C@](c1ccncc1F)(C(=O)N[C@@]1(C[C@@H](C1)C(F)(F)F)C(=O)NC/C=C/C(=O)NCc1ccc(cc1)Cl)C,COc1ccc(c(c1)F)S(=O)(=O)N[C@](c1ccncc1F)(C(=O)N[C@@]1(C[C@@H](C1)C(F)(F)F)C(=O)NC/C=C/C(=O)NCc1ccc(cc1)Cl)C,,1,0.3
INSC-33,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(/C=C/[C@H](c1ccc(cc1)O)NC(=O)C1(NC(=O)c2cc3c(N)cn(c3cc2C)C)CC(C1)(C)C)NCc1cccc(c1)F,O=C(/C=C/[C@H](c1ccc(cc1)O)NC(=O)C1(NC(=O)c2cc3c(N)cn(c3cc2C)C)CC(C1)(C)C)NCc1cccc(c1)F,,1,0.3
INSC-34,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(NCc1ccccc1)/C=C/[C@H]([C@H]1CCOC1)NC(=O)C1(CC1)NC(=O)c1cc2CNCCc2cc1C,O=C(NCc1ccccc1)/C=C/[C@H]([C@H]1CCOC1)NC(=O)C1(CC1)NC(=O)c1cc2CNCCc2cc1C,,1,0.3
INSC-35,SARS-CoV-2,10.1101/2020.03.03.972133,computational,C[C@@H]1C[C@@](C1)(NC(=O)c1cn2c(N)ncc2cc1C)C(=O)N[C@@H](c1ccnnc1)/C=C/C(=O)NCc1ccc(cc1)O,C[C@@H]1C[C@@](C1)(NC(=O)c1cn2c(N)ncc2cc1C)C(=O)N[C@@H](c1ccnnc1)/C=C/C(=O)NCc1ccc(cc1)O,,1,0.3
INSC-36,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(NC1(CCOCC1)C(=O)N[C@@H](c1ccncn1)/C=C/C(=O)OCc1ccccc1)NCc1ccc2c(c1)OCCN2,O=C(NC1(CCOCC1)C(=O)N[C@@H](c1ccncn1)/C=C/C(=O)OCc1ccccc1)NCc1ccc2c(c1)OCCN2,,1,0.3
INSC-37,SARS-CoV-2,10.1101/2020.03.03.972133,computational,C[C@@H](Cc1cn[nH]c1C)NC(=O)NC1(CCCCC1)C(=O)N[C@H](c1c[nH]cc1)/C=C/C(=O)Oc1ccccc1,C[C@@H](Cc1cn[nH]c1C)NC(=O)NC1(CCCCC1)C(=O)N[C@H](c1c[nH]cc1)/C=C/C(=O)Oc1ccccc1,,1,0.3
INSC-38,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CC1CCN(CC1)C(=O)c1ccc(cc1)NC(=O)CNC(=O)c1csc(n1)NC(=O)C1(CCC1)c1cccnc1,CC1CCN(CC1)C(=O)c1ccc(cc1)NC(=O)CNC(=O)c1csc(n1)NC(=O)C1(CCC1)c1cccnc1,,1,0.3
INSC-39,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(Nc1ccc(cc1)F)Nc1cc(C)c(c(c1)F)c1nc(cnc1OCC1CC1)OCC1(O)CCN(CC1)C1CCC1,O=C(Nc1ccc(cc1)F)Nc1cc(C)c(c(c1)F)c1nc(cnc1OCC1CC1)OCC1(O)CCN(CC1)C1CCC1,,1,0.3
INSC-40,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1cccc(c1)[C@](NC(=O)N[C@H]1C[C@H](c2c1c(cc(c2)F)C(=O)Cc1ccccc1OC)O)(CO)C,COc1cccc(c1)[C@](NC(=O)N[C@H]1C[C@H](c2c1c(cc(c2)F)C(=O)Cc1ccccc1OC)O)(CO)C,,1,0.3
INSC-41,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1cc(OCC(=O)N)cc(c1)[C@@H](c1ccc(c(c1)C)OC)NC(=O)[C@@H](C(F)(F)F)C(=O)NCC(=O)O,COc1cc(OCC(=O)N)cc(c1)[C@@H](c1ccc(c(c1)C)OC)NC(=O)[C@@H](C(F)(F)F)C(=O)NCC(=O)O,,1,0.3
INSC-42,SARS-CoV-2,10.1101/2020.03.03.972133,computational,OC[C@H](C[C@H](C(=O)Nc1ccc(c(c1)F)O)NC(=O)Cc1noc(n1)c1ccc(cc1)C(=O)NCC(C)C)C,OC[C@H](C[C@H](C(=O)Nc1ccc(c(c1)F)O)NC(=O)Cc1noc(n1)c1ccc(cc1)C(=O)NCC(C)C)C,,1,0.3
INSC-43,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Fc1cc(cc(c1)S(=O)(=O)[C@@H]1CC[C@@H]([C@H]1C)N)c1[nH]c(=O)c2n(c1)ccc2Cc1cccc2c1nc([nH]2)C,Fc1cc(cc(c1)S(=O)(=O)[C@@H]1CC[C@@H]([C@H]1C)N)c1[nH]c(=O)c2n(c1)ccc2Cc1cccc2c1nc([nH]2)C,,1,0.3
INSC-44,SARS-CoV-2,10.1101/2020.03.03.972133,computational,OCC1(CCN(CC1)Cc1noc(n1)c1cc(ccc1C)C(=O)N1CCOCC1)CCc1ccc(c(c1)F)O,OCC1(CCN(CC1)Cc1noc(n1)c1cc(ccc1C)C(=O)N1CCOCC1)CCc1ccc(c(c1)F)O,,1,0.3
INSC-45,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(c1cc(O)c(c(c1)F)O)N[C@@H]1CCC[C@@]2(C1)CC[C@H](S(=O)(=O)N2)N1CCN(CC1)c1ccccc1Cl,O=C(c1cc(O)c(c(c1)F)O)N[C@@H]1CCC[C@@]2(C1)CC[C@H](S(=O)(=O)N2)N1CCN(CC1)c1ccccc1Cl,,1,0.3
INSC-46,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CCC(=O)N[C@@H](C(=O)Nc1cc(ccc1C)C1=NNS(=O)(=O)C2=C1CCC(=O)N2c1ccc(cc1)F)Cc1ccc(cc1F)C,CCC(=O)N[C@@H](C(=O)Nc1cc(ccc1C)C1=NNS(=O)(=O)C2=C1CCC(=O)N2c1ccc(cc1)F)Cc1ccc(cc1F)C,,1,0.3
INSC-47,SARS-CoV-2,10.1101/2020.03.03.972133,computational,OC[C@@H]1CC[C@H](CC1)N(C(=O)c1nn(c(c1)C)C(=O)CC)c1nc2c(s1)c(ccc2)C(OC)(F)F,OC[C@@H]1CC[C@H](CC1)N(C(=O)c1nn(c(c1)C)C(=O)CC)c1nc2c(s1)c(ccc2)C(OC)(F)F,,1,0.3
INSC-48,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CCC(=O)Nc1ccc(cc1)C(=O)N[C@@]1(CC[C@@H](CC1)O)C(=O)Nc1ccc(cc1)C(=O)NCc1ccc(cn1)F,CCC(=O)Nc1ccc(cc1)C(=O)N[C@@]1(CC[C@@H](CC1)O)C(=O)Nc1ccc(cc1)C(=O)NCc1ccc(cn1)F,,1,0.3
INSC-49,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CCC(=O)N1C[C@H]([C@](C1)(O)C(=O)Nc1ccc(cc1)c1nnc(o1)C)C(=O)Nc1ccc(cc1)NC,CCC(=O)N1C[C@H]([C@](C1)(O)C(=O)Nc1ccc(cc1)c1nnc(o1)C)C(=O)Nc1ccc(cc1)NC,,1,0.3
INSC-50,SARS-CoV-2,10.1101/2020.03.03.972133,computational,OCCN1CCN(CC1)c1ccccc1NC(=O)c1ccc(cc1)NC(=O)C(NCc1[nH]c2c(c1)cc(cc2)F)(C)C,OCCN1CCN(CC1)c1ccccc1NC(=O)c1ccc(cc1)NC(=O)C(NCc1[nH]c2c(c1)cc(cc2)F)(C)C,,1,0.3
INSC-51,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CC[C@@H](c1ccc(cc1)Cl)CC(=O)N(c1sc2c(n1)c(OC)ccc2O)CCN1CC[C@@]21C[C@H]2N,CC[C@@H](c1ccc(cc1)Cl)CC(=O)N(c1sc2c(n1)c(OC)ccc2O)CCN1CC[C@@]21C[C@H]2N,,1,0.3
INSC-52,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(NCC1(N)CC1)NCc1c(C)cc(cc1F)C(=O)N[C@H](c1c(Cl)cccc1C(F)(F)F)[C@@H]1CCCO1,O=C(NCC1(N)CC1)NCc1c(C)cc(cc1F)C(=O)N[C@H](c1c(Cl)cccc1C(F)(F)F)[C@@H]1CCCO1,,1,0.3
INSC-53,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CC(CNC(=O)[C@H](N1C(=O)N[C@@](c2c1cc(cc2)C(=O)N1CCCC1)(Cc1ccc(cc1)F)C(=O)NCC1(O)CCC(CC1)(F)F)c1ccc(cc1)O)C,CC(CNC(=O)[C@H](N1C(=O)N[C@@](c2c1cc(cc2)C(=O)N1CCCC1)(Cc1ccc(cc1)F)C(=O)NCC1(O)CCC(CC1)(F)F)c1ccc(cc1)O)C,,1,0.3
INSC-54,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(Nc1ccc(c2c1CCC2)NC(=O)C(C(=O)N1CCC[C@H]1C(=O)c1ccc(cc1Cl)O)(C)C)Nc1ccc(cc1)F,O=C(Nc1ccc(c2c1CCC2)NC(=O)C(C(=O)N1CCC[C@H]1C(=O)c1ccc(cc1Cl)O)(C)C)Nc1ccc(cc1)F,,1,0.3
INSC-55,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CNc1ccc(c(c1)OC[C@H]([C@@H]1C[C@H](C1)CC(=O)n1nnc2c1ccc(c2OC(c1ccc(cc1)OC)(F)F)O)O)F,CNc1ccc(c(c1)OC[C@H]([C@@H]1C[C@H](C1)CC(=O)n1nnc2c1ccc(c2OC(c1ccc(cc1)OC)(F)F)O)O)F,,1,0.3
INSC-56,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CCOC(=O)c1noc(n1)[C@H](c1cc(O)ccc1OC1(CCCC1)C1CC1)N[C@@H](CCc1ncc([nH]1)C)C,CCOC(=O)c1noc(n1)[C@H](c1cc(O)ccc1OC1(CCCC1)C1CC1)N[C@@H](CCc1ncc([nH]1)C)C,,1,0.3
INSC-57,SARS-CoV-2,10.1101/2020.03.03.972133,computational,C[C@@H](CCc1cc(O)cc(c1Cl)c1nc(=O)n(c2c1C(=O)N([C@H]2N(Cc1ccccc1F)C)C)C)N,C[C@@H](CCc1cc(O)cc(c1Cl)c1nc(=O)n(c2c1C(=O)N([C@H]2N(Cc1ccccc1F)C)C)C)N,,1,0.3
INSC-58,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Oc1cc(CC[C@@](CCc2ccc(c(c2)F)O)(N)C)c(c(c1)c1ncc(=O)n2c1C(=O)C[C@@]12COCCO1)C,Oc1cc(CC[C@@](CCc2ccc(c(c2)F)O)(N)C)c(c(c1)c1ncc(=O)n2c1C(=O)C[C@@]12COCCO1)C,,1,0.3
INSC-59,SARS-CoV-2,10.1101/2020.03.03.972133,computational,NCCNS(=O)(=O)c1ccc2c(c1)CN(C[C@]2(C)C(=O)c1cnc2n1ccc(c2)O)Cc1ccc(s1)C,NCCNS(=O)(=O)c1ccc2c(c1)CN(C[C@]2(C)C(=O)c1cnc2n1ccc(c2)O)Cc1ccc(s1)C,,1,0.3
INSC-60,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CCNC(=O)c1ccc(c(c1)NC(=O)c1ccc(cc1)[C@](c1ccc(cc1F)O[C@@H](C(=O)N[C@H]1CCS(=O)(=O)C1)CC)(O)C)C,CCNC(=O)c1ccc(c(c1)NC(=O)c1ccc(cc1)[C@](c1ccc(cc1F)O[C@@H](C(=O)N[C@H]1CCS(=O)(=O)C1)CC)(O)C)C,,1,0.3
INSC-61,SARS-CoV-2,10.1101/2020.03.03.972133,computational,NC(=O)Nc1ccc(cc1)[C@@H](c1c(nc2c(c1CN1CCCC1)cccc2)C(=O)N1CC[C@H]([C@@](C1)(C)O)Cc1ccc(cc1)F)O,NC(=O)Nc1ccc(cc1)[C@@H](c1c(nc2c(c1CN1CCCC1)cccc2)C(=O)N1CC[C@H]([C@@](C1)(C)O)Cc1ccc(cc1)F)O,,1,0.3
INSC-62,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O[C@H]1CC[C@@H](C1)N[C@H](C1(CCN(CC1)C)Cc1onc(c1)c1ccc(cc1F)F)C(=O)Nc1cc(n(c1)C)O,O[C@H]1CC[C@@H](C1)N[C@H](C1(CCN(CC1)C)Cc1onc(c1)c1ccc(cc1F)F)C(=O)Nc1cc(n(c1)C)O,,1,0.3
INSC-63,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1ccc(cc1C[C@]1(COCC1)CNC(=O)c1scc(n1)C(=O)OCCNc1ccc(nc1)C)O,COc1ccc(cc1C[C@]1(COCC1)CNC(=O)c1scc(n1)C(=O)OCCNc1ccc(nc1)C)O,,1,0.3
INSC-64,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Fc1ccc2c(c1)NC(=O)[C@H]2CC(=O)N1CCC(CC1)(O)c1ccc2c(c1)nc([nH]2)c1ccc(cc1O)F,Fc1ccc2c(c1)NC(=O)[C@H]2CC(=O)N1CCC(CC1)(O)c1ccc2c(c1)nc([nH]2)c1ccc(cc1O)F,,1,0.3
INSC-65,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O[C@@H]1CC[C@H](CC1)NC(=O)[C@@H](S(=O)(=O)c1ccc(c(c1)C)NC(=O)NCc1ccc(cc1)C(F)(F)F)C,O[C@@H]1CC[C@H](CC1)NC(=O)[C@@H](S(=O)(=O)c1ccc(c(c1)C)NC(=O)NCc1ccc(cc1)C(F)(F)F)C,,1,0.3
INSC-66,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1cc(O)ccc1CNC(=O)c1cc(ccc1NC(=O)CC1CC1)N1C(=O)N[C@@](C1=O)(C)c1ccc(cc1)F,COc1cc(O)ccc1CNC(=O)c1cc(ccc1NC(=O)CC1CC1)N1C(=O)N[C@@](C1=O)(C)c1ccc(cc1)F,,1,0.3
INSC-67,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CN1CCC(=CC1)Cc1ccncc1S(=O)(=O)c1ncccc1O[C@@H]1CCN(C1)[C@@H](C(=O)Nc1ccc(c(c1)F)C1(C)CCOCC1)C,CN1CCC(=CC1)Cc1ccncc1S(=O)(=O)c1ncccc1O[C@@H]1CCN(C1)[C@@H](C(=O)Nc1ccc(c(c1)F)C1(C)CCOCC1)C,,1,0.3
INSC-68,SARS-CoV-2,10.1101/2020.03.03.972133,computational,OCc1nsc(c1C(=O)N[C@H]1COCC1)N[C@H]1CCCC[C@H]1C(=O)Nc1c(C)sc2c1cccc2,OCc1nsc(c1C(=O)N[C@H]1COCC1)N[C@H]1CCCC[C@H]1C(=O)Nc1c(C)sc2c1cccc2,,1,0.3
INSC-69,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COCC(=O)N[C@@]1(CC[C@H](C1)O)C(=O)Nc1ccc(cc1OC)CNc1cc([nH]c1C)c1ccc(cc1)F,COCC(=O)N[C@@]1(CC[C@H](C1)O)C(=O)Nc1ccc(cc1OC)CNc1cc([nH]c1C)c1ccc(cc1)F,,1,0.3
INSC-70,SARS-CoV-2,10.1101/2020.03.03.972133,computational,NC[C@H]1CCN(C1)C(=O)c1cc(ccc1NC(=O)N1CCCC1)C(=O)NCc1ccc(cc1)C(F)(F)F,NC[C@H]1CCN(C1)C(=O)c1cc(ccc1NC(=O)N1CCCC1)C(=O)NCc1ccc(cc1)C(F)(F)F,,1,0.3
INSC-71,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CNCc1cccn1c1ccc(c(c1)F)NC(=O)[C@@H]1C[C@@H](CN1c1cccc(c1)NC(=O)Nc1ccc2c(c1)OCCO2)O,CNCc1cccn1c1ccc(c(c1)F)NC(=O)[C@@H]1C[C@@H](CN1c1cccc(c1)NC(=O)Nc1ccc2c(c1)OCCO2)O,,1,0.3
INSC-72,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CNc1cc(n2c1cncc2)NC(=O)[C@@H](C1(CCN(CC1)C(=O)C)Cc1onc(c1)c1ccc(cc1F)F)N[C@H]1CC[C@@H](C1)O,CNc1cc(n2c1cncc2)NC(=O)[C@@H](C1(CCN(CC1)C(=O)C)Cc1onc(c1)c1ccc(cc1F)F)N[C@H]1CC[C@@H](C1)O,,1,0.3
INSC-73,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Fc1cc2c(c(c1)c1cncc(c1C)CCC1(N)COC1)C(=O)NC12CCCCC1,Fc1cc2c(c(c1)c1cncc(c1C)CCC1(N)COC1)C(=O)NC12CCCCC1,,1,0.3
INSC-74,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1ccc(cc1)[C@H]1C[C@]1(N)CCc1cc(O)cc(c1C)c1nc2N(C)C(=O)C[C@@H](c2c(=O)[nH]1)C(F)(F)F,COc1ccc(cc1)[C@H]1C[C@]1(N)CCc1cc(O)cc(c1C)c1nc2N(C)C(=O)C[C@@H](c2c(=O)[nH]1)C(F)(F)F,,1,0.3
INSC-75,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CNC(=O)[C@@H](c1cncc(c1)C1(N)CC1)N[C@@H]([C@@H]1Cc2c(C1)cccc2NC(=O)N1CC(C1)O)C,CNC(=O)[C@@H](c1cncc(c1)C1(N)CC1)N[C@@H]([C@@H]1Cc2c(C1)cccc2NC(=O)N1CC(C1)O)C,,1,0.3
INSC-76,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O[C@H]1[C@H](CC21C[C@H](C2)CC(=O)n1cnc2c1cccc2C#Cc1ccncc1)C(=O)N(C1CC1)C,O[C@H]1[C@H](CC21C[C@H](C2)CC(=O)n1cnc2c1cccc2C#Cc1ccncc1)C(=O)N(C1CC1)C,,1,0.3
INSC-77,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(C1CCC1)N[C@@H]1CCC[C@@]2(C1)C[C@@H](S(=O)(=O)N2)N1CCN(CC1)c1cccnc1,O=C(C1CCC1)N[C@@H]1CCC[C@@]2(C1)C[C@@H](S(=O)(=O)N2)N1CCN(CC1)c1cccnc1,,1,0.3
INSC-78,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Fc1cc(cc(c1)c1ccc(cc1C)F)C(=O)Nc1cccc(c1)NC(=O)C1(N)CC1,Fc1cc(cc(c1)c1ccc(cc1C)F)C(=O)Nc1cccc(c1)NC(=O)C1(N)CC1,,1,0.3
INSC-79,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1cc(F)ccc1[C@H](C(=O)NCC(=O)N1CC[C@H](C1)c1ccc2c(c1)nc([nH]2)c1ccc(cc1C)F)CNC(C)C,COc1cc(F)ccc1[C@H](C(=O)NCC(=O)N1CC[C@H](C1)c1ccc2c(c1)nc([nH]2)c1ccc(cc1C)F)CNC(C)C,,1,0.3
INSC-80,SARS-CoV-2,10.1101/2020.03.03.972133,computational,NCc1ccc(cc1)N[C@@H]1NC(=O)N(C21CCC2)C[C@H]([C@H](Cc1ccc(cc1)F)NC(=O)C1CC1)O,NCc1ccc(cc1)N[C@@H]1NC(=O)N(C21CCC2)C[C@H]([C@H](Cc1ccc(cc1)F)NC(=O)C1CC1)O,,1,0.3
INSC-81,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1cc(O)ccc1NC(=O)N(CC(=O)N(C1(C)CC1)Cc1nccc(c1)C)CCN1CCOCC1,COc1cc(O)ccc1NC(=O)N(CC(=O)N(C1(C)CC1)Cc1nccc(c1)C)CCN1CCOCC1,,1,0.3
INSC-82,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CN1CCC(CC1)c1nccc(c1C(=O)CCCc1ccc2c(c1)S(=O)(=O)CCN2C(=O)Cc1ccc(cc1)O)c1ccc(cc1)F,CN1CCC(CC1)c1nccc(c1C(=O)CCCc1ccc2c(c1)S(=O)(=O)CCN2C(=O)Cc1ccc(cc1)O)c1ccc(cc1)F,,1,0.3
INSC-83,SARS-CoV-2,10.1101/2020.03.03.972133,computational,OCC(c1cccc2c1CN(CC12CN(C1)C)C(=O)N[C@@H]([C@H]1CCOC1)CCC1(N)CC1)c1[nH]c2c(n1)ccc(c2)F,OCC(c1cccc2c1CN(CC12CN(C1)C)C(=O)N[C@@H]([C@H]1CCOC1)CCC1(N)CC1)c1[nH]c2c(n1)ccc(c2)F,,1,0.3
INSC-84,SARS-CoV-2,10.1101/2020.03.03.972133,computational,NCC(=O)c1c(F)cccc1N(C(=O)Nc1ccc2c(c1)[C@H](CC2)C(=O)c1ccc2c(c1)CCN2)C,NCC(=O)c1c(F)cccc1N(C(=O)Nc1ccc2c(c1)[C@H](CC2)C(=O)c1ccc2c(c1)CCN2)C,,1,0.3
INSC-85,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(Nc1c(O)ccc(c1C)O)Nc1ccc2c(c1)[C@H](OC2)C(=O)c1c(cncc1C1CCNCC1)Nc1ccc(cc1F)F,O=C(Nc1c(O)ccc(c1C)O)Nc1ccc2c(c1)[C@H](OC2)C(=O)c1c(cncc1C1CCNCC1)Nc1ccc(cc1F)F,,1,0.3
INSC-86,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CCC(=O)N[C@H]([C@@H](C[C@H]1CCC2=C1S(=O)(=O)N=C(N2)c1cccc(c1)Cc1cc(F)c(c(c1)F)N1CCN(CC1)C)O)Cc1ccc(cc1)F,CCC(=O)N[C@H]([C@@H](C[C@H]1CCC2=C1S(=O)(=O)N=C(N2)c1cccc(c1)Cc1cc(F)c(c(c1)F)N1CCN(CC1)C)O)Cc1ccc(cc1)F,,1,0.3
INSC-87,SARS-CoV-2,10.1101/2020.03.03.972133,computational,C[C@@H](Cc1cccc(c1)F)NC[C@@H]1COCC[C@@]21NC(=O)N(C2=O)c1ccc(cc1Cl)CNC(=O)C1CC1,C[C@@H](Cc1cccc(c1)F)NC[C@@H]1COCC[C@@]21NC(=O)N(C2=O)c1ccc(cc1Cl)CNC(=O)C1CC1,,1,0.3
INSC-88,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CCS(=O)(=O)N1CCc2c1ccc1c2[C@H](CC1)C(=O)c1c(cncc1c1cccc(c1C)F)C1CCN(CC1)C,CCS(=O)(=O)N1CCc2c1ccc1c2[C@H](CC1)C(=O)c1c(cncc1c1cccc(c1C)F)C1CCN(CC1)C,,1,0.3
INSC-89,SARS-CoV-2,10.1101/2020.03.03.972133,computational,N[C@@H](Cc1ccc([nH]1)C)CCNC1=CC=C(S(=O)(=O)N1C)c1cc(NC(=O)C2CC2)c(cc1Cl)C,N[C@@H](Cc1ccc([nH]1)C)CCNC1=CC=C(S(=O)(=O)N1C)c1cc(NC(=O)C2CC2)c(cc1Cl)C,,1,0.3
INSC-90,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CC(C[C@@H]1NC(=O)[C@H](CCOCc2n(C[C@H](NC1=O)/C=C/C(=O)OCc1ccccc1)c(=O)[nH]c2)NC(=O)[C@H](C(F)(F)F)N)C,CC(C[C@@H]1NC(=O)[C@H](CCOCc2n(C[C@H](NC1=O)/C=C/C(=O)OCc1ccccc1)c(=O)[nH]c2)NC(=O)[C@H](C(F)(F)F)N)C,,1,0.3
INSC-91,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(/C=C/[C@@H]1CN2C[C@H](CCC[C@@H](C(=O)N[C@H](C(=O)N1)CC(C)C)NC(=O)[C@@H](Nc1ccccc1)C)CNC2=O)OCc1ccccc1,O=C(/C=C/[C@@H]1CN2C[C@H](CCC[C@@H](C(=O)N[C@H](C(=O)N1)CC(C)C)NC(=O)[C@@H](Nc1ccccc1)C)CNC2=O)OCc1ccccc1,,1,0.3
INSC-92,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C([C@H](C(F)(F)F)Nc1ccccc1)N[C@H]1CCC[C@@H]2CNC(=O)N(C2)C[C@H](NC(=O)[C@@H](NC1=O)CC(F)(C)C)/C=C/C(=O)c1cnn[nH]1,O=C([C@H](C(F)(F)F)Nc1ccccc1)N[C@H]1CCC[C@@H]2CNC(=O)N(C2)C[C@H](NC(=O)[C@@H](NC1=O)CC(F)(C)C)/C=C/C(=O)c1cnn[nH]1,,1,0.3
INSC-93,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CC[C@@H](Nc1nc(nc2c1C(=O)C(=C)C[C@]1(O2)CCNC1=O)c1ccc([nH]1)[C@@H](NC(=O)c1nccs1)CC)C,CC[C@@H](Nc1nc(nc2c1C(=O)C(=C)C[C@]1(O2)CCNC1=O)c1ccc([nH]1)[C@@H](NC(=O)c1nccs1)CC)C,,1,0.3
INSC-94,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CC(CNc1nc(nc2c1C(=O)C(=C)C(=O)[C@]1(O2)CCNC1=O)C(=O)NC[C@H](C(F)(F)F)O)C,CC(CNc1nc(nc2c1C(=O)C(=C)C(=O)[C@]1(O2)CCNC1=O)C(=O)NC[C@H](C(F)(F)F)O)C,,1,0.3
INSC-95,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CC(CNc1nc(nc2c1C(=O)C(=C)C(=O)[C@]1(O2)CCNC1=O)n1c(C)cc2c1cccc2)C,CC(CNc1nc(nc2c1C(=O)C(=C)C(=O)[C@]1(O2)CCNC1=O)n1c(C)cc2c1cccc2)C,,1,0.3
INSC-96,SARS-CoV-2,10.1101/2020.03.03.972133,computational,NCC(=O)N[C@@]12CCN(C1)CCC/C=C/C[C@H](NC(=O)[C@@H](NC2=O)CC(C)C)/C=C/C(=O)OCc1ccccc1,NCC(=O)N[C@@]12CCN(C1)CCC/C=C/C[C@H](NC(=O)[C@@H](NC2=O)CC(C)C)/C=C/C(=O)OCc1ccccc1,,1,0.3
INSC-97,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CN[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C/C=C\CC[C@H]2[C@@H]1C2)/C=C/C(=O)OCc1ccccc1,CN[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C/C=C\CC[C@H]2[C@@H]1C2)/C=C/C(=O)OCc1ccccc1,,1,0.3
Glycyrrhizin,SARS,10.1016/j.jcv.2004.03.003,experimental,CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C,OC1C(OC2OC(C(=O)O)C(C(C2O)O)O)C(OC(C1O)C(=O)O)OC1CCC2(C(C1(C)C)CCC1(C2C(=O)C=C2C1(C)CCC1(C2CC(C)(CC1)C(=O)O)C)C)C,14982,1,0.3
Ribavirin,SARS,10.1016/j.jcv.2004.03.003,experimental,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542,1,0.3
Lopinavir,SARS,10.1016/j.jcv.2004.03.003,experimental,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727,1,0.3
Rimantadine,SARS,10.1016/j.jcv.2004.03.003,experimental,CC(C12CC3CC(C1)CC(C3)C2)N,CC(C12CC3CC(C2)CC(C1)C3)N,5071,1,0.3
Baicalin,SARS,10.1016/j.jcv.2004.03.003,experimental,C1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)C(=O)O)O)O)O)O)O,OC(=O)C1OC(Oc2cc3oc(cc(=O)c3c(c2O)O)c2ccccc2)C(C(C1O)O)O,64982,1,0.3
Dihydrotanshinone,MERS,10.1016/j.ijantimicag.2018.05.003,experimental,CC1COC2=C1C(=O)C(=O)C3=C2C=CC4=C(C=CC=C43)C,CC1COC2=C1C(=O)C(=O)c1c2ccc2c1cccc2C,5316743,1,0.3
Ribavirin,SARS,10.1371/journal.pmed.0030343,experimental,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542,1,0.3
Lopinavir,SARS,10.1371/journal.pmed.0030343,experimental,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727,1,0.3
Ribavirin,MERS,10.1038/nrd.2015.37,experimental,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542,1,0.3
Lopinavir,MERS,10.1038/nrd.2015.37,experimental,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727,1,0.3
ritonavir,MERS,10.1038/nrd.2015.37,experimental,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622,1,0.3
hydrocortisone,MERS,10.1038/nrd.2015.37,experimental,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,OCC(=O)C1(O)CCC2C1(C)CC(O)C1C2CCC2=CC(=O)CCC12C,5754,1,0.3
methylprednisolone,MERS,10.1038/nrd.2015.37,experimental,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,OCC(=O)C1(O)CCC2C1(C)CC(O)C1C2CC(C2=CC(=O)C=CC12C)C,6741,1,0.3
Nitazoxanide A,MERS,10.1038/nrd.2015.37,experimental,CC(=O)Oc1ccccc1C(=O)Nc1ncc(s1)[N+](=O)[O-],CC(=O)Oc1ccccc1C(=O)Nc1ncc(s1)[N+](=O)[O-],,1,0.3
Chlorpromazine,MERS,10.1038/nrd.2015.37,experimental,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,2726,1,0.3
Ouabain,MERS,10.1038/nrd.2015.37,experimental,CC1C(C(C(C(O1)OC2CC(C3(C4C(CCC3(C2)O)C5(CCC(C5(CC4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O,OCC12C(O)CC(CC2(O)CCC2C1C(O)CC1(C2(O)CCC1C1=CC(=O)OC1)C)OC1OC(C)C(C(C1O)O)O,439501,1,0.3
Bufalin,MERS,10.1038/nrd.2015.37,experimental,CC12CCC(CC1CCC3C2CCC4(C3(CCC4C5=COC(=O)C=C5)O)C)O,OC1CCC2(C(C1)CCC1C2CCC2(C1(O)CCC2c1ccc(=O)oc1)C)C,9547215,1,0.3
Chloroquine,MERS,10.1038/nrd.2015.37,experimental,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,2719,1,0.3
Camostat mesylate,MERS,10.1038/nrd.2015.37,experimental,CN(C)C(=O)COC(=O)CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N.CS(=O)(=O)O,CS(=O)(=O)O.CN(C(=O)COC(=O)Cc1ccc(cc1)OC(=O)c1ccc(cc1)N=C(N)N)C,5284360,1,0.3
Trametinib,MERS,10.1038/nrd.2015.37,experimental,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,CC(=O)Nc1cccc(c1)n1c(=O)n(C2CC2)c(=O)c2c1c(C)c(=O)n(c2Nc1ccc(cc1F)I)C,11707110,1,0.3
Selumetinib,MERS,10.1038/nrd.2015.37,experimental,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,OCCONC(=O)c1cc2n(C)cnc2c(c1Nc1ccc(cc1Cl)Br)F,10127622,1,0.3
Everolimus,MERS,10.1038/nrd.2015.37,experimental,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC,OCCOC1CCC(CC1OC)CC(C1OC(=O)C2CCCCN2C(=O)C(=O)C2(O)OC(CCC2C)CC(OC)C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)C1)C)C)O)OC)C)C)C)C,6442177,1,0.3
Rapamycin,MERS,10.1038/nrd.2015.37,experimental,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,COC1CC(CCC1O)CC(C1OC(=O)C2CCCCN2C(=O)C(=O)C2(O)OC(CCC2C)CC(OC)C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)C1)C)C)O)OC)C)C)C)C,5284616,1,0.3
Dasatinib,MERS,10.1038/nrd.2015.37,experimental,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,OCCN1CCN(CC1)c1cc(nc(n1)C)Nc1ncc(s1)C(=O)Nc1c(C)cccc1Cl,3062316,1,0.3
Imatinib,MERS,10.1038/nrd.2015.37,experimental,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,CN1CCN(CC1)Cc1ccc(cc1)C(=O)Nc1ccc(c(c1)Nc1nccc(n1)c1cccnc1)C,5291,1,0.3
Ribavirin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542,1,0.3
Valganciclovir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N,OCC(OCn1cnc2c1nc(N)[nH]c2=O)COC(=O)C(C(C)C)N,135413535,1,0.3
β-Thymidine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1OC(CC1O)n1cc(C)c(=O)[nH]c1=O,OCC1OC(CC1O)n1cc(C)c(=O)[nH]c1=O,,1,0.3
Aspartame,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(=O)O)N,COC(=O)C(NC(=O)C(CC(=O)O)N)Cc1ccccc1,134601,1,0.3
Oxprenolol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C)NCC(COC1=CC=CC=C1OCC=C)O,C=CCOc1ccccc1OCC(CNC(C)C)O,4631,1,0.3
Doxycycline,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,CN(C1C(=O)C(=C(C2(C1C(O)C1C(C)c3cccc(c3C(=C1C2=O)O)O)O)O)C(=O)N)C,54671203,1,0.3
Acetophenazine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)CCO,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(=O)C,17676,1,0.3
Iopromide,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CN(CC(CO)O)C(=O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)NC(=O)COC)I,COCC(=O)Nc1c(I)c(C(=O)NCC(CO)O)c(c(c1I)C(=O)N(CC(CO)O)C)I,3736,1,0.3
Riboflavin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O,OCC(C(C(Cn1c2-c(nc3c1cc(C)c(c3)C)c(=O)[nH]c(=O)n2)O)O)O,493570,1,0.3
Reproterol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCCNCC(C3=CC(=CC(=C3)O)O)O,Oc1cc(O)cc(c1)C(CNCCCn1cnc2c1c(=O)n(C)c(=O)n2C)O,25654,1,0.3
"2,2′-Cyclocytidine",SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1OC2C(C1O)Oc1n2ccc(=N)n1,OCC1OC2C(C1O)Oc1n2ccc(=N)n1,,1,0.3
Chloramphenicol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],OCC(C(c1ccc(cc1)[N+](=O)[O-])O)NC(=O)C(Cl)Cl,5959,1,0.3
Chlorphenesin carbamate,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=CC(=CC=C1OCC(COC(=O)N)O)Cl,OC(COC(=O)N)COc1ccc(cc1)Cl,2724,1,0.3
Levodropropizine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1CN(CCN1CC(CO)O)C2=CC=CC=C2,OCC(CN1CCN(CC1)c1ccccc1)O,65859,1,0.3
Cefamandole,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(C4=CC=CC=C4)O)SC2)C(=O)O,OC(C(=O)NC1C(=O)N2C1SCC(=C2C(=O)O)CSc1nnnn1C)c1ccccc1,456255,1,0.3
Floxuridine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O,OCC1OC(CC1O)n1cc(F)c(=O)[nH]c1=O,5790,1,0.3
Tigecycline,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C,O=C(Nc1cc(N(C)C)c2c(c1O)C(=C1C(C2)CC2C(C1=O)(O)C(=C(C(=O)C2N(C)C)C(=O)N)O)O)CNC(C)(C)C,54686904,1,0.3
Pemetrexed,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)O)C(=O)O,OC(=O)CCC(C(=O)O)NC(=O)c1ccc(cc1)CCc1c[nH]c2c1c(=O)[nH]c(n2)N,135410875,1,0.3
L(+)-Ascorbic acid,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C(C(C1C(=C(C(=O)O1)O)O)O)O,OCC(C1OC(=O)C(=C1O)O)O,54670067,1,0.3
Glutathione,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C(CC(=O)NC(CS)C(=O)NCC(=O)O)C(C(=O)O)N,SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N,124886,1,0.3
Hesperetin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COC1=C(C=C(C=C1)C2CC(=O)C3=C(C=C(C=C3O2)O)O)O,COc1ccc(cc1O)C1CC(=O)c2c(O1)cc(cc2O)O,72281,1,0.3
Ademetionine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C[S+](CCC(C(=O)[O-])N)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O,C[S+](CC1OC(C(C1O)O)n1cnc2c1ncnc2N)CCC(C(=O)[O-])N,34755,1,0.3
Masoprocol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(CC1=CC(=C(C=C1)O)O)C(C)CC2=CC(=C(C=C2)O)O,CC(C(Cc1ccc(c(c1)O)O)C)Cc1ccc(c(c1)O)O,71398,1,0.3
Isotretinoin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,CC(=CC=CC(=CC(=O)O)C)C=CC1=C(C)CCCC1(C)C,5282379,1,0.3
Dantrolene,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1C(=O)NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-],O=C1CN(C(=O)N1)N=Cc1ccc(o1)c1ccc(cc1)[N+](=O)[O-],6914273,1,0.3
Sulfasalazine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,OC(=O)c1cc(N=Nc2ccc(cc2)S(=O)(=O)Nc2ccccn2)ccc1O,5339,1,0.3
Silybin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COC1=C(C=CC(=C1)C2C(OC3=C(O2)C=C(C=C3)C4C(C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O,OCC1Oc2ccc(cc2OC1c1ccc(c(c1)OC)O)C1Oc2cc(O)cc(c2C(=O)C1O)O,31553,1,0.3
Nicardipine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C,4474,1,0.3
Sildenafil,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,CCCc1nn(c2c1nc([nH]c2=O)c1cc(ccc1OCC)S(=O)(=O)N1CCN(CC1)C)C,135398744,1,0.3
Platycodin D,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1C(C(C(C(O1)OC2C(C(COC2OC(=O)C34CCC(CC3C5=CCC6C(C5(CC4O)C)(CCC7C6(CC(C(C7(CO)CO)OC8C(C(C(C(O8)CO)O)O)O)O)C)C)(C)C)O)O)O)O)OC9C(C(C(CO9)O)OC1C(C(CO1)(CO)O)O)O,OCC1(CO)C(OC2OC(CO)C(C(C2O)O)O)C(O)CC2(C1CCC1(C2CC=C2C1(C)CC(O)C1(C2CC(CC1)(C)C)C(=O)OC1OCC(C(C1OC1OC(C)C(C(C1O)O)OC1OCC(C(C1O)OC1OCC(C1O)(O)CO)O)O)O)C)C,162859,1,0.3
Chrysin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=CC=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O,Oc1cc(O)c2c(c1)oc(cc2=O)c1ccccc1,5281607,1,0.3
Neohesperidin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1C(C(C(C(O1)OC2C(C(C(OC2OC3=CC(=C4C(=O)CC(OC4=C3)C5=CC(=C(C=C5)OC)O)O)CO)O)O)O)O)O,OCC1OC(Oc2cc3OC(CC(=O)c3c(c2)O)c2ccc(c(c2)O)OC)C(C(C1O)O)OC1OC(C)C(C(C1O)O)O,442439,1,0.3
Baicalin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)C(=O)O)O)O)O)O)O,OC(=O)C1OC(Oc2cc3oc(cc(=O)c3c(c2O)O)c2ccccc2)C(C(C1O)O)O,64982,1,0.3
(–)-Epigallocatechin gallate,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,O=C1OCC23C1c1ccccc1N3C(=O)c1c(N2)cccc1,O=C1OCC23C1c1ccccc1N3C(=O)c1c(N2)cccc1,,1,0.3
Phaitanthrin D,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1C23C(C4=CC=CC=C4N2C(=O)C5=CC=CC=C5N3)C(=O)O1,O=C1OCC23C1c1ccccc1N3C(=O)c1c(N2)cccc1,24970703,1,0.3
Piceatannol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=CC(=C(C=C1C=CC2=CC(=CC(=C2)O)O)O)O,Oc1cc(C=Cc2ccc(c(c2)O)O)cc(c1)O,667639,1,0.3
Rosmarinic acid,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=CC(=C(C=C1CC(C(=O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O)O)O,O=C(OC(C(=O)O)Cc1ccc(c(c1)O)O)C=Cc1ccc(c(c1)O)O,5281792,1,0.3
Magnolol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C=CCC1=CC(=C(C=C1)O)C2=C(C=CC(=C2)CC=C)O,C=CCc1ccc(c(c1)c1cc(CC=C)ccc1O)O,72300,1,0.3
Lymecycline,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)NCNCCCCC(C(=O)O)N)N(C)C)O,NC(C(=O)O)CCCCNCNC(=O)C1=C(O)C2(C(C(C1=O)N(C)C)CC1C(=C(O)c3c(C1(C)O)cccc3O)C2=O)O,54707177,1,0.3
Chlorhexidine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,NC(=NCCCCCCN=C(N=C(Nc1ccc(cc1)Cl)N)N)N=C(Nc1ccc(cc1)Cl)N,9552079,1,0.3
Alfuzosin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,COc1cc2nc(nc(c2cc1OC)N)N(CCCNC(=O)C1CCCO1)C,2092,1,0.3
Cilastatin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1(CC1C(=O)NC(=CCCCCSCC(C(=O)O)N)C(=O)O)C,OC(=O)C(CSCCCCC=C(C(=O)O)NC(=O)C1CC1(C)C)N,6435415,1,0.3
Famotidine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,NC(=Nc1scc(n1)CSCCC(=NS(=O)(=O)N)N)N,5702160,1,0.3
Almitrine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C=CCNC1=NC(=NC(=N1)N2CCN(CC2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)NCC=C,C=CCNc1nc(nc(n1)NCC=C)N1CCN(CC1)C(c1ccc(cc1)F)c1ccc(cc1)F,33887,1,0.3
Progabide,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=CC(=CC=C1C(=NCCCC(=O)N)C2=C(C=CC(=C2)F)O)Cl,NC(=O)CCCN=C(c1cc(F)ccc1O)c1ccc(cc1)Cl,44115,1,0.3
Nepafenac,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=CC=C(C=C1)C(=O)C2=CC=CC(=C2N)CC(=O)N,NC(=O)Cc1cccc(c1N)C(=O)c1ccccc1,151075,1,0.3
Carvedilol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O,2585,1,0.3
Amprenavir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N,CC(CN(S(=O)(=O)c1ccc(cc1)N)CC(C(Cc1ccccc1)NC(=O)OC1CCOC1)O)C,65016,1,0.3
Tigecycline,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C,O=C(Nc1cc(N(C)C)c2c(c1O)C(=C1C(C2)CC2C(C1=O)(O)C(=C(C(=O)C2N(C)C)C(=O)N)O)O)CNC(C)(C)C,54686904,1,0.3
Demeclocycline,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CN(C)C1C2CC3C(C4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)Cl)O,CN(C1C(=O)C(=C(C2(C1CC1C(=C(O)c3c(C1O)c(Cl)ccc3O)C2=O)O)O)C(=O)N)C,54680690,1,0.3
Montelukast,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,OC(=O)CC1(CSC(c2cccc(c2)C=Cc2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1,5281040,1,0.3
Carminic acid,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1=C2C(=CC(=C1C(=O)O)O)C(=O)C3=C(C2=O)C(=C(C(=C3O)O)C4C(C(C(C(O4)CO)O)O)O)O,OCC1OC(C(C(C1O)O)O)c1c(O)c2c(c(c1O)O)C(=O)c1c(C2=O)c(C)c(c(c1)O)C(=O)O,10255083,1,0.3
Mimosine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=CN(C=C(C1=O)O)CC(C(=O)O)N,OC(=O)C(Cn1ccc(=O)c(c1)O)N,3862,1,0.3
Flavin mononucleotide,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,O=c1[nH]c(=O)c2c(n1)n(CC(C(C(COP(=O)(O)O)O)O)O)c1c(n2)cc(c(c1)C)C,O=c1[nH]c(=O)c2c(n1)n(CC(C(C(COP(=O)(O)O)O)O)O)c1c(n2)cc(c(c1)C)C,,1,0.3
Lutein,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1=C(C(CC(C1)O)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2C(=CC(CC2(C)C)O)C)C)C,CC(=CC=CC=C(C=CC=C(C=CC1=C(C)CC(CC1(C)C)O)C)C)C=CC=C(C=CC1C(=CC(CC1(C)C)O)C)C,,1,0.3
Cefpiramide,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1=CC(=O)C(=CN1)C(=O)NC(C2=CC=C(C=C2)O)C(=O)NC3C4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O,Oc1ccc(cc1)C(C(=O)NC1C(=O)N2C1SCC(=C2C(=O)O)CSc1nnnn1C)NC(=O)c1c[nH]c(cc1=O)C,5281243,1,0.3
Phenethicillin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C(=O)NC1C2N(C1=O)C(C(S2)(C)C)C(=O)O)OC3=CC=CC=C3,CC(C(=O)NC1C(=O)N2C1SC(C2C(=O)O)(C)C)Oc1ccccc1,636405,1,0.3
Candoxatril,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COCCOCC(CC1(CCCC1)C(=O)NC2CCC(CC2)C(=O)O)C(=O)OC3=CC4=C(CCC4)C=C3,COCCOCC(C(=O)Oc1ccc2c(c1)CCC2)CC1(CCCC1)C(=O)NC1CCC(CC1)C(=O)O,272833,1,0.3
Nicardipine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C,5362417,1,0.3
Estradiol valerate,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCCCC(=O)OC1CCC2C1(CCC3C2CCC4=C3C=CC(=C4)O)C,CCCCC(=O)OC1CCC2C1(C)CCC1C2CCc2c1ccc(c2)O,4474,1,0.3
Pioglitazone,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,CCc1ccc(nc1)CCOc1ccc(cc1)CC1SC(=O)NC1=O,13791,1,0.3
Conivaptan,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6,Cc1[nH]c2c(-c3ccccc3N(CC2)C(=O)c2ccc(cc2)NC(=O)c2ccccc2c2ccccc2)n1,4829,1,0.3
Telmisartan,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2,151171,1,0.3
Doxycycline,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,CN(C1C(=O)C(=C(C2(C1C(O)C1C(C)c3cccc(c3C(=C1C2=O)O)O)O)O)C(=O)N)C,65999,1,0.3
Oxytetracycline,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O,CN(C1C(=O)C(=C(C2(C1C(O)C1C(=C(O)c3c(C1(C)O)cccc3O)C2=O)O)O)C(=O)N)C,54671203,1,0.3
Valganciclovir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N,OCC(OCn1cnc2c1nc(N)[nH]c2=O)COC(=O)C(C(C)C)N,54675779,1,0.3
Chlorhexidine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,NC(=NCCCCCCN=C(N=C(Nc1ccc(cc1)Cl)N)N)N=C(Nc1ccc(cc1)Cl)N,135413535,1,0.3
Ceftibuten,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1C=C(N2C(S1)C(C2=O)NC(=O)C(=CCC(=O)O)C3=CSC(=N3)N)C(=O)O,OC(=O)CC=C(C(=O)NC1C(=O)N2C1SCC=C2C(=O)O)c1csc(n1)N,9552079,1,0.3
Fenoterol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(CC1=CC=C(C=C1)O)NCC(C2=CC(=CC(=C2)O)O)O,CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O,5282242,1,0.3
Fludarabine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,OCC1OC(C(C1O)O)n1cnc2c1nc(F)nc2N,3343,1,0.3
Itraconazole,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,CCC(n1ncn(c1=O)c1ccc(cc1)N1CCN(CC1)c1ccc(cc1)OCC1COC(O1)(Cn1cncn1)c1ccc(cc1Cl)Cl)C,657237,1,0.3
Cefuroxime,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O,CON=C(C(=O)NC1C(=O)N2C1SCC(=C2C(=O)O)COC(=O)N)c1ccco1,3793,1,0.3
Atovaquone,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O,Clc1ccc(cc1)C1CCC(CC1)C1=C(O)c2c(C(=O)C1=O)cccc2,5479529,1,0.3
Chenodeoxycholic acid,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,OC1CCC2(C(C1)CC(C1C2CCC2(C1CCC2C(CCC(=O)O)C)C)O)C,74989,1,0.3
Cromolyn,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)O)O)C(=O)C=C(O2)C(=O)O,OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O,10133,1,0.3
Pancuronium bromide,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(=O)OC1CC2CCC3C(C2(CC1[N+]4(CCCCC4)C)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-].[Br-],CC(=O)OC1CC2CCC3C(C2(CC1[N+]1(C)CCCCC1)C)CCC1(C3CC(C1OC(=O)C)[N+]1(C)CCCCC1)C.[Br-].[Br-],2882,1,0.3
Cortisone,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC12CCC(=O)C=C1CCC3C2C(=O)CC4(C3CCC4(C(=O)CO)O)C,OCC(=O)C1(O)CCC2C1(C)CC(=O)C1C2CCC2=CC(=O)CCC12C,27350,1,0.3
Tibolone,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1CC2=C(CCC(=O)C2)C3C1C4CCC(C4(CC3)C)(C#C)O,C#CC1(O)CCC2C1(C)CCC1C2C(C)CC2=C1CCC(=O)C2,222786,1,0.3
Novobiocin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1=C(C=CC2=C1OC(=O)C(=C2O)NC(=O)C3=CC(=C(C=C3)O)CC=C(C)C)OC4C(C(C(C(O4)(C)C)OC)OC(=O)N)O,COC1C(OC(=O)N)C(O)C(OC1(C)C)Oc1ccc2c(c1C)oc(=O)c(c2O)NC(=O)c1ccc(c(c1)CC=C(C)C)O,444008,1,0.3
Silybin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COC1=C(C=CC(=C1)C2C(OC3=C(O2)C=C(C=C3)C4C(C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O,OCC1Oc2ccc(cc2OC1c1ccc(c(c1)OC)O)C1Oc2cc(O)cc(c2C(=O)C1O)O,54675769,1,0.3
Idarubicin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O,OC1C(N)CC(OC1C)OC1CC(O)(Cc2c1c(O)c1c(c2O)C(=O)c2c(C1=O)cccc2)C(=O)C,31553,1,0.3
Bromocriptine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,CC(CC1C(=O)N2CCCC2C2(N1C(=O)C(O2)(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C,42890,1,0.3
Diphenoxylate,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCOC(=O)C1(CCN(CC1)CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4,CCOC(=O)C1(CCN(CC1)CCC(c1ccccc1)(c1ccccc1)C#N)c1ccccc1,31101,1,0.3
Benzylpenicilloyl G,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1(C(NC(S1)C(C(=O)NCCCCCC(=O)O)NC(=O)CC2=CC=CC=C2)C(=O)O)C,O=C(NC(C1NC(C(S1)(C)C)C(=O)O)C(=O)NCCCCCC(=O)O)Cc1ccccc1,13505,1,0.3
Dabigatran etexilate,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCCCCCOC(=O)N=C(C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4)N,CCCCCCOC(=O)N=C(c1ccc(cc1)NCc1nc2c(n1C)ccc(c2)C(=O)N(c1ccccn1)CCC(=O)OCC)N,119212,1,0.3
Betulonal,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(=C)C1CCC2(C1C3CCC4C5(CCC(=O)C(C5CCC4(C3(CC2)C)C)(C)C)C)C=O,O=CC12CCC(C2C2C(CC1)(C)C1(C)CCC3C(C1CC2)(C)CCC(=O)C3(C)C)C(=C)C,,1,0.3
Andrographiside,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC12CCC(C(C1CCC(=C)C2CC=C3C(COC3=O)O)(C)COC4C(C(C(C(O4)CO)O)O)O)O,OCC1OC(OCC2(C)C(O)CCC3(C2CCC(=C)C3CC=C2C(O)COC2=O)C)C(C(C1O)O)O,,1,0.3
Cerevisterol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C2=CC(C4(C3(CCC(C4)O)C)O)O)C,OC1CCC2(C(C1)(O)C(O)C=C1C2CCC2(C1CCC2C(C=CC(C(C)C)C)C)C)C,,1,0.3
Hesperidin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC(=C4C(=O)CC(OC4=C3)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O,COc1ccc(cc1O)C1CC(=O)c2c(O1)cc(cc2O)OC1OC(COC2OC(C)C(C(C2O)O)O)C(C(C1O)O)O,10181133,1,0.3
Neohesperidin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1C(C(C(C(O1)OC2C(C(C(OC2OC3=CC(=C4C(=O)CC(OC4=C3)C5=CC(=C(C=C5)OC)O)O)CO)O)O)O)O)O,OCC1OC(Oc2cc3OC(CC(=O)c3c(c2)O)c2ccc(c(c2)O)OC)C(C(C1O)O)OC1OC(C)C(C(C1O)O)O,10621,1,0.3
Andrograpanin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1(CCCC2(C1CCC(=C)C2CCC3=CCOC3=O)C)CO,OCC1(C)CCCC2(C1CCC(=C)C2CCC1=CCOC1=O)C,442439,1,0.3
Cosmosiin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)OC4C(C(C(C(O4)CO)O)O)O)O)O,OCC1OC(Oc2cc(O)c3c(c2)oc(cc3=O)c2ccc(cc2)O)C(C(C1O)O)O,,1,0.3
Biorobin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC=C(C=C5)O)O)O)O)O)O)O,Oc1ccc(cc1)c1oc2cc(O)cc(c2c(=O)c1OC1OC(COC2OC(C)C(C(C2O)O)O)C(C(C1O)O)O)O,,1,0.3
Gnidicin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1C(C2(C3C4C1(C5C=C(C(=O)C5(C(C6(C4O6)CO)O)O)C)OC(O3)(O2)C7=CC=CC=C7)C(=C)C)OC(=O)C=CC8=CC=CC=C8,OCC12OC1C1C3OC4(OC1(C1C(C2O)(O)C(=O)C(=C1)C)C(C(C3(O4)C(=C)C)OC(=O)C=Cc1ccccc1)C)c1ccccc1,12313332,1,0.3
Rosmarinic acid,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=CC(=C(C=C1CC(C(=O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O)O)O,O=C(OC(C(=O)O)Cc1ccc(c(c1)O)O)C=Cc1ccc(c(c1)O)O,,1,0.3
Oleanolic acid,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1)C)C(=O)O)C,OC1CCC2(C(C1(C)C)CCC1(C2CC=C2C1(C)CCC1(C2CC(C)(C)CC1)C(=O)O)C)C,,1,0.3
Stigmast-5-en-3-ol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C,CCC(C(C)C)CCC(C1CCC2C1(C)CCC1C2CC=C2C1(C)CCC(C2)O)C,10494,1,0.3
Berchemol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COC1=C(C=CC(=C1)CC2COC(C2(CO)O)C3=CC(=C(C=C3)O)OC)O,COc1cc(ccc1O)CC1COC(C1(O)CO)c1ccc(c(c1)OC)O,,1,0.3
Betulonal,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(=C)C1CCC2(C1C3CCC4C5(CCC(=O)C(C5CCC4(C3(CC2)C)C)(C)C)C)C=O,O=CC12CCC(C2C2C(CC1)(C)C1(C)CCC3C(C1CC2)(C)CCC(=O)C3(C)C)C(=C)C,14521044,1,0.3
Gnidicin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1C(C2(C3C4C1(C5C=C(C(=O)C5(C(C6(C4O6)CO)O)O)C)OC(O3)(O2)C7=CC=CC=C7)C(=C)C)OC(=O)C=CC8=CC=CC=C8,OCC12OC1C1C3OC4(OC1(C1C(C2O)(O)C(=O)C(=C1)C)C(C(C3(O4)C(=C)C)OC(=O)C=Cc1ccccc1)C)c1ccccc1,473111,1,0.3
Gniditrin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCCC=CC=CC=CC(=O)OC1C(C23C4C=C(C(=O)C4(C(C5(C(C2C6C1(OC(O6)(O3)C7=CC=CC=C7)C(=C)C)O5)CO)O)O)C)C,CCCC=CC=CC=CC(=O)OC1C(C)C23OC4(OC1(C(=C)C)C(C2C1OC1(C(C1(C3C=C(C1=O)C)O)O)CO)O4)c1ccccc1,,1,0.3
"Theaflavin 3,3′-di-O-gallate",SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Oc1cc2OC(C(Cc2c(c1)O)OC(=O)c1cc(O)c(c(c1)O)O)c1cc(O)c(=O)c2c(c1)c(cc(c2O)O)C1Oc2cc(O)cc(c2CC1OC(=O)c1cc(O)c(c(c1)O)O)O,Oc1cc2OC(C(Cc2c(c1)O)OC(=O)c1cc(O)c(c(c1)O)O)c1cc(O)c(=O)c2c(c1)c(cc(c2O)O)C1Oc2cc(O)cc(c2CC1OC(=O)c1cc(O)c(c(c1)O)O)O,,1,0.3
Phyllaemblicin B,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1COC2(CC1OC(=O)C3=CC=CC=C3)C(=O)C4(C(CC(CC4O2)C(=O)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)O)O,OCC1OC(OC(=O)C2CC(O)C3(C(C2)OC2(C3=O)OCC(C(C2)OC(=O)c2ccccc2)C)O)C(C(C1O)O)OC1OC(CO)C(C(C1O)O)O,,1,0.3
Andrographiside,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC12CCC(C(C1CCC(=C)C2CC=C3C(COC3=O)O)(C)COC4C(C(C(C(O4)CO)O)O)O)O,OCC1OC(OCC2(C)C(O)CCC3(C2CCC(=C)C3CC=C2C(O)COC2=O)C)C(C(C1O)O)O,,1,0.3
Baicalin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)C(=O)O)O)O)O)O)O,OC(=O)C1OC(Oc2cc3oc(cc(=O)c3c(c2O)O)c2ccccc2)C(C(C1O)O)O,44593583,1,0.3
"1,7-Dihydroxy-3-methoxyxanthone",SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COC1=CC(=C2C(=C1)OC3=C(C2=O)C=C(C=C3)O)O,COc1cc(O)c2c(c1)oc1c(c2=O)cc(cc1)O,,1,0.3
Emtricitabine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,Nc1nc(=O)n(cc1F)C1CSC(O1)CO,,1,0.3
Tenofovir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O,CC(Cn1cnc2c1ncnc2N)OCP(=O)(O)O,,1,0.3
Efavirenz,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,FC(C1(C#CC2CC2)OC(=O)Nc2c1cc(Cl)cc2)(F)F,,1,0.3
Nevirapine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,O=C1Nc2c(C)ccnc2N(c2c1cccn2)C1CC1,60877,1,0.3
Saquinavir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O,NC(=O)CC(C(=O)NC(C(CN1CC2CCCCC2CC1C(=O)NC(C)(C)C)O)Cc1ccccc1)NC(=O)c1ccc2c(n1)cccc2,464205,1,0.3
Indinavir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,OC(CN1CCN(CC1C(=O)NC(C)(C)C)Cc1cccnc1)CC(C(=O)NC1C(O)Cc2c1cccc2)Cc1ccccc1,64139,1,0.3
Nelfinavir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O,OC(C(NC(=O)c1cccc(c1C)O)CSc1ccccc1)CN1CC2CCCCC2CC1C(=O)NC(C)(C)C,4463,1,0.3
Atazanavir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,COC(=O)NC(C(C)(C)C)C(=O)NN(Cc1ccc(cc1)c1ccccn1)CC(C(Cc1ccccc1)NC(=O)C(C(C)(C)C)NC(=O)OC)O,441243,1,0.3
Tipranavir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCCC1(CC(=C(C(=O)O1)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4,CCCC1(CCc2ccccc2)CC(=C(C(=O)O1)C(c1cccc(c1)NS(=O)(=O)c1ccc(cn1)C(F)(F)F)CC)O,5362440,1,0.3
Abacavir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,OCC1C=CC(C1)n1cnc2c1nc(N)nc2NC1CC1,64143,1,0.3
Doravirine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CN1C(=NNC1=O)CN2C=CC(=C(C2=O)OC3=CC(=CC(=C3)C#N)Cl)C(F)(F)F,N#Cc1cc(cc(c1)Cl)Oc1c(=O)n(ccc1C(F)(F)F)Cc1n[nH]c(=O)n1C,148192,1,0.3
Etravirine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N,N#Cc1ccc(cc1)Nc1nc(N)c(c(n1)Oc1c(C)cc(cc1C)C#N)Br,54682461,1,0.3
Rilpivirine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N,N#CC=Cc1cc(C)c(c(c1)C)Nc1ccnc(n1)Nc1ccc(cc1)C#N,441300,1,0.3
Dolutegravir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,Fc1ccc(c(c1)F)CNC(=O)c1cn2CC3OCCC(N3C(=O)c2c(c1=O)O)C,58460047,1,0.3
Raltegravir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F,Fc1ccc(cc1)CNC(=O)c1nc(n(c(=O)c1O)C)C(NC(=O)c1nnc(o1)C)(C)C,193962,1,0.3
Penciclovir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=NC2=C(N1CCC(CO)CO)N=C(NC2=O)N,OCC(CCn1cnc2c1nc(N)[nH]c2=O)CO,6451164,1,0.3
Cytarabine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,OCC1OC(C(C1O)O)n1ccc(nc1=O)N,54726191,1,0.3
Cidofovir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O,OCC(Cn1ccc(nc1=O)N)OCP(=O)(O)O,54671008,1,0.3
Tromantadine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CN(C)CCOCC(=O)NC12CC3CC(C1)CC(C3)C2,CN(CCOCC(=O)NC12CC3CC(C2)CC(C1)C3)C,135398748,1,0.3
Imiquimod,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,CC(Cn1cnc2c1c1ccccc1nc2N)C,6253,1,0.3
Podophyllotoxin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O,COc1cc(cc(c1OC)OC)C1C2C(=O)OCC2C(c2c1cc1OCOc1c2)O,60613,1,0.3
Adefovir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=NC(=C2C(=N1)N(C=N2)CCOCP(=O)(O)O)N,Nc1ncnc2c1ncn2CCOCP(=O)(O)O,64377,1,0.3
Clevudine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)F,OCC1OC(C(C1O)F)n1cc(C)c(=O)[nH]c1=O,57469,1,0.3
Telbivudine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O,OCC1OC(CC1O)n1cc(C)c(=O)[nH]c1=O,10607,1,0.3
Ribavirin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,60172,1,0.3
Boceprevir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C,O=C(NC(C)(C)C)NC(C(C)(C)C)C(=O)N1CC2C(C1C(=O)NC(C(=O)C(=O)N)CC1CCC1)C2(C)C,73115,1,0.3
Telaprevir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5,CCCC(C(=O)C(=O)NC1CC1)NC(=O)C1C2CCCC2CN1C(=O)C(C(C)(C)C)NC(=O)C(C1CCCCC1)NC(=O)c1nccnc1,159269,1,0.3
Arbidol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3,CCOC(=O)c1c(CSc2ccccc2)n(c2c1c(CN(C)C)c(O)c(c2)Br)C,37542,1,0.3
Inosine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)CO)O)O,OCC1OC(C(C1O)O)n1cnc2c1nc[nH]c2=O,10324367,1,0.3
Rimantadine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C12CC3CC(C1)CC(C3)C2)N,CC(C12CC3CC(C2)CC(C1)C3)N,3010818,1,0.3
Amantadine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1C2CC3CC1CC(C2)(C3)N,NC12CC3CC(C2)CC(C1)C3,131411,1,0.3
Maraviroc,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,O=C(C1CCC(CC1)(F)F)NC(c1ccccc1)CCN1C2CCC1CC(C2)n1c(C)nnc1C(C)C,135398641,1,0.3
Zanamivir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N,OCC(C(C1OC(=CC(C1NC(=O)C)N=C(N)N)C(=O)O)O)O,5071,1,0.3
Acyclovir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=NC2=C(N1COCCO)N=C(NC2=O)N,OCCOCn1cnc2c1nc(N)[nH]c2=O,2130,1,0.3
Ganciclovir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N,OCC(OCn1cnc2c1nc(N)[nH]c2=O)CO,3002977,1,0.3
Valganciclovir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N,OCC(OCn1cnc2c1nc(N)[nH]c2=O)COC(=O)C(C(C)C)N,60855,1,0.3
Valaciclovir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N,CC(C(C(=O)OCCOCn1cnc2c1nc(N)[nH]c2=O)N)C,135398513,1,0.3
Suramin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1=C(C=C(C=C1)C(=O)NC2=C3C(=CC(=CC3=C(C=C2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)NC(=O)C4=CC(=CC=C4)NC(=O)NC5=CC=CC(=C5)C(=O)NC6=C(C=CC(=C6)C(=O)NC7=C8C(=CC(=CC8=C(C=C7)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)C,O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,135398740,1,0.3
"DHPA (S)-9-(2,3-Dihydroxypropyl)adenine",SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC(Cn1cnc2c1ncnc2N)O,OCC(Cn1cnc2c1ncnc2N)O,135413535,1,0.3
BVDU Brivudine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Br/C=C/c1cn([C@H]2C[C@@H]([C@H](O2)CO)O)c(=O)nc1O,Br/C=C/c1cn([C@H]2C[C@@H]([C@H](O2)CO)O)c(=O)nc1O,135398742,1,0.3
ACV triphosphate Acycloguanosine triphosphate,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Nc1[nH]c(=O)c2c(n1)n(COCCOP(=O)(OP(=O)(OP(=O)(O)O)O)O)cn2,Nc1[nH]c(=O)c2c(n1)n(COCCOP(=O)(OP(=O)(OP(=O)(O)O)O)O)cn2,,1,0.3
(S)-HPMPA (S)-9-(3-hydroxy-2-phosphonomethoxypropyl)adenine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC(Cn1cnc2c1ncnc2N)OCP(=O)(O)O,OCC(Cn1cnc2c1ncnc2N)OCP(=O)(O)O,,1,0.3
STAVUDINE,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,Cc1cn(C2OC(C=C2)CO)c(=O)[nH]c1=O,,1,0.3
Didanosine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1CC(OC1CO)N2C=NC3=C2N=CNC3=O,OCC1CCC(O1)n1cnc2c1nc[nH]c2=O,,1,0.3
Zalcitabine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1CC(OC1CO)N2C=CC(=NC2=O)N,Nc1ccn(c(=O)n1)C1CCC(O1)CO,,1,0.3
Pyrimidinedione,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=CNC(=O)NC1=O,O=c1cc[nH]c(=O)[nH]1,,1,0.3
Emivirine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCOCN1C(=C(C(=O)NC1=O)C(C)C)CC2=CC=CC=C2,CCOCn1c(=O)[nH]c(=O)c(c1Cc1ccccc1)C(C)C,,1,0.3
Delavirdine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C,CC(Nc1cccnc1N1CCN(CC1)C(=O)c1cc2c([nH]1)ccc(c2)NS(=O)(=O)C)C,,1,0.3
Dapivirine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1=CC(=C(C(=C1)C)NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C,N#Cc1ccc(cc1)Nc1nccc(n1)Nc1c(C)cc(cc1C)C,,1,0.3
TIBO,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1CN2C3=C(CN1CC=C(C)C)C=CC=C3NC2=S,CC(=CCN1Cc2cccc3c2n(CC1C)c(=S)[nH]3)C,,1,0.3
Tivirapine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1CN2C3=C(C=CC(=C3CN1CC=C(C)C)Cl)NC2=S,CC(=CCN1Cc2c(Cl)ccc3c2n(CC1C)c(=S)[nH]3)C,,1,0.3
Elvitegravir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C)C(CO)N1C=C(C(=O)C2=C1C=C(C(=C2)CC3=C(C(=CC=C3)Cl)F)OC)C(=O)O,OCC(n1cc(C(=O)O)c(=O)c2c1cc(OC)c(c2)Cc1cccc(c1F)Cl)C(C)C,,1,0.3
Cobicistat,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5,O=C(NC(Cc1ccccc1)CCC(Cc1ccccc1)NC(=O)C(NC(=O)N(Cc1csc(n1)C(C)C)C)CCN1CCOCC1)OCc1cncs1,18283,1,0.3
Plerixafor,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3,C1CNCCN(CCCNCCNC1)Cc1ccc(cc1)CN1CCNCCCNCCNCCC1,135398739,1,0.3
Bictegravir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1CC2CC1N3C(O2)CN4C=C(C(=O)C(=C4C3=O)O)C(=O)NCC5=C(C=C(C=C5F)F)F,Fc1cc(F)c(c(c1)F)CNC(=O)c1cn2CC3OC4CCC(N3C(=O)c2c(c1=O)O)C4,24066,1,0.3
Rabacfosadine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCOC(=O)C(C)NP(=O)(COCCN1C=NC2=C(N=C(N=C21)N)NC3CC3)NC(C)C(=O)OCC,CCOC(=O)C(NP(=O)(NC(C(=O)OCC)C)COCCn1cnc2c1nc(N)nc2NC1CC1)C,,1,0.3
FV 100 Valnivudine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCCCCc1ccc(cc1)c1oc2c(c1)cn(c(=O)n2)C1CC(C(O1)COC(=O)C(C(C)C)N)O,CCCCCc1ccc(cc1)c1oc2c(c1)cn(c(=O)n2)C1CC(C(O1)COC(=O)C(C(C)C)N)O,65013,1,0.3
GS 9191,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C)COC(=O)C(CC1=CC=CC=C1)NP(=O)(COCCN2C=NC3=C(N=C(N=C32)N)NC4CC4)NC(CC5=CC=CC=C5)C(=O)OCC(C)C,CC(COC(=O)C(NP(=O)(NC(C(=O)OCC(C)C)Cc1ccccc1)COCCn1cnc2c1nc(N)nc2NC1CC1)Cc1ccccc1)C,5625,1,0.3
PMEO-DAPy,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=C(N=C(N=C1OCCOCP(=O)(O)O)N)N,Nc1cc(OCCOCP(=O)(O)O)nc(n1)N,3000236,1,0.3
Ritonavir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,5277135,1,0.3
Lopinavir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,25151504,1,0.3
Darunavir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,CC(CN(S(=O)(=O)c1ccc(cc1)N)CC(C(Cc1ccccc1)NC(=O)OC1COC2C1CCO2)O)C,65015,1,0.3
Favipiravir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1=C(N=C(C(=O)N1)C(=O)N)F,Fc1c[nH]c(=O)c(n1)C(=O)N,90311989,1,0.3
Famciclovir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C,CC(=O)OCC(CCn1cnc2c1nc(N)nc2)COC(=O)C,16047979,1,0.3
Foscarnet,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C(=O)(O)P(=O)(O)O,OC(=O)P(=O)(O)O,,1,0.3
Lamivudine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,Nc1ccn(c(=O)n1)C1CSC(O1)CO,,1,0.3
Emtricitabine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,Nc1nc(=O)n(cc1F)C1CSC(O1)CO,,1,0.3
Entecavir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C=C1C(CC(C1CO)O)N2C=NC3=C2N=C(NC3=O)N,OCC1C(O)CC(C1=C)n1cnc2c1nc(N)[nH]c2=O,,1,0.3
Beclabuvir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CN1CC2CCC(C1)N2C(=O)C34CC3C5=C(C=CC(=C5)OC)C6=C(C7=C(N6C4)C=C(C=C7)C(=O)NS(=O)(=O)N(C)C)C8CCCCC8,COc1ccc2-c3c(C4CCCCC4)c4c(n3CC3(C(c2c1)C3)C(=O)N1C2CCC1CN(C2)C)cc(cc4)C(=O)NS(=O)(=O)N(C)C,,1,0.3
dec-RVKR-CMK,MERS,nrd.2015.37,experimental,CCCCCCCCCC(=O)NC(CCCN=C(N)N)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)CCl,NCCCCC(C(=O)NC(C(=O)CCl)CCCN=C(N)N)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CCCCCCCCC)CCCN=C(N)N,,1,0.3
β-D-N4-hydroxycytidine,SARS-COV-2,10.1101/2020.03.19.997890,experimental,OCC1OC(C(C1O)O)n1ccc(nc1=O)NO,OCC1OC(C(C1O)O)n1ccc(nc1=O)NO,,1,0.3
dichlorobenzyl alcohol,SARS-COV-2,10.1177/095632020501600205,experimental,OCc1cc(Cl)cc(c1)Cl,OCc1cc(Cl)cc(c1)Cl,,1,0.3
Amylmetacresol,SARS-COV-2,10.1177/095632020501600205,experimental,CCCCCC1=C(C=C(C=C1)C)O,CCCCCc1ccc(cc1O)C,,1,0.3
oseltamivir,Mixed,Kaggle,mixed,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,CCOC(=O)C1=CC(C(C(C1)N)NC(=O)C)OC(CC)CC,65028,1,0.3
abacavir,Mixed,Kaggle,mixed,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,OCC1C=CC(C1)n1cnc2c1nc(N)nc2NC1CC1,441300,1,0.3
acyclovir,Mixed,Kaggle,mixed,C1=NC2=C(N1COCCO)N=C(NC2=O)N,OCCOCn1cnc2c1nc(N)[nH]c2=O,135398513,1,0.3
adefovir,Mixed,Kaggle,mixed,C1=NC(=C2C(=N1)N(C=N2)CCOCP(=O)(O)O)N,Nc1ncnc2c1ncn2CCOCP(=O)(O)O,60172,1,0.3
alisporivir,Mixed,Kaggle,mixed,CCC1C(=O)N(C(C(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)C(C)C)CC)C)C,CC=CCC(C(C1C(=O)NC(CC)C(=O)N(C)C(C)C(=O)N(CC)C(C(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)O)C,11513676,1,0.3
amdoxovir,Mixed,Kaggle,mixed,C1C(OC(O1)CO)N2C=NC3=C(N=C(N=C32)N)N,OCC1OCC(O1)n1cnc2c1nc(N)nc2N,124088,1,0.3
amprenavir,Mixed,Kaggle,mixed,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N,CC(CN(S(=O)(=O)c1ccc(cc1)N)CC(C(Cc1ccccc1)NC(=O)OC1CCOC1)O)C,65016,1,0.3
atazanavir,Mixed,Kaggle,mixed,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,COC(=O)NC(C(C)(C)C)C(=O)NN(Cc1ccc(cc1)c1ccccn1)CC(C(Cc1ccccc1)NC(=O)C(C(C)(C)C)NC(=O)OC)O,148192,1,0.3
balapiravir,Mixed,Kaggle,mixed,CC(C)C(=O)OCC1(C(C(C(O1)N2C=CC(=NC2=O)N)OC(=O)C(C)C)OC(=O)C(C)C)N=[N+]=[N-],[N-]=[N+]=NC1(COC(=O)C(C)C)OC(C(C1OC(=O)C(C)C)OC(=O)C(C)C)n1ccc(nc1=O)N,11691726,1,0.3
baloxavir,Mixed,Kaggle,mixed,C1COCC2N1C(=O)C3=C(C(=O)C=CN3N2C4C5=C(CSC6=CC=CC=C46)C(=C(C=C5)F)F)O,Fc1c(F)ccc2c1CSc1c(C2N2C3COCCN3C(=O)c3n2ccc(=O)c3O)cccc1,124081876,1,0.3
beclabuvir,Mixed,Kaggle,mixed,CN1CC2CCC(C1)N2C(=O)C34CC3C5=C(C=CC(=C5)OC)C6=C(C7=C(N6C4)C=C(C=C7)C(=O)NS(=O)(=O)N(C)C)C8CCCCC8,COc1ccc2-c3c(C4CCCCC4)c4c(n3CC3(C(c2c1)C3)C(=O)N1C2CCC1CN(C2)C)cc(cc4)C(=O)NS(=O)(=O)N(C)C,49773361,1,0.3
boceprevir,Mixed,Kaggle,mixed,CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C,O=C(NC(C)(C)C)NC(C(C)(C)C)C(=O)N1CC2C(C1C(=O)NC(C(=O)C(=O)N)CC1CCC1)C2(C)C,10324367,1,0.3
brincidofovir,Mixed,Kaggle,mixed,CCCCCCCCCCCCCCCCOCCCOP(=O)(COC(CN1C=CC(=NC1=O)N)CO)O,CCCCCCCCCCCCCCCCOCCCOP(=O)(COC(Cn1ccc(nc1=O)N)CO)O,483477,1,0.3
carbovir,Mixed,Kaggle,mixed,C1C(C=CC1N2C=NC3=C2N=C(NC3=O)N)CO,OCC1C=CC(C1)n1cnc2c1nc(N)[nH]c2=O,135403630,1,0.3
celgosivir,Mixed,Kaggle,mixed,CCCC(=O)OC1CN2CCC(C2C(C1O)O)O,CCCC(=O)OC1CN2CCC(C2C(C1O)O)O,60734,1,0.3
cidofovir,Mixed,Kaggle,mixed,C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O,OCC(Cn1ccc(nc1=O)N)OCP(=O)(O)O,60613,1,0.3
combivir,Mixed,Kaggle,mixed,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)N=[N+]=[N-],[N-]=[N+]=NC1CC(OC1COP(=O)(OP(=O)(OP(=O)(O)O)O)O)n1cc(C)c(=O)[nH]c1=O,72187,1,0.3
daclatasvir,Mixed,Kaggle,mixed,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,COC(=O)NC(C(=O)N1CCCC1c1ncc([nH]1)c1ccc(cc1)c1ccc(cc1)c1cnc([nH]1)C1CCCN1C(=O)C(C(C)C)NC(=O)OC)C(C)C,25154714,1,0.3
danoprevir,Mixed,Kaggle,mixed,CC(C)(C)OC(=O)NC1CCCCCC=CC2CC2(NC(=O)C3CC(CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)NS(=O)(=O)C6CC6,O=C(OC(C)(C)C)NC1CCCCCC=CC2C(NC(=O)C3N(C1=O)CC(C3)OC(=O)N1Cc3c(C1)cccc3F)(C2)C(=O)NS(=O)(=O)C1CC1,11285588,1,0.3
darunavir,Mixed,Kaggle,mixed,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,CC(CN(S(=O)(=O)c1ccc(cc1)N)CC(C(Cc1ccccc1)NC(=O)OC1COC2C1CCO2)O)C,213039,1,0.3
dasabuvir,Mixed,Kaggle,mixed,CC(C)(C)C1=CC(=CC(=C1OC)C2=CC3=C(C=C2)C=C(C=C3)NS(=O)(=O)C)N4C=CC(=O)NC4=O,COc1c(cc(cc1C(C)(C)C)n1ccc(=O)[nH]c1=O)c1ccc2c(c1)ccc(c2)NS(=O)(=O)C,56640146,1,0.3
dolutegravir,Mixed,Kaggle,mixed,CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,Fc1ccc(c(c1)F)CNC(=O)c1cn2CC3OCCC(N3C(=O)c2c(c1=O)O)C,54726191,1,0.3
elbasvir,Mixed,Kaggle,mixed,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC4=C(C=C3)N5C(OC6=C(C5=C4)C=CC(=C6)C7=CN=C(N7)C8CCCN8C(=O)C(C(C)C)NC(=O)OC)C9=CC=CC=C9)NC(=O)OC,COC(=O)NC(C(=O)N1CCCC1c1ncc([nH]1)c1ccc2-c3cc4c(n3C(Oc2c1)c1ccccc1)ccc(c4)c1cnc([nH]1)C1CCCN1C(=O)C(C(C)C)NC(=O)OC)C(C)C,71661251,1,0.3
elvitegravir,Mixed,Kaggle,mixed,CC(C)C(CO)N1C=C(C(=O)C2=C1C=C(C(=C2)CC3=C(C(=CC=C3)Cl)F)OC)C(=O)O,OCC(n1cc(C(=O)O)c(=O)c2c1cc(OC)c(c2)Cc1cccc(c1F)Cl)C(C)C,5277135,1,0.3
entecavir,Mixed,Kaggle,mixed,C=C1C(CC(C1CO)O)N2C=NC3=C2N=C(NC3=O)N,OCC1C(O)CC(C1=C)n1cnc2c1nc(N)[nH]c2=O,135398508,1,0.3
famciclovir,Mixed,Kaggle,mixed,CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C,CC(=O)OCC(CCn1cnc2c1nc(N)nc2)COC(=O)C,3324,1,0.3
famvir,Mixed,Kaggle,mixed,CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C,CC(=O)OCC(CCn1cnc2c1nc(N)nc2)COC(=O)C,3324,1,0.3
favipiravir,Mixed,Kaggle,mixed,C1=C(N=C(C(=O)N1)C(=O)N)F,Fc1c[nH]c(=O)c(n1)C(=O)N,492405,1,0.3
fosamprenavir,Mixed,Kaggle,mixed,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N,CC(CN(S(=O)(=O)c1ccc(cc1)N)CC(C(Cc1ccccc1)NC(=O)OC1CCOC1)OP(=O)(O)O)C,131536,1,0.3
galidesivir,Mixed,Kaggle,mixed,C1=C(C2=C(N1)C(=NC=N2)N)C3C(C(C(N3)CO)O)O,OCC1NC(C(C1O)O)c1c[nH]c2c1ncnc2N,10445549,1,0.3
ganciclovir,Mixed,Kaggle,mixed,C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N,OCC(OCn1cnc2c1nc(N)[nH]c2=O)CO,135398740,1,0.3
glecaprevir,Mixed,Kaggle,mixed,CC1(CC1)S(=O)(=O)NC(=O)C2(CC2C(F)F)NC(=O)C3CC4CN3C(=O)C(NC(=O)OC5CCCC5OCC=CC(C6=NC7=CC=CC=C7N=C6O4)(F)F)C(C)(C)C,O=C1OC2CCCC2OCC=CC(F)(F)c2c(OC3CN(C(=O)C(N1)C(C)(C)C)C(C3)C(=O)NC1(CC1C(F)F)C(=O)NS(=O)(=O)C1(C)CC1)nc1c(n2)cccc1,66828839,1,0.3
grazoprevir,Mixed,Kaggle,mixed,CC(C)(C)C1C(=O)N2CC(CC2C(=O)NC3(CC3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCCC7CC7OC(=O)N1,C=CC1CC1(NC(=O)C1CC2CN1C(=O)C(NC(=O)OC1CC1CCCCCc1c(O2)nc2cc(OC)ccc2n1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,44603531,1,0.3
laninamivir,Mixed,Kaggle,mixed,CC(=O)NC1C(C=C(OC1C(C(CO)O)OC)C(=O)O)N=C(N)N,OCC(C(C1OC(=CC(C1NC(=O)C)N=C(N)N)C(=O)O)OC)O,502272,1,0.3
ledipasvir,Mixed,Kaggle,mixed,CC(C)C(C(=O)N1CC2(CC2)CC1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)C9C1CCC(C1)N9C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,COC(=O)NC(C(=O)N1CC2(CC1c1ncc([nH]1)c1ccc3-c4c(C(c3c1)(F)F)cc(cc4)c1ccc3c(c1)[nH]c(n3)C1C3CCC(N1C(=O)C(C(C)C)NC(=O)OC)C3)CC2)C(C)C,67505836,1,0.3
letermovir,Mixed,Kaggle,mixed,COC1=C(C=C(C=C1)C(F)(F)F)N2C(C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O,COc1cccc(c1)N1CCN(CC1)C1=Nc2c(F)cccc2C(N1c1cc(ccc1OC)C(F)(F)F)CC(=O)O,45138674,1,0.3
lobucavir,Mixed,Kaggle,mixed,C1C(C(C1N2C=NC3=C2N=C(NC3=O)N)CO)CO,OCC1C(CO)CC1n1cnc2c1nc(N)[nH]c2=O,135413519,1,0.3
lopinavir,Mixed,Kaggle,mixed,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727,1,0.3
maribavir,Mixed,Kaggle,mixed,CC(C)NC1=NC2=CC(=C(C=C2N1C3C(C(C(O3)CO)O)O)Cl)Cl,OCC1OC(C(C1O)O)n1c(NC(C)C)nc2c1cc(Cl)c(c2)Cl,471161,1,0.3
nelfinavir,Mixed,Kaggle,mixed,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O,OC(C(NC(=O)c1cccc(c1C)O)CSc1ccccc1)CN1CC2CCCCC2CC1C(=O)NC(C)(C)C,64143,1,0.3
ombitasvir,Mixed,Kaggle,mixed,CC(C)C(C(=O)N1CCCC1C(=O)NC2=CC=C(C=C2)C3CCC(N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(C=C5)NC(=O)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,COC(=O)NC(C(=O)N1CCCC1C(=O)Nc1ccc(cc1)C1CCC(N1c1ccc(cc1)C(C)(C)C)c1ccc(cc1)NC(=O)C1CCCN1C(=O)C(C(C)C)NC(=O)OC)C(C)C,54767916,1,0.3
oseltamivir,Mixed,Kaggle,mixed,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,CCOC(=O)C1=CC(C(C(C1)N)NC(=O)C)OC(CC)CC,65028,1,0.3
paritaprevir,Mixed,Kaggle,mixed,CC1=CN=C(C=N1)C(=O)NC2CCCCCC=CC3CC3(NC(=O)C4CC(CN4C2=O)OC5=NC6=CC=CC=C6C7=CC=CC=C75)C(=O)NS(=O)(=O)C8CC8,Cc1ncc(nc1)C(=O)NC1CCCCCC=CC2C(NC(=O)C3N(C1=O)CC(C3)Oc1nc3ccccc3c3c1cccc3)(C2)C(=O)NS(=O)(=O)C1CC1,45110509,1,0.3
penciclovir,Mixed,Kaggle,mixed,C1=NC2=C(N1CCC(CO)CO)N=C(NC2=O)N,OCC(CCn1cnc2c1nc(N)[nH]c2=O)CO,135398748,1,0.3
pencyclovir,Mixed,Kaggle,mixed,C1=NC2=C(N1CCC(CO)CO)N=C(NC2=O)N,OCC(CCn1cnc2c1nc(N)[nH]c2=O)CO,135398748,1,0.3
peramivir,Mixed,Kaggle,mixed,CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C,CCC(C(C1C(N=C(N)N)CC(C1O)C(=O)O)NC(=O)C)CC,154234,1,0.3
pibrentasvir,Mixed,Kaggle,mixed,CC(C(C(=O)N1CCCC1C2=NC3=C(N2)C=C(C(=C3)F)C4CCC(N4C5=CC(=C(C(=C5)F)N6CCC(CC6)C7=CC=C(C=C7)F)F)C8=CC9=C(C=C8F)N=C(N9)C1CCCN1C(=O)C(C(C)OC)NC(=O)OC)NC(=O)OC)OC,COC(=O)NC(C(=O)N1CCCC1c1[nH]c2c(n1)cc(c(c2)C1CCC(N1c1cc(F)c(c(c1)F)N1CCC(CC1)c1ccc(cc1)F)c1cc2[nH]c(nc2cc1F)C1CCCN1C(=O)C(C(OC)C)NC(=O)OC)F)C(OC)C,58031952,1,0.3
pimodivir,Mixed,Kaggle,mixed,C1CC2CCC1C(C2NC3=NC(=NC=C3F)C4=CNC5=C4C=C(C=N5)F)C(=O)O,OC(=O)C1C2CCC(C1Nc1nc(ncc1F)c1c[nH]c3c1cc(F)cn3)CC2,67286591,1,0.3
pirodavir,Mixed,Kaggle,mixed,CCOC(=O)C1=CC=C(C=C1)OCCC2CCN(CC2)C3=NN=C(C=C3)C,CCOC(=O)c1ccc(cc1)OCCC1CCN(CC1)c1ccc(nn1)C,71345,1,0.3
pocapavir,Mixed,Kaggle,mixed,COC1=CC(=C(C=C1)OCC2=CC=C(C=C2)COC3=C(C=CC=C3Cl)Cl)Cl,COc1ccc(c(c1)Cl)OCc1ccc(cc1)COc1c(Cl)cccc1Cl,1455,1,0.3
presatovir,Mixed,Kaggle,mixed,CC1=CN2C(=CC(=N2)C3CCCCN3C(=O)C4=C(C=CC(=C4)Cl)NS(=O)(=O)C)N=C1N5CCC(C5)N,NC1CCN(C1)c1nc2cc(nn2cc1C)C1CCCCN1C(=O)c1cc(Cl)ccc1NS(=O)(=O)C,58029842,1,0.3
raltegravir,Mixed,Kaggle,mixed,CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F,Fc1ccc(cc1)CNC(=O)c1nc(n(c(=O)c1O)C)C(NC(=O)c1nnc(o1)C)(C)C,54671008,1,0.3
remdesivir,Mixed,Kaggle,mixed,CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4,CCC(COC(=O)C(NP(=O)(Oc1ccccc1)OCC1OC(C(C1O)O)(C#N)c1ccc2n1ncnc2N)C)CC,121304016,1,0.3
ritonavir,Mixed,Kaggle,mixed,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622,1,0.3
rupintrivir,Mixed,Kaggle,mixed,CCOC(=O)C=CC(CC1CCNC1=O)NC(=O)C(CC2=CC=C(C=C2)F)CC(=O)C(C(C)C)NC(=O)C3=NOC(=C3)C,CCOC(=O)C=CC(CC1CCNC1=O)NC(=O)C(Cc1ccc(cc1)F)CC(=O)C(C(C)C)NC(=O)c1noc(c1)C,6440352,1,0.3
saquinavir,Mixed,Kaggle,mixed,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O,NC(=O)CC(C(=O)NC(C(CN1CC2CCCCC2CC1C(=O)NC(C)(C)C)O)Cc1ccccc1)NC(=O)c1ccc2c(n1)cccc2,441243,1,0.3
simeprevir,Mixed,Kaggle,mixed,CC1=C(C=CC2=C1N=C(C=C2OC3CC4C(C3)C(=O)N(CCCCC=CC5CC5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC,COc1ccc2c(c1C)nc(cc2OC1CC2C(C1)C(=O)N(C)CCCCC=CC1C(NC2=O)(C1)C(=O)NS(=O)(=O)C1CC1)c1scc(n1)C(C)C,24873435,1,0.3
sofosbuvir,Mixed,Kaggle,mixed,CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,CC(OC(=O)C(NP(=O)(Oc1ccccc1)OCC1OC(C(C1O)(C)F)n1ccc(=O)[nH]c1=O)C)C,45375808,1,0.3
telaprevir,Mixed,Kaggle,mixed,CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5,CCCC(C(=O)C(=O)NC1CC1)NC(=O)C1C2CCCC2CN1C(=O)C(C(C)(C)C)NC(=O)C(C1CCCCC1)NC(=O)c1nccnc1,3010818,1,0.3
tenofovir,Mixed,Kaggle,mixed,CC(CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O,CC(Cn1cnc2c1ncnc2N)OCP(=O)(O)O,464205,1,0.3
tipranavir,Mixed,Kaggle,mixed,CCCC1(CC(=C(C(=O)O1)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4,CCCC1(CCc2ccccc2)CC(=C(C(=O)O1)C(c1cccc(c1)NS(=O)(=O)c1ccc(cn1)C(F)(F)F)CC)O,54682461,1,0.3
umifenovir,Mixed,Kaggle,mixed,CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3,CCOC(=O)c1c(CSc2ccccc2)n(c2c1c(CN(C)C)c(O)c(c2)Br)C,131411,1,0.3
valacyclovir,Mixed,Kaggle,mixed,CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N,CC(C(C(=O)OCCOCn1cnc2c1nc(N)[nH]c2=O)N)C,135398742,1,0.3
valganciclovir,Mixed,Kaggle,mixed,CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N,OCC(OCn1cnc2c1nc(N)[nH]c2=O)COC(=O)C(C(C)C)N,135413535,1,0.3
vapendavir,Mixed,Kaggle,mixed,CCOC1=NOC2=C1C=CC(=C2)OCCC3CCN(CC3)C4=NN=C(C=C4)C,CCOc1noc2c1ccc(c2)OCCC1CCN(CC1)c1ccc(nn1)C,504457,1,0.3
velpatasvir,Mixed,Kaggle,mixed,CC1CCC(N1C(=O)C(C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)C8CC(CN8C(=O)C(C9=CC=CC=C9)NC(=O)OC)COC,COCC1CC(N(C1)C(=O)C(c1ccccc1)NC(=O)OC)c1ncc([nH]1)c1ccc2-c3cc4ccc5c(c4cc3OCc2c1)nc([nH]5)C1CCC(N1C(=O)C(C(C)C)NC(=O)OC)C,67683363,1,0.3
voxilaprevir,Mixed,Kaggle,mixed,CCC1C2CN(C1C(=O)NC3(CC3C(F)F)C(=O)NS(=O)(=O)C4(CC4)C)C(=O)C(NC(=O)OC5CC5CCCCC(C6=NC7=C(C=C(C=C7)OC)N=C6O2)(F)F)C(C)(C)C,CCC1C2CN(C1C(=O)NC1(CC1C(F)F)C(=O)NS(=O)(=O)C1(C)CC1)C(=O)C(NC(=O)OC1CC1CCCCC(c1c(O2)nc2cc(OC)ccc2n1)(F)F)C(C)(C)C,89921642,1,0.3
zanamivir,Mixed,Kaggle,mixed,CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N,OCC(C(C1OC(=CC(C1NC(=O)C)N=C(N)N)C(=O)O)O)O,60855,1,0.3
zintevir,Mixed,Kaggle,mixed,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=O)(O)OC4CC(OC4COP(=O)(O)OC5CC(OC5COP(=O)(O)OC6CC(OC6COP(=O)(O)OC7CC(OC7COP(=O)(O)OC8CC(OC8COP(=O)(O)OC9CC(OC9COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1COP(=O)(OC1CC(OC1CO)N1C=NC2=C1N=C(NC2=O)N)S)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)O,OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=S)(OCC1OC(CC1O)n1cc(C)c(=O)[nH]c1=O)O)n1cnc2c1nc(N)[nH]c2=O)O)n1cnc2c1nc(N)[nH]c2=O)O)n1cnc2c1nc(N)[nH]c2=O)O)n1cc(C)c(=O)[nH]c1=O)O)n1cnc2c1nc(N)[nH]c2=O)O)n1cnc2c1nc(N)[nH]c2=O)O)n1cnc2c1nc(N)[nH]c2=O)O)n1cc(C)c(=O)[nH]c1=O)O)n1cnc2c1nc(N)[nH]c2=O)O)n1cnc2c1nc(N)[nH]c2=O)O)n1cnc2c1nc(N)[nH]c2=O)O)n1cc(C)c(=O)[nH]c1=O)O)n1cnc2c1nc(N)[nH]c2=O)O)n1cnc2c1nc(N)[nH]c2=O)O)n1cc(C)c(=O)[nH]c1=O)S)n1cnc2c1nc(N)[nH]c2=O,16130283,1,0.3
ziresovir,Mixed,Kaggle,mixed,CC1=CC2=C(C=C1)N=C(N=C2NCC3(COC3)N)N4CCS(=O)(=O)C5=CC=CC=C5C4,Cc1ccc2c(c1)c(NCC1(N)COC1)nc(n2)N1CCS(=O)(=O)c2c(C1)cccc2,71262247,1,0.3
prulifloxacin,SARS-COV-2,10.1101/2020.01.28.922922,experimental,CC1N2C3=CC(=C(C=C3C(=O)C(=C2S1)C(=O)O)F)N4CCN(CC4)CC5=C(OC(=O)O5)C,O=c1oc(c(o1)CN1CCN(CC1)c1cc2c(cc1F)c(=O)c(c1n2C(C)S1)C(=O)O)C,65947,1,0.3
tegobuvir,SARS-COV-2,10.1101/2020.01.28.922922,experimental,C1=CC=C(C(=C1)C2=NC3=CN(C=CC3=N2)CC4=NN=C(C=C4)C5=C(C=C(C=C5)C(F)(F)F)C(F)(F)F)F,Fc1ccccc1c1nc2-c(n1)cn(cc2)Cc1ccc(nn1)c1ccc(cc1C(F)(F)F)C(F)(F)F,23649154,1,0.3
bictegravir,SARS-COV-2,10.1101/2020.01.28.922922,experimental,C1CC2CC1N3C(O2)CN4C=C(C(=O)C(=C4C3=O)O)C(=O)NCC5=C(C=C(C=C5F)F)F,Fc1cc(F)c(c(c1)F)CNC(=O)c1cn2CC3OC4CCC(N3C(=O)c2c(c1=O)O)C4,90311989,1,0.3
nelfinavir,SARS-COV-2,10.1101/2020.01.28.922922,experimental,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O,OC(C(NC(=O)c1cccc(c1C)O)CSc1ccccc1)CN1CC2CCCCC2CC1C(=O)NC(C)(C)C,64143,1,0.3
Lopinavir,SARS-COV-2,missing,experimental,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727,0,0.3
ritonavir,SARS-COV-2,missing,experimental,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622,0,0.3
favipiravir,SARS-COV-2,missing,experimental,C1=C(N=C(C(=O)N1)C(=O)N)F,Fc1c[nH]c(=O)c(n1)C(=O)N,492405,0,0.3
ribavirin,SARS-COV-2,missing,experimental,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542,0,0.3
monophosphoramidate,SARS-COV-2,missing,experimental,O[C@@H]1[C@H](O)[C@H](O[C@H]1n1cnc2c1ncnc2N)COP(=O)(N)[O-].[Na+],O[C@@H]1[C@H](O)[C@H](O[C@H]1n1cnc2c1ncnc2N)COP(=O)(N)[O-].[Na+],,0,0.3
remdesivir,SARS-COV-2,missing,experimental,CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4,CCC(COC(=O)C(NP(=O)(Oc1ccccc1)OCC1OC(C(C1O)O)(C#N)c1ccc2n1ncnc2N)C)CC,121304016,0,0.3
ASC09 (TMC-310911),SARS-COV-2,missing,experimental,CC(CN(S(=O)(=O)c1ccc2c(c1)sc(n2)NC1CCN(CC1)C1CCCC1)CC(C(Cc1ccccc1)NC(=O)OC1COC2C1CCO2)O)C,CC(CN(S(=O)(=O)c1ccc2c(c1)sc(n2)NC1CCN(CC1)C1CCCC1)CC(C(Cc1ccccc1)NC(=O)OC1COC2C1CCO2)O)C,,0,0.3
arbidol,SARS-COV-2,missing,experimental,CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3,CCOC(=O)c1c(CSc2ccccc2)n(c2c1c(CN(C)C)c(O)c(c2)Br)C,131411,0,0.3
Chlorpromazine hydrochloride,MERS-CoV/SARS-CoV,10.1128/AAC.03036-14,experimental,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl.Cl,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C.Cl,6240,0,0.3
ribavirin,MERS-CoV/SARS-CoV,10.1128/AAC.03036-14,experimental,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542,0,0.3
mycophenolic acid,MERS-CoV/SARS-CoV,10.1128/AAC.03036-14,experimental,CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O,COc1c(CC=C(CCC(=O)O)C)c(O)c2c(c1C)COC2=O,446541,0,0.3
Disulfiram,SARS-COV-2,https://blogs.sciencemag.org/pipeline/archives/2020/03/27/known-drugs-against-the-coronovirus-runner-up-candidates,experimental,CCN(CC)C(=S)SSC(=S)N(CC)CC,CCN(C(=S)SSC(=S)N(CC)CC)CC,3117,0,0.3
Nitazoxonide,SARS-COV-2,https://blogs.sciencemag.org/pipeline/archives/2020/03/27/known-drugs-against-the-coronovirus-runner-up-candidates,experimental,CC(=O)Oc1ccccc1C(=O)Nc1ncc(s1)[N+](=O)[O-],CC(=O)Oc1ccccc1C(=O)Nc1ncc(s1)[N+](=O)[O-],,0,0.3
Niclosamide,SARS-COV-2,https://blogs.sciencemag.org/pipeline/archives/2020/03/27/known-drugs-against-the-coronovirus-runner-up-candidates,experimental,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,Clc1ccc(c(c1)C(=O)Nc1ccc(cc1Cl)[N+](=O)[O-])O,4477,0,0.3
ciclesonide,SARS-COV-2,https://blogs.sciencemag.org/pipeline/archives/2020/03/27/known-drugs-against-the-coronovirus-runner-up-candidates,experimental,CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6,O=C(C(C)C)OCC(=O)C12OC(OC1CC1C2(C)CC(O)C2C1CCC1=CC(=O)C=CC21C)C1CCCCC1,6918155,0,0.3
quercetin,SARS-COV-2,https://blogs.sciencemag.org/pipeline/archives/2020/03/27/known-drugs-against-the-coronovirus-runner-up-candidates,experimental,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,Oc1cc(O)c2c(c1)oc(c(c2=O)O)c1ccc(c(c1)O)O,5280343,0,0.3
tetra-O-galloyl-D-glucose (TGG),SARS-COV-2,10.1128/JVI.78.20.11334–11339.2004,experimental,OC1C(OC(C(C1OC(=O)c1cc(O)c(c(c1)O)O)OC(=O)c1cc(O)c(c(c1)O)O)COC(=O)c1cc(O)c(c(c1)O)O)OC(=O)c1cc(O)c(c(c1)O)O,OC1C(OC(C(C1OC(=O)c1cc(O)c(c(c1)O)O)OC(=O)c1cc(O)c(c(c1)O)O)COC(=O)c1cc(O)c(c(c1)O)O)OC(=O)c1cc(O)c(c(c1)O)O,,0,0.3
luteolin,SARS-COV-2,10.1128/JVI.78.20.11334–11339.2004,experimental,C1=CC(=C(C=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O)O,Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O,5280445,0,0.3
Scutellarein,SARS,10.7150/ijbs.45538,experimental,C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=C(C(=C3O)O)O)O,Oc1ccc(cc1)c1cc(=O)c2c(o1)cc(c(c2O)O)O,5281697,0,0.3
Glycyrrhizin,SARS,10.7150/ijbs.45538,experimental,CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C,OC1C(OC2OC(C(=O)O)C(C(C2O)O)O)C(OC(C1O)C(=O)O)OC1CCC2(C(C1(C)C)CCC1(C2C(=O)C=C2C1(C)CCC1(C2CC(C)(CC1)C(=O)O)C)C)C,14982,0,0.3
Herbacetin,MERS,10.7150/ijbs.45538,experimental,C1=CC(=CC=C1C2=C(C(=O)C3=C(O2)C(=C(C=C3O)O)O)O)O,Oc1ccc(cc1)c1oc2c(O)c(O)cc(c2c(=O)c1O)O,5280544,0,0.3
helichrysetin,MERS,10.7150/ijbs.45538,experimental,COC1=CC(=CC(=C1C(=O)C=CC2=CC=C(C=C2)O)O)O,COc1cc(O)cc(c1C(=O)C=Cc1ccc(cc1)O)O,6253344,0,0.3
Tetrandrine,SARS,10.7150/ijbs.45538,experimental,CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=C(O3)C(=C(C=C7CCN6C)OC)OC)OC)OC,COc1c(OC)cc2c3c1Oc1cc4c(cc1OC)CCN(C4Cc1ccc(Oc4cc(CC3N(CC2)C)ccc4OC)cc1)C,73078,0,0.3
fangchinoline,SARS,10.7150/ijbs.45538,experimental,CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=C(O3)C(=C(C=C7CCN6C)OC)O)OC)OC,COc1cc2CCN(C3c2c(c1O)Oc1cc2c(cc1OC)CCN(C2Cc1ccc(Oc2cc(C3)ccc2OC)cc1)C)C,73481,0,0.3
cepharanthine,SARS,10.7150/ijbs.45538,experimental,CN1CCC2=CC3=C(C4=C2C1CC5=CC=C(C=C5)OC6=C(C=CC(=C6)CC7C8=CC(=C(C=C8CCN7C)OC)O4)OC)OCO3,COc1cc2CCN(C3c2cc1Oc1c2c(CCN(C2Cc2ccc(Oc4cc(C3)ccc4OC)cc2)C)cc2c1OCO2)C,10206,0,0.3
pectolinarin,SARS,10.7150/ijbs.45538,experimental,CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(C(=C4C(=C3)OC(=CC4=O)C5=CC=C(C=C5)OC)O)OC)O)O)O)O)O)O,COc1c(OC2OC(COC3OC(C)C(C(C3O)O)O)C(C(C2O)O)O)cc2c(c1O)c(=O)cc(o2)c1ccc(cc1)OC,168849,0,0.3
epigallocatechin gallate,SARS,10.7150/ijbs.45538,experimental,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O,Oc1cc(O)c2c(c1)OC(C(C2)OC(=O)c1cc(O)c(c(c1)O)O)c1cc(O)c(c(c1)O)O,65064,0,0.3
gallocatechin gallate,SARS,10.7150/ijbs.45538,experimental,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O,Oc1cc(O)c2c(c1)OC(C(C2)OC(=O)c1cc(O)c(c(c1)O)O)c1cc(O)c(c(c1)O)O,199472,0,0.3
Emodin,SARS,10.7150/ijbs.45538,experimental,CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O)O,Cc1cc(O)c2c(c1)C(=O)c1c(C2=O)c(O)cc(c1)O,3220,0,0.3
Baicalin,SARS,10.7150/ijbs.45538,experimental,C1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)C(=O)O)O)O)O)O)O,OC(=O)C1OC(Oc2cc3oc(cc(=O)c3c(c2O)O)c2ccccc2)C(C(C1O)O)O,64982,0,0.3
Imatinib mesylate,MERS-CoV/SARS-CoV,10.1128/AAC.03036-14,experimental,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,CS(=O)(=O)O.CN1CCN(CC1)Cc1ccc(cc1)C(=O)Nc1ccc(c(c1)Nc1nccc(n1)c1cccnc1)C,123596,0,0.3
gemcitabine hydrochloride,MERS-CoV/SARS-CoV,10.1128/AAC.03036-14,experimental,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F.Cl,OCC1OC(C(C1O)(F)F)n1ccc(nc1=O)N.Cl,60749,0,0.3
toremifene citrate,MERS-CoV/SARS-CoV,10.1128/AAC.03036-14,experimental,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,OC(=O)C(CC(=O)O)(CC(=O)O)O.ClCCC(=C(c1ccccc1)c1ccc(cc1)OCCN(C)C)c1ccccc1,3005572,0,0.3
Triflupromazine hydrochloride,MERS-CoV/SARS-CoV,10.1128/AAC.03036-14,experimental,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F.Cl,CN(CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F)C.Cl,66069,0,0.3
Dasatinib,MERS-CoV/SARS-CoV,10.1128/AAC.03036-14,experimental,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,OCCN1CCN(CC1)c1cc(nc(n1)C)Nc1ncc(s1)C(=O)Nc1c(C)cccc1Cl,3062316,0,0.3
Dimethyl sulfoxide,MERS-CoV/SARS-CoV,10.1128/AAC.03036-14,experimental,CS(=O)C,CS(=O)C,679,0,0.3
Toremifene citrate,MERS-CoV/SARS-CoV,10.1128/AAC.03036-14,experimental,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,OC(=O)C(CC(=O)O)(CC(=O)O)O.ClCCC(=C(c1ccccc1)c1ccc(cc1)OCCN(C)C)c1ccccc1,3005572,0,0.3
chloroquine,MERS-CoV/SARS-CoV,10.1128/AAC.03036-14,experimental,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,2719,0,0.3
Lasinavir,SARS-COV-2,https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032712,computational,CC(C)C(C(=O)NCCOC)NC(=O)C(CC1=C(C(=C(C=C1)OC)OC)OC)CC(C(CC2=CC=CC=C2)NC(=O)OC(C)(C)C)O,COCCNC(=O)C(C(C)C)NC(=O)C(Cc1ccc(c(c1OC)OC)OC)CC(C(Cc1ccccc1)NC(=O)OC(C)(C)C)O,464372,0,0.3
Brecanavir,SARS-COV-2,https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032712,computational,CC1=NC(=CS1)COC2=CC=C(C=C2)CC(C(CN(CC(C)C)S(=O)(=O)C3=CC4=C(C=C3)OCO4)O)NC(=O)OC5COC6C5CCO6,CC(CN(S(=O)(=O)c1ccc2c(c1)OCO2)CC(C(Cc1ccc(cc1)OCc1csc(n1)C)NC(=O)OC1COC2C1CCO2)O)C,5743186,0,0.3
Telinavir,SARS-COV-2,https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032713,computational,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)C(CC(=O)N)NC(=O)C2=NC3=CC=CC=C3C=C2)O)C(=O)NC(C)(C)C,CC(CN(C(=O)NC(C)(C)C)CC(C(NC(=O)C(NC(=O)c1ccc2c(n1)cccc2)CC(=O)N)Cc1ccccc1)O)C,382974,0,0.3
Rotigaptide,SARS-COV-2,https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032714,computational,CC(C(=O)NCC(=O)N)NC(=O)CNC(=O)C1CC(CN1C(=O)C2CCCN2C(=O)C(CC3=CC=C(C=C3)O)NC(=O)C)O,OC1CC(N(C1)C(=O)C1CCCN1C(=O)C(Cc1ccc(cc1)O)NC(=O)C)C(=O)NCC(=O)NC(C(=O)NCC(=O)N)C,9938933,0,0.3
Pimelautide,SARS-COV-2,https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032715,computational,CCCCCCCCCCCC(=O)NC(C)C(=O)NC(CCC(=O)NC(CCCC(C(=O)N)NC(=O)CN)C(=O)O)C(=O)O,CCCCCCCCCCCC(=O)NC(C(=O)NC(C(=O)O)CCC(=O)NC(C(=O)O)CCCC(C(=O)N)NC(=O)CN)C,70697634,0,0.3
"1,3-Bis-(2-ethoxycarbonylchromon-5-yloxy)-2-(lysyloxy)propane",SARS-COV-2,https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032716,computational,CCOC(=O)C1=CC(=O)C2=C(O1)C=CC=C2OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)OCC)OC(=O)C(CCCCN)N.Cl.Cl,NCCCCC(C(=O)OC(COc1cccc2c1c(=O)cc(o2)C(=O)OCC)COc1cccc2c1c(=O)cc(o2)C(=O)OCC)N.Cl.Cl,196638,0,0.3
Ociltide,SARS-COV-2,https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032717,computational,C1CSC(=O)C1NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)C(CCCCNC=O)NC(=O)C(CC3=CC=C(C=C3)O)N,O=CNCCCCC(C(=O)NCC(=O)NC(C(=O)NC1CCSC1=O)Cc1ccccc1)NC(=O)C(Cc1ccc(cc1)O)N,76965368,0,0.3
Arzoxifene,SARS-COV-2,https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032718,computational,COC1=CC=C(C=C1)C2=C(C3=C(S2)C=C(C=C3)O)OC4=CC=C(C=C4)OCCN5CCCCC5,COc1ccc(cc1)c1sc2c(c1Oc1ccc(cc1)OCCN1CCCCC1)ccc(c2)O,179337,0,0.3
Tertamyloxycarbonyltetragastrin,SARS-COV-2,https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032719,computational,,,,0,0.3
Truxicurium,SARS-COV-2,https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032720,computational,CC[N+](C)(CC)CCCOC(=O)C1C(C(C1C2=CC=CC=C2)C(=O)OCCC[N+](C)(CC)CC)C3=CC=CC=C3,CC[N+](CCCOC(=O)C1C(c2ccccc2)C(C1c1ccccc1)C(=O)OCCC[N+](CC)(CC)C)(CC)C,20290,0,0.3
Ivermectin,SARS-COV-2,10.1016/j.antiviral.2020.104787,experimental,CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C,COC1CC(OC2C(C)C=CC=C3COC4C3(O)C(C=C(C4O)C)C(=O)OC3CC(CC=C2C)OC2(C3)CCC(C(O2)C(CC)C)C)OC(C1OC1CC(OC)C(C(O1)C)O)C,6321424,0,0.3
Oseltamivir,SARS-COV-2,https://doi.org/10.1101/2020.03.09.20033068,experimental,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,CCOC(=O)C1=CC(C(C(C1)N)NC(=O)C)OC(CC)CC,65028,0,0.3
Ribavirin,SARS-COV-2,https://doi.org/10.1101/2020.03.09.20033068,experimental,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542,0,0.3
Lopinavir,SARS-COV-2,https://doi.org/10.1101/2020.03.09.20033068,experimental,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727,0,0.3
Ritonavir,SARS-COV-2,https://doi.org/10.1101/2020.03.09.20033068,experimental,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622,0,0.3
Ganciclovir,SARS-COV-2,https://doi.org/10.1101/2020.03.09.20033068,experimental,C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N,OCC(OCn1cnc2c1nc(N)[nH]c2=O)CO,135398740,0,0.3
Lopinavir/Ritonavir,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O.CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C.O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,11979606,0,0.3
Chloroquine phosphate,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl.OP(=O)(O)O.OP(=O)(O)O,OP(=O)(O)O.OP(=O)(O)O.CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,64927,0,0.3
Umifenovir,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3,CCOC(=O)c1c(CSc2ccccc2)n(c2c1c(CN(C)C)c(O)c(c2)Br)C,131411,0,0.3
Hydroxychloroquine,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,OCCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,3652,0,0.3
Favipiravir,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,C1=C(N=C(C(=O)N1)C(=O)N)F,Fc1c[nH]c(=O)c(n1)C(=O)N,492405,0,0.3
Methylprednisolone,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,OCC(=O)C1(O)CCC2C1(C)CC(O)C1C2CC(C2=CC(=O)C=CC12C)C,6741,0,0.3
Remdesivir,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4,CCC(COC(=O)C(NP(=O)(Oc1ccccc1)OCC1OC(C(C1O)O)(C#N)c1ccc2n1ncnc2N)C)CC,121304016,0,0.3
Oseltamivir,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,CCOC(=O)C1=CC(C(C(C1)N)NC(=O)C)OC(CC)CC,65028,0,0.3
Baloxavir Marboxil,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,COC(=O)OCOC1=C2C(=O)N3CCOCC3N(N2C=CC1=O)C4C5=C(CSC6=CC=CC=C46)C(=C(C=C5)F)F,COC(=O)OCOc1c(=O)ccn2c1C(=O)N1CCOCC1N2C1c2ccccc2SCc2c1ccc(c2F)F,124081896,0,0.3
Thalidomide,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,O=C1CCC(C(=O)N1)N1C(=O)c2c(C1=O)cccc2,5426,0,0.3
Darunavir,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,CC(CN(S(=O)(=O)c1ccc(cc1)N)CC(C(Cc1ccccc1)NC(=O)OC1COC2C1CCO2)O)C,213039,0,0.3
cobicistat,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5,O=C(NC(Cc1ccccc1)CCC(Cc1ccccc1)NC(=O)C(NC(=O)N(Cc1csc(n1)C(C)C)C)CCN1CCOCC1)OCc1cncs1,25151504,0,0.3
Thymosin,SARS-COV-2,10.1101/2020.03.18.20038190v2,,CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NC(CCC(=O)O)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CS)N,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CCC(=O)O)C)CCC(=O)O)CCC(=O)O)C(C)C)C(C)C)CCC(=O)O)CCCCN)CCCCN)CCC(=O)O)CCCCN)CC(C)C)CC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(O)C)NC(=O)C(C(CC)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(CS)N)CO)CC(=O)O)C)C)CC(=O)O)CO)CO)CCC(=O)O,44286042,0,0.3
hydroxychloroquine,SARS-COV-2,10.1101/2020.03.25.008482v1,,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,OCCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,3652,0,0.3
chloroquine phosphate,SARS-COV-2,10.1101/2020.03.25.008482v1,,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl.OP(=O)(O)O.OP(=O)(O)O,OP(=O)(O)O.OP(=O)(O)O.CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,64927,0,0.3
Decitabine,SARS-COV-2,10.20944/preprints202003.0279.v1,experimental,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,OCC1OC(CC1O)n1cnc(nc1=O)N,451668,0,0.3
Omeprazole,SARS-COV-2,10.20944/preprints202003.0279.v1,experimental,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,COc1ccc2c(c1)[nH]c(n2)S(=O)Cc1ncc(c(c1C)OC)C,4594,0,0.3
Icatibant,SARS-COV-2,10.20944/preprints202003.0279.v1,experimental,C1CCC2C(C1)CC(N2C(=O)C3CC4=CC=CC=C4CN3C(=O)C(CO)NC(=O)C(CC5=CC=CS5)NC(=O)CNC(=O)C6CC(CN6C(=O)C7CCCN7C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)O)C(=O)NC(CCCN=C(N)N)C(=O)O,OCC(C(=O)N1Cc2ccccc2CC1C(=O)N1C2CCCCC2CC1C(=O)NC(C(=O)O)CCCN=C(N)N)NC(=O)C(Cc1cccs1)NC(=O)CNC(=O)C1CC(CN1C(=O)C1CCCN1C(=O)C(NC(=O)C(CCCN=C(N)N)N)CCCN=C(N)N)O,6918173,0,0.3
Atazanavir,SARS-COV-2,10.20944/preprints202003.0279.v1,experimental,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,COC(=O)NC(C(C)(C)C)C(=O)NN(Cc1ccc(cc1)c1ccccn1)CC(C(Cc1ccccc1)NC(=O)C(C(C)(C)C)NC(=O)OC)O,148192,0,0.3
Ceftolozane,SARS-COV-2,10.20944/preprints202003.0279.v1,experimental,CC(C)(C(=O)O)ON=C(C1=NSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC(=C(N4C)N)NC(=O)NCCN)C(=O)[O-],NCCNC(=O)Nc1c[n+](n(c1N)C)CC1=C(C(=O)[O-])N2C(SC1)C(C2=O)NC(=O)C(=NOC(C(=O)O)(C)C)c1nsc(n1)N,53234134,0,0.3
Hesperidin,SARS-COV-2,10.20944/preprints202003.0279.v1,experimental,CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC(=C4C(=O)CC(OC4=C3)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O,COc1ccc(cc1O)C1CC(=O)c2c(O1)cc(cc2O)OC1OC(COC2OC(C)C(C(C2O)O)O)C(C(C1O)O)O,10621,0,0.3
Carfilzomib,SARS-COV-2,10.20944/preprints202003.0279.v1,experimental,CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,CC(CC(C(=O)NC(C(=O)NC(C(=O)C1(C)CO1)CC(C)C)Cc1ccccc1)NC(=O)C(NC(=O)CN1CCOCC1)CCc1ccccc1)C,11556711,0,0.3
Oseltamivir,SARS-COV-2,10.1016/j.jaut.2020.102433,experimental,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,CCOC(=O)C1=CC(C(C(C1)N)NC(=O)C)OC(CC)CC,65028,0,0.3
Lopinavir,SARS-COV-2,10.1016/j.jaut.2020.102433,experimental,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727,0,0.3
Ritonavir,SARS-COV-2,10.1016/j.jaut.2020.102433,experimental,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622,0,0.3
Ganciclovir,SARS-COV-2,10.1016/j.jaut.2020.102433,experimental,C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N,OCC(OCn1cnc2c1nc(N)[nH]c2=O)CO,135398740,0,0.3
Remdesivir,SARS-COV-2,10.1016/j.jaut.2020.102433,experimental,CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4,CCC(COC(=O)C(NP(=O)(Oc1ccccc1)OCC1OC(C(C1O)O)(C#N)c1ccc2n1ncnc2N)C)CC,121304016,0,0.3
Chloroquine,SARS-COV-2,10.1016/j.jaut.2020.102433,experimental,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,2719,0,0.3
EIDD-2801,SARS-COV-2,10.1016/j.jaut.2020.102433,experimental,CC(C)C(=O)OCC1C(C(C(O1)N2C=CC(=NC2=O)NO)O)O,ONc1ccn(c(=O)n1)C1OC(C(C1O)O)COC(=O)C(C)C,145996610,0,0.3
Cepharanthine,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,CN1CCC2=CC3=C(C4=C2C1CC5=CC=C(C=C5)OC6=C(C=CC(=C6)CC7C8=CC(=C(C=C8CCN7C)OC)O4)OC)OCO3,COc1cc2CCN(C3c2cc1Oc1c2c(CCN(C2Cc2ccc(Oc4cc(C3)ccc4OC)cc2)C)cc2c1OCO2)C,10206,0,0.3
Tegobuvir,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,C1=CC=C(C(=C1)C2=NC3=CN(C=CC3=N2)CC4=NN=C(C=C4)C5=C(C=C(C=C5)C(F)(F)F)C(F)(F)F)F,Fc1ccccc1c1nc2-c(n1)cn(cc2)Cc1ccc(nn1)c1ccc(cc1C(F)(F)F)C(F)(F)F,23649154,0,0.3
Saquinavir,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O,NC(=O)CC(C(=O)NC(C(CN1CC2CCCCC2CC1C(=O)NC(C)(C)C)O)Cc1ccccc1)NC(=O)c1ccc2c(n1)cccc2,441243,0,0.3
Tipranavir,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,CCCC1(CC(=C(C(=O)O1)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4,CCCC1(CCc2ccccc2)CC(=C(C(=O)O1)C(c1cccc(c1)NS(=O)(=O)c1ccc(cn1)C(F)(F)F)CC)O,54682461,0,0.3
Lonafarnib,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,C1CN(CCC1CC(=O)N2CCC(CC2)C3C4=C(CCC5=C3N=CC(=C5)Br)C=C(C=C4Br)Cl)C(=O)N,Clc1cc(Br)c2c(c1)CCc1c(C2C2CCN(CC2)C(=O)CC2CCN(CC2)C(=O)N)ncc(c1)Br,148195,0,0.3
Filibuvir,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,CCC1=CC(=CC(=N1)CC)CCC2(CC(=C(C(=O)O2)CC3=NN4C(=CC(=NC4=N3)C)C)O)C5CCCC5,CCc1cc(CCC2(CC(=C(C(=O)O2)Cc2nn3c(n2)nc(cc3C)C)O)C2CCCC2)cc(n1)CC,54708673,0,0.3
Olysio,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,CC1=C(C=CC2=C1N=C(C=C2OC3CC4C(C3)C(=O)N(CCCCC=CC5CC5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC,COc1ccc2c(c1C)nc(cc2OC1CC2C(C1)C(=O)N(C)CCCCC=CC1C(NC2=O)(C1)C(=O)NS(=O)(=O)C1CC1)c1scc(n1)C(C)C,24873435,0,0.3
Beclabuvir,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,CN1CC2CCC(C1)N2C(=O)C34CC3C5=C(C=CC(=C5)OC)C6=C(C7=C(N6C4)C=C(C=C7)C(=O)NS(=O)(=O)N(C)C)C8CCCCC8,COc1ccc2-c3c(C4CCCCC4)c4c(n3CC3(C(c2c1)C3)C(=O)N1C2CCC1CN(C2)C)cc(cc4)C(=O)NS(=O)(=O)N(C)C,49773361,0,0.3
Saquinavir,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O,NC(=O)CC(C(=O)NC(C(CN1CC2CCCCC2CC1C(=O)NC(C)(C)C)O)Cc1ccccc1)NC(=O)c1ccc2c(n1)cccc2,441243,0,0.3
Methylprednisolone,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,OCC(=O)C1(O)CCC2C1(C)CC(O)C1C2CC(C2=CC(=O)C=CC12C)C,6741,0,0.3
Thalidomide,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,O=C1CCC(C(=O)N1)N1C(=O)c2c(C1=O)cccc2,5426,0,0.3
Nilotinib,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,Cc1ncn(c1)c1cc(NC(=O)c2ccc(c(c2)Nc2nccc(n2)c2cccnc2)C)cc(c1)C(F)(F)F,644241,0,0.3
Tadalafil,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,O=C1N(C)CC(=O)N2C1Cc1c(C2c2ccc3c(c2)OCO3)[nH]c2c1cccc2,110635,0,0.3
Lifitegrast,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,CS(=O)(=O)C1=CC=CC(=C1)CC(C(=O)O)NC(=O)C2=C(C=C3CN(CCC3=C2Cl)C(=O)C4=CC5=C(C=C4)C=CO5)Cl,OC(=O)C(NC(=O)c1c(Cl)cc2c(c1Cl)CCN(C2)C(=O)c1ccc2c(c1)occ2)Cc1cccc(c1)S(=O)(=O)C,11965427,0,0.3
Digitoxin,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CCC7(C6(CCC7C8=CC(=O)OC8)O)C)C)C)C)O)O,O=C1OCC(=C1)C1CCC2(C1(C)CCC1C2CCC2C1(C)CCC(C2)OC1CC(O)C(C(O1)C)OC1CC(O)C(C(O1)C)OC1CC(O)C(C(O1)C)O)O,441207,0,0.3
Tirilazad,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,CC1CC2C3CCC4=CC(=O)C=CC4(C3=CCC2(C1C(=O)CN5CCN(CC5)C6=NC(=NC(=C6)N7CCCC7)N8CCCC8)C)C,O=C1C=CC2(C(=C1)CCC1C2=CCC2(C1CC(C2C(=O)CN1CCN(CC1)c1cc(nc(n1)N1CCCC1)N1CCCC1)C)C)C,104903,0,0.3
Danoprevir,SARS-COV-2,10.1101/2020.03.22.20034041,experimental,CC(C)(C)OC(=O)NC1CCCCCC=CC2CC2(NC(=O)C3CC(CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)NS(=O)(=O)C6CC6,O=C(OC(C)(C)C)NC1CCCCCC=CC2C(NC(=O)C3N(C1=O)CC(C3)OC(=O)N1Cc3c(C1)cccc3F)(C2)C(=O)NS(=O)(=O)C1CC1,11285588,0,0.3
Ritonavir,SARS-COV-2,10.1101/2020.03.22.20034041,experimental,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622,0,0.3
Catechin Gallate,SARS,10.2147/IJN.S31379,experimental,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O,Oc1cc(O)c2c(c1)OC(C(C2)OC(=O)c1cc(O)c(c(c1)O)O)c1ccc(c(c1)O)O,6419835,0,0.3
Gallocatechin Gallate,SARS,10.2147/IJN.S31379,experimental,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O,Oc1cc(O)c2c(c1)OC(C(C2)OC(=O)c1cc(O)c(c(c1)O)O)c1cc(O)c(c(c1)O)O,199472,0,0.3
Lopinavir,SARS/MERS,10.1016/j.antiviral.2013.08.015,experimental,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727,0,0.3
Ritonavir,SARS/MERS,10.1016/j.antiviral.2013.08.015,experimental,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622,0,0.3
Losartan,SARS-CoV-2,10.1002/ddr.21656,experimental,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,CCCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CO)Cl,3961,0,0.3
Telmisartan,SARS-CoV-2,10.1002/ddr.21656,experimental,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2,65999,0,0.3
Chloroquine,SARS-CoV-2,10.1002/ddr.21656,experimental,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,2719,0,0.3
Favipiravir,SARS-CoV-2,10.1002/ddr.21656,experimental,C1=C(N=C(C(=O)N1)C(=O)N)F,Fc1c[nH]c(=O)c(n1)C(=O)N,492405,0,0.3
Remdesivir,SARS-CoV-2,10.1002/ddr.21656,experimental,CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4,CCC(COC(=O)C(NP(=O)(Oc1ccccc1)OCC1OC(C(C1O)O)(C#N)c1ccc2n1ncnc2N)C)CC,121304016,0,0.3
Lopinavir,SARS-COV-2,10.31219/osf.io/hczra,experimental,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727,0,0.3
Ritonavir,SARS-COV-2,10.31219/osf.io/hczra,experimental,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622,0,0.3
Atazanavir,SARS-COV-2,10.31219/osf.io/hczra,experimental,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,COC(=O)NC(C(C)(C)C)C(=O)NN(Cc1ccc(cc1)c1ccccn1)CC(C(Cc1ccccc1)NC(=O)C(C(C)(C)C)NC(=O)OC)O,148192,0,0.3
Carfilzomib,SARS-COV-2,10.31219/osf.io/hczra,experimental,CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,CC(CC(C(=O)NC(C(=O)NC(C(=O)C1(C)CO1)CC(C)C)Cc1ccccc1)NC(=O)C(NC(=O)CN1CCOCC1)CCc1ccccc1)C,11556711,0,0.3
Cobicistat,SARS-COV-2,10.31219/osf.io/hczra,experimental,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5,O=C(NC(Cc1ccccc1)CCC(Cc1ccccc1)NC(=O)C(NC(=O)N(Cc1csc(n1)C(C)C)C)CCN1CCOCC1)OCc1cncs1,25151504,0,0.3
Ombitasvir,SARS-COV-2,10.31219/osf.io/hczra,experimental,CC(C)C(C(=O)N1CCCC1C(=O)NC2=CC=C(C=C2)C3CCC(N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(C=C5)NC(=O)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,COC(=O)NC(C(=O)N1CCCC1C(=O)Nc1ccc(cc1)C1CCC(N1c1ccc(cc1)C(C)(C)C)c1ccc(cc1)NC(=O)C1CCCN1C(=O)C(C(C)C)NC(=O)OC)C(C)C,54767916,0,0.3
Lopinavir,SARS,10.1007+s10156-003-0296-9,experimental,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727,0,0.3
Ritonavir,SARS,10.1007+s10156-003-0296-9,experimental,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622,0,0.3
Ribavirin,SARS,10.1007+s10156-003-0296-9,experimental,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542,0,0.3
Glycyrrhizin,SARS,10.1007+s10156-003-0296-9,experimental,CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C,OC1C(OC2OC(C(=O)O)C(C(C2O)O)O)C(OC(C1O)C(=O)O)OC1CCC2(C(C1(C)C)CCC1(C2C(=O)C=C2C1(C)CCC1(C2CC(C)(CC1)C(=O)O)C)C)C,14982,0,0.3
Chlorpromazine,MERS,10.1016/j.onehlt.2016.12.001,experimental,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,2726,0,0.3
Chloroquine,MERS,10.1016/j.onehlt.2016.12.001,experimental,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,2719,0,0.3
Beclabuvir,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,CN1CC2CCC(C1)N2C(=O)C34CC3C5=C(C=CC(=C5)OC)C6=C(C7=C(N6C4)C=C(C=C7)C(=O)NS(=O)(=O)N(C)C)C8CCCCC8,COc1ccc2-c3c(C4CCCCC4)c4c(n3CC3(C(c2c1)C3)C(=O)N1C2CCC1CN(C2)C)cc(cc4)C(=O)NS(=O)(=O)N(C)C,49773361,0,0.3
Saquinavir,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O,NC(=O)CC(C(=O)NC(C(CN1CC2CCCCC2CC1C(=O)NC(C)(C)C)O)Cc1ccccc1)NC(=O)c1ccc2c(n1)cccc2,441243,0,0.3
Methylprednisolone,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,OCC(=O)C1(O)CCC2C1(C)CC(O)C1C2CC(C2=CC(=O)C=CC12C)C,6741,0,0.3
Thalidomide,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,O=C1CCC(C(=O)N1)N1C(=O)c2c(C1=O)cccc2,5426,0,0.3
Nilotinib,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,Cc1ncn(c1)c1cc(NC(=O)c2ccc(c(c2)Nc2nccc(n2)c2cccnc2)C)cc(c1)C(F)(F)F,644241,0,0.3
Tadalafil,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,O=C1N(C)CC(=O)N2C1Cc1c(C2c2ccc3c(c2)OCO3)[nH]c2c1cccc2,110635,0,0.3
Lifitegrast,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,CS(=O)(=O)C1=CC=CC(=C1)CC(C(=O)O)NC(=O)C2=C(C=C3CN(CCC3=C2Cl)C(=O)C4=CC5=C(C=C4)C=CO5)Cl,OC(=O)C(NC(=O)c1c(Cl)cc2c(c1Cl)CCN(C2)C(=O)c1ccc2c(c1)occ2)Cc1cccc(c1)S(=O)(=O)C,11965427,0,0.3
Digitoxin,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CCC7(C6(CCC7C8=CC(=O)OC8)O)C)C)C)C)O)O,O=C1OCC(=C1)C1CCC2(C1(C)CCC1C2CCC2C1(C)CCC(C2)OC1CC(O)C(C(O1)C)OC1CC(O)C(C(O1)C)OC1CC(O)C(C(O1)C)O)O,441207,0,0.3
Tirilazad,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,CC1CC2C3CCC4=CC(=O)C=CC4(C3=CCC2(C1C(=O)CN5CCN(CC5)C6=NC(=NC(=C6)N7CCCC7)N8CCCC8)C)C,O=C1C=CC2(C(=C1)CCC1C2=CCC2(C1CC(C2C(=O)CN1CCN(CC1)c1cc(nc(n1)N1CCCC1)N1CCCC1)C)C)C,104903,0,0.3
Cepharanthine,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,CN1CCC2=CC3=C(C4=C2C1CC5=CC=C(C=C5)OC6=C(C=CC(=C6)CC7C8=CC(=C(C=C8CCN7C)OC)O4)OC)OCO3,COc1cc2CCN(C3c2cc1Oc1c2c(CCN(C2Cc2ccc(Oc4cc(C3)ccc4OC)cc2)C)cc2c1OCO2)C,10206,0,0.3
Tegobuvir,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,C1=CC=C(C(=C1)C2=NC3=CN(C=CC3=N2)CC4=NN=C(C=C4)C5=C(C=C(C=C5)C(F)(F)F)C(F)(F)F)F,Fc1ccccc1c1nc2-c(n1)cn(cc2)Cc1ccc(nn1)c1ccc(cc1C(F)(F)F)C(F)(F)F,23649154,0,0.3
Saquinavir,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O,NC(=O)CC(C(=O)NC(C(CN1CC2CCCCC2CC1C(=O)NC(C)(C)C)O)Cc1ccccc1)NC(=O)c1ccc2c(n1)cccc2,441243,0,0.3
Tipranavir,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,CCCC1(CC(=C(C(=O)O1)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4,CCCC1(CCc2ccccc2)CC(=C(C(=O)O1)C(c1cccc(c1)NS(=O)(=O)c1ccc(cn1)C(F)(F)F)CC)O,54682461,0,0.3
Lonafarnib,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,C1CN(CCC1CC(=O)N2CCC(CC2)C3C4=C(CCC5=C3N=CC(=C5)Br)C=C(C=C4Br)Cl)C(=O)N,Clc1cc(Br)c2c(c1)CCc1c(C2C2CCN(CC2)C(=O)CC2CCN(CC2)C(=O)N)ncc(c1)Br,148195,0,0.3
Filibuvir,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,CCC1=CC(=CC(=N1)CC)CCC2(CC(=C(C(=O)O2)CC3=NN4C(=CC(=NC4=N3)C)C)O)C5CCCC5,CCc1cc(CCC2(CC(=C(C(=O)O2)Cc2nn3c(n2)nc(cc3C)C)O)C2CCCC2)cc(n1)CC,54708673,0,0.3
Olysio,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,CC1=C(C=CC2=C1N=C(C=C2OC3CC4C(C3)C(=O)N(CCCCC=CC5CC5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC,COc1ccc2c(c1C)nc(cc2OC1CC2C(C1)C(=O)N(C)CCCCC=CC1C(NC2=O)(C1)C(=O)NS(=O)(=O)C1CC1)c1scc(n1)C(C)C,24873435,0,0.3
Decitabine,SARS-COV-2,10.20944/preprints202003.0279.v1,computational,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,OCC1OC(CC1O)n1cnc(nc1=O)N,451668,0,0.3
Omeprazole,SARS-COV-2,10.20944/preprints202003.0279.v1,computational,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,COc1ccc2c(c1)[nH]c(n2)S(=O)Cc1ncc(c(c1C)OC)C,4594,0,0.3
Icatibant,SARS-COV-2,10.20944/preprints202003.0279.v1,computational,C1CCC2C(C1)CC(N2C(=O)C3CC4=CC=CC=C4CN3C(=O)C(CO)NC(=O)C(CC5=CC=CS5)NC(=O)CNC(=O)C6CC(CN6C(=O)C7CCCN7C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)O)C(=O)NC(CCCN=C(N)N)C(=O)O,OCC(C(=O)N1Cc2ccccc2CC1C(=O)N1C2CCCCC2CC1C(=O)NC(C(=O)O)CCCN=C(N)N)NC(=O)C(Cc1cccs1)NC(=O)CNC(=O)C1CC(CN1C(=O)C1CCCN1C(=O)C(NC(=O)C(CCCN=C(N)N)N)CCCN=C(N)N)O,6918173,0,0.3
Atazanavir,SARS-COV-2,10.20944/preprints202003.0279.v1,computational,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,COC(=O)NC(C(C)(C)C)C(=O)NN(Cc1ccc(cc1)c1ccccn1)CC(C(Cc1ccccc1)NC(=O)C(C(C)(C)C)NC(=O)OC)O,148192,0,0.3
Ceftolozane,SARS-COV-2,10.20944/preprints202003.0279.v1,computational,CC(C)(C(=O)O)ON=C(C1=NSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC(=C(N4C)N)NC(=O)NCCN)C(=O)[O-],NCCNC(=O)Nc1c[n+](n(c1N)C)CC1=C(C(=O)[O-])N2C(SC1)C(C2=O)NC(=O)C(=NOC(C(=O)O)(C)C)c1nsc(n1)N,53234134,0,0.3
Hesperidin,SARS-COV-2,10.20944/preprints202003.0279.v1,computational,CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC(=C4C(=O)CC(OC4=C3)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O,COc1ccc(cc1O)C1CC(=O)c2c(O1)cc(cc2O)OC1OC(COC2OC(C)C(C(C2O)O)O)C(C(C1O)O)O,10621,0,0.3
Carfilzomib,SARS-COV-2,10.20944/preprints202003.0279.v1,computational,CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,CC(CC(C(=O)NC(C(=O)NC(C(=O)C1(C)CO1)CC(C)C)Cc1ccccc1)NC(=O)C(NC(=O)CN1CCOCC1)CCc1ccccc1)C,11556711,0,0.3
Ribavirin,SARS,10.3201/eid1004.030458,experimental,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542,0,0.3
Lopinavir,MERS,10.1038/nrd.2015.37,experimental,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727,0,0.3
Ritonavir,MERS,10.1038/nrd.2015.37,experimental,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622,0,0.3
Abemaciclib,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,CCN1CCN(CC1)Cc1ccc(nc1)Nc1ncc(c(n1)c1cc(F)c2c(c1)n(C(C)C)c(n2)C)F,46220502,0,0.3
Amodiaquine,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O,CCN(Cc1cc(ccc1O)Nc1ccnc2c1ccc(c2)Cl)CC,2165,0,0.3
Anidulafungin,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC=C(C=C7)O)O)O)C(C)O)C)O)O)O,CCCCCOc1ccc(cc1)c1ccc(cc1)c1ccc(cc1)C(=O)NC1CC(O)C(O)NC(=O)C2C(O)C(CN2C(=O)C(NC(=O)C(NC(=O)C2N(C(=O)C(NC1=O)C(O)C)CC(C2)O)C(C(c1ccc(cc1)O)O)O)C(O)C)C,166548,0,0.3
Bazedoxifene,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O,Oc1ccc2c(c1)c(C)c(n2Cc1ccc(cc1)OCCN1CCCCCC1)c1ccc(cc1)O,154257,0,0.3
Berbamine hydrochloride,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=C(O3)C(=C(C=C7CCN6C)OC)OC)O)OC.Cl,COc1c(OC)cc2c3c1Oc1cc4c(cc1OC)CCN(C4Cc1ccc(Oc4cc(CC3N(CC2)C)ccc4O)cc1)C.Cl,56845155,0,0.3
Camostat,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CN(C)C(=O)COC(=O)CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N,CN(C(=O)COC(=O)Cc1ccc(cc1)OC(=O)c1ccc(cc1)N=C(N)N)C,2536,0,0.3
Cepharanthine,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CN1CCC2=CC3=C(C4=C2C1CC5=CC=C(C=C5)OC6=C(C=CC(=C6)CC7C8=CC(=C(C=C8CCN7C)OC)O4)OC)OCO3,COc1cc2CCN(C3c2cc1Oc1c2c(CCN(C2Cc2ccc(Oc4cc(C3)ccc4OC)cc2)C)cc2c1OCO2)C,10206,0,0.3
Chloroquine diphosphate,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl.OP(=O)(O)O.OP(=O)(O)O,OP(=O)(O)O.OP(=O)(O)O.CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,64927,0,0.3
Ciclesonide,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6,O=C(C(C)C)OCC(=O)C12OC(OC1CC1C2(C)CC(O)C2C1CCC1=CC(=O)C=CC21C)C1CCCCC1,6918155,0,0.3
Clomiphene citrate,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,OC(=O)C(CC(=O)O)(CC(=O)O)O.CCN(CCOc1ccc(cc1)C(=C(c1ccccc1)Cl)c1ccccc1)CC,3033832,0,0.3
Cyclosporine,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,CC=CCC(C(C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)O)C,5284373,0,0.3
Digitoxin,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CCC7(C6(CCC7C8=CC(=O)OC8)O)C)C)C)C)O)O,O=C1OCC(=C1)C1CCC2(C1(C)CCC1C2CCC2C1(C)CCC(C2)OC1CC(O)C(C(O1)C)OC1CC(O)C(C(O1)C)OC1CC(O)C(C(O1)C)O)O,441207,0,0.3
Digoxin,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,O=C1OCC(=C1)C1CCC2(C1(C)C(O)CC1C2CCC2C1(C)CCC(C2)OC1CC(O)C(C(O1)C)OC1CC(O)C(C(O1)C)OC1CC(O)C(C(O1)C)O)O,2724385,0,0.3
Dihydrogambogic acid,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CC(=CCCC1(C=CC2=C(C3=C(C(=C2O1)CC=C(C)C)OC45C6CC(C=C4C3=O)C(C5(OC6(C)C)CC=C(C)C(=O)O)O)O)C)C,CC(=CCc1c2OC34C5(CC=C(C(=O)O)C)OC(C4CC(C5O)C=C3C(=O)c2c(c2c1OC(C)(CCC=C(C)C)C=C2)O)(C)C)C,6857793,0,0.3
Droloxifene,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCC(=C(C1=CC=C(C=C1)OCCN(C)C)C2=CC(=CC=C2)O)C3=CC=CC=C3,CCC(=C(c1cccc(c1)O)c1ccc(cc1)OCCN(C)C)c1ccccc1,3033767,0,0.3
Dronedarone HCl,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC.Cl,CCCCc1oc2c(c1C(=O)c1ccc(cc1)OCCCN(CCCC)CCCC)cc(cc2)NS(=O)(=O)C.Cl,219025,0,0.3
Ebastine,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4,O=C(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)OC(c1ccccc1)c1ccccc1,3191,0,0.3
Eltrombopag,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C,OC(=O)c1cccc(c1)c1cccc(c1O)N=Nc1c(C)[nH]n(c1=O)c1ccc(c(c1)C)C,135449332,0,0.3
Gilteritinib,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,COc1cc(ccc1N1CCC(CC1)N1CCN(CC1)C)Nc1nc(NC2CCOCC2)c(nc1C(=O)N)CC,49803313,0,0.3
Hexachlorophene,SARS-COV-2,10.1101/2020.03.20.999730,experimental,C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl,Clc1cc(Cl)c(c(c1O)Cc1c(O)c(Cl)cc(c1Cl)Cl)Cl,3598,0,0.3
Hydroxyprogesterone caproate,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCCCCC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)C(=O)C,CCCCCC(=O)OC1(CCC2C1(C)CCC1C2CCC2=CC(=O)CCC12C)C(=O)C,169870,0,0.3
Isoosajin,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CC1(CCC2=C3C(=C4C(=C2O1)C(=O)C(=CO4)C5=CC=C(C=C5)O)C=CC(O3)(C)C)C,Oc1ccc(cc1)c1coc2c(c1=O)c1OC(C)(C)CCc1c1c2C=CC(O1)(C)C,1069873,0,0.3
Isopomiferin,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CC1(CCC2=C3C(=C4C(=C2O1)C(=O)C(=CO4)C5=CC(=C(C=C5)O)O)C=CC(O3)(C)C)C,Oc1ccc(cc1O)c1coc2c(c1=O)c1OC(C)(C)CCc1c1c2C=CC(O1)(C)C,20055152,0,0.3
Ivacaftor,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,O=C(c1c[nH]c2c(c1=O)cccc2)Nc1cc(O)c(cc1C(C)(C)C)C(C)(C)C,16220172,0,0.3
Lanatoside C,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CC(C5(C4(CCC5C6=CC(=O)OC6)O)C)O)C)O)OC7CC(C(C(O7)C)OC8CC(C(C(O8)C)OC9C(C(C(C(O9)CO)O)O)O)OC(=O)C)O,OCC1OC(OC2C(C)OC(CC2OC(=O)C)OC2C(O)CC(OC2C)OC2C(O)CC(OC2C)OC2CCC3(C(C2)CCC2C3CC(O)C3(C2(O)CCC3C2=CC(=O)OC2)C)C)C(C(C1O)O)O,656630,0,0.3
LDK378,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,CC(Oc1cc(C2CCNCC2)c(cc1Nc1ncc(c(n1)Nc1ccccc1S(=O)(=O)C(C)C)Cl)C)C,57379345,0,0.3
Loperamid hydrochloride,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4.Cl.Cl,Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1.Cl.Cl,67764865,0,0.3
Lopinavir,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727,0,0.3
Lusutrombopag,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCCCCCOC(C)C1=CC=CC(=C1OC)C2=CSC(=N2)NC(=O)C3=CC(=C(C(=C3)Cl)C=C(C)C(=O)O)Cl,CCCCCCOC(c1cccc(c1OC)c1csc(n1)NC(=O)c1cc(Cl)c(c(c1)Cl)C=C(C(=O)O)C)C,49843517,0,0.3
Mefloquine,SARS-COV-2,10.1101/2020.03.20.999730,experimental,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1,40692,0,0.3
Mequitazine,SARS-COV-2,10.1101/2020.03.20.999730,experimental,C1CN2CCC1C(C2)CN3C4=CC=CC=C4SC5=CC=CC=C53,c1ccc2c(c1)N(CC1CN3CCC1CC3)c1c(S2)cccc1,4066,0,0.3
Niclosamide,SARS-COV-2,10.1101/2020.03.20.999730,experimental,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,Clc1ccc(c(c1)C(=O)Nc1ccc(cc1Cl)[N+](=O)[O-])O,4477,0,0.3
Osajin,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CC(=CCC1=C2C(=C3C(=C1O)C(=O)C(=CO3)C4=CC=C(C=C4)O)C=CC(O2)(C)C)C,CC(=CCc1c2OC(C)(C)C=Cc2c2c(c1O)c(=O)c(co2)c1ccc(cc1)O)C,95168,0,0.3
Osimertinib mesylate,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC.CS(=O)(=O)O,CS(=O)(=O)O.C=CC(=O)Nc1cc(Nc2nccc(n2)c2cn(c3c2cccc3)C)c(cc1N(CCN(C)C)C)OC,78357807,0,0.3
Ouabain,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CC1C(C(C(C(O1)OC2CC(C3(C4C(CCC3(C2)O)C5(CCC(C5(CC4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O,OCC12C(O)CC(CC2(O)CCC2C1C(O)CC1(C2(O)CCC1C1=CC(=O)OC1)C)OC1OC(C)C(C(C1O)O)O,439501,0,0.3
Oxyclozanide,SARS-COV-2,10.1101/2020.03.20.999730,experimental,C1=C(C=C(C(=C1NC(=O)C2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl)Cl,Clc1cc(NC(=O)c2c(O)c(Cl)cc(c2Cl)Cl)c(c(c1)Cl)O,16779,0,0.3
Penfluridol,SARS-COV-2,10.1101/2020.03.20.999730,experimental,C1CN(CCC1(C2=CC(=C(C=C2)Cl)C(F)(F)F)O)CCCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)(O)c1ccc(c(c1)C(F)(F)F)Cl,33630,0,0.3
Perhexiline maleate,SARS-COV-2,10.1101/2020.03.20.999730,experimental,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3.C(=CC(=O)O)C(=O)O,C1CCC(NC1)CC(C1CCCCC1)C1CCCCC1.OC(=O)C=CC(=O)O,5284439,0,0.3
Phenazopyridine hydrochloride,SARS-COV-2,10.1101/2020.03.20.999730,experimental,C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N.Cl,Nc1ccc(c(n1)N)N=Nc1ccccc1.Cl,8691,0,0.3
Pralatrexate,SARS-COV-2,10.1101/2020.03.20.999730,experimental,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C#CCC(c1ccc(cc1)C(=O)NC(C(=O)O)CCC(=O)O)Cc1cnc2c(n1)c(N)nc(n2)N,148121,0,0.3
Proscillaridin,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CC1C(C(C(C(O1)OC2CCC3(C4CCC5(C(CCC5(C4CCC3=C2)O)C6=COC(=O)C=C6)C)C)O)O)O,OC1C(OC2CCC3(C(=C2)CCC2C3CCC3(C2(O)CCC3c2ccc(=O)oc2)C)C)OC(C(C1O)O)C,5284613,0,0.3
Pyronaridine tetraphosphate,SARS-COV-2,10.1101/2020.03.20.999730,experimental,COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NC4=CC(=C(C(=C4)CN5CCCC5)O)CN6CCCC6.OP(=O)(O)O.OP(=O)(O)O.OP(=O)(O)O.OP(=O)(O)O,OP(=O)(O)O.OP(=O)(O)O.OP(=O)(O)O.OP(=O)(O)O.COc1ccc2c(n1)c(Nc1cc(CN3CCCC3)c(c(c1)CN1CCCC1)O)c1c(n2)cc(cc1)Cl,156867,0,0.3
Quinacrine hydrochloride,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC.Cl.Cl,CCN(CCCC(Nc1c2cc(OC)ccc2nc2c1ccc(c2)Cl)C)CC.Cl.Cl,6239,0,0.3
Remdesivir,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4,CCC(COC(=O)C(NP(=O)(Oc1ccccc1)OCC1OC(C(C1O)O)(C#N)c1ccc2n1ncnc2N)C)CC,,0,0.3
"Salinomycin, sodium",SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCC(C1CCC(C(O1)C(C)C(C(C)C(=O)C(CC)C2C(CC(C3(O2)C=CC(C4(O3)CCC(O4)(C)C5CCC(C(O5)C)(CC)O)O)C)C)O)C)C(=O)[O-].[Na+],CCC(C1OC2(C=CC(C3(O2)CCC(O3)(C)C2CCC(C(O2)C)(O)CC)O)C(CC1C)C)C(=O)C(C(C(C1OC(CCC1C)C(C(=O)[O-])CC)C)O)C.[Na+],23682228,0,0.3
Tetrandrine,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=C(O3)C(=C(C=C7CCN6C)OC)OC)OC)OC,COc1c(OC)cc2c3c1Oc1cc4c(cc1OC)CCN(C4Cc1ccc(Oc4cc(CC3N(CC2)C)ccc4OC)cc1)C,73078,0,0.3
Thioridazine hydrochloride,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC.Cl,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1.Cl,66062,0,0.3
Tilorone,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCN(CC)CCOC1=CC2=C(C=C1)C3=C(C2=O)C=C(C=C3)OCCN(CC)CC,CCN(CCOc1ccc2-c3c(C(=O)c2c1)cc(cc3)OCCN(CC)CC)CC,5475,0,0.3
Toremiphene,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3,3005573,0,0.3
Triparanol,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCN(CC)CCOC1=CC=C(C=C1)C(CC2=CC=C(C=C2)Cl)(C3=CC=C(C=C3)C)O,CCN(CCOc1ccc(cc1)C(c1ccc(cc1)C)(Cc1ccc(cc1)Cl)O)CC,6536,0,0.3
Saquinavir,SARS-COV-2,10.1101/2020.04.05.20054254,computational,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O,NC(=O)CC(C(=O)NC(C(CN1CC2CCCCC2CC1C(=O)NC(C)(C)C)O)Cc1ccccc1)NC(=O)c1ccc2c(n1)cccc2,441243,0,0.3
Atazanavir,SARS-COV-2,10.1101/2020.04.05.20054254,computational,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,COC(=O)NC(C(C)(C)C)C(=O)NN(Cc1ccc(cc1)c1ccccn1)CC(C(Cc1ccccc1)NC(=O)C(C(C)(C)C)NC(=O)OC)O,148192,0,0.3
Lopinavir,SARS-COV-2,10.1101/2020.04.05.20054254,computational,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727,0,0.3
Tipranavir,SARS-COV-2,10.1101/2020.04.05.20054254,computational,CCCC1(CC(=C(C(=O)O1)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4,CCCC1(CCc2ccccc2)CC(=C(C(=O)O1)C(c1cccc(c1)NS(=O)(=O)c1ccc(cn1)C(F)(F)F)CC)O,54682461,0,0.3
Amprenavir,SARS-COV-2,10.1101/2020.04.05.20054254,computational,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N,CC(CN(S(=O)(=O)c1ccc(cc1)N)CC(C(Cc1ccccc1)NC(=O)OC1CCOC1)O)C,65016,0,0.3
Fosamprenavir,SARS-COV-2,10.1101/2020.04.05.20054254,computational,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N,CC(CN(S(=O)(=O)c1ccc(cc1)N)CC(C(Cc1ccccc1)NC(=O)OC1CCOC1)OP(=O)(O)O)C,131536,0,0.3
Ritonavir,SARS-COV-2,10.1101/2020.04.05.20054254,computational,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622,0,0.3
Darunavir,SARS-COV-2,10.1101/2020.04.05.20054254,computational,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,CC(CN(S(=O)(=O)c1ccc(cc1)N)CC(C(Cc1ccccc1)NC(=O)OC1COC2C1CCO2)O)C,213039,0,0.3
Paritaprevir,SARS-COV-2,10.1101/2020.04.05.20054254,computational,CC1=CN=C(C=N1)C(=O)NC2CCCCCC=CC3CC3(NC(=O)C4CC(CN4C2=O)OC5=NC6=CC=CC=C6C7=CC=CC=C75)C(=O)NS(=O)(=O)C8CC8,Cc1ncc(nc1)C(=O)NC1CCCCCC=CC2C(NC(=O)C3N(C1=O)CC(C3)Oc1nc3ccccc3c3c1cccc3)(C2)C(=O)NS(=O)(=O)C1CC1,45110509,0,0.3
Azithromycine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,CCC1OC(=O)C(C)C(OC2OC(C)C(C(C2)(C)OC)O)C(C)C(OC2OC(C)CC(C2O)N(C)C)C(CC(CN(C(C(C1(C)O)O)C)C)C)(C)O,447043,0,0.3
Opipramol,SARS-COV-2,10.1101/2020.04.03.023846,mixed,C1CN(CCN1CCCN2C3=CC=CC=C3C=CC4=CC=CC=C42)CCO,OCCN1CCN(CC1)CCCN1c2ccccc2C=Cc2c1cccc2,9417,0,0.3
Quinidine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,C=CC1CN2CCC1CC2C(c1ccnc2c1cc(OC)cc2)O,441074,0,0.3
Omeprazol,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,COc1ccc2c(c1)[nH]c(n2)S(=O)Cc1ncc(c(c1C)OC)C,4594,0,0.3
Oxprenolol hydrochloride,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC(C)NCC(COC1=CC=CC=C1OCC=C)O.Cl,C=CCOc1ccccc1OCC(CNC(C)C)O.Cl,71172,0,0.3
Clemizole hydrochloride,SARS-COV-2,10.1101/2020.04.03.023846,mixed,C1CCN(C1)CC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)Cl.Cl,Clc1ccc(cc1)Cn1c(CN2CCCC2)nc2c1cccc2.Cl,5309446,0,0.3
Alprostadil,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,CCCCCC(C=CC1C(O)CC(=O)C1CCCCCCC(=O)O)O,5280723,0,0.3
Dolutegravir,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,Fc1ccc(c(c1)F)CNC(=O)c1cn2CC3OCCC(N3C(=O)c2c(c1=O)O)C,54726191,0,0.3
Sulfadoxine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N,COc1c(OC)ncnc1NS(=O)(=O)c1ccc(cc1)N,17134,0,0.3
Arbidol,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3,CCOC(=O)c1c(CSc2ccccc2)n(c2c1c(CN(C)C)c(O)c(c2)Br)C,131411,0,0.3
Remdesivir,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4,CCC(COC(=O)C(NP(=O)(Oc1ccccc1)OCC1OC(C(C1O)O)(C#N)c1ccc2n1ncnc2N)C)CC,121304016,0,0.3
Oxymetholone,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC12CCC3C(C1CCC2(C)O)CCC4C3(CC(=CO)C(=O)C4)C,OC=C1CC2(C)C(CC1=O)CCC1C2CCC2(C1CCC2(C)O)C,5281034,0,0.3
Equilin,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC12CCC3C(=CCC4=C3C=CC(=C4)O)C1CCC2=O,Oc1ccc2c(c1)CC=C1C2CCC2(C1CCC2=O)C,223368,0,0.3
Pregnenolone,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C,OC1CCC2(C(=CCC3C2CCC2(C3CCC2C(=O)C)C)C1)C,8955,0,0.3
Formestane,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC12CCC(=O)C(=C1CCC3C2CCC4(C3CCC4=O)C)O,O=C1CCC2(C(=C1O)CCC1C2CCC2(C1CCC2=O)C)C,11273,0,0.3
Exemestane,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,O=C1C=CC2(C(=C1)C(=C)CC1C2CCC2(C1CCC2=O)C)C,60198,0,0.3
Methandrostenolone,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC12CCC3C(C1CCC2(C)O)CCC4=CC(=O)C=CC34C,O=C1C=CC2(C(=C1)CCC1C2CCC2(C1CCC2(C)O)C)C,6300,0,0.3
Prednicarbate,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)OC(=O)OCC,CCOC(=O)OC1(CCC2C1(C)CC(O)C1C2CCC2=CC(=O)C=CC12C)C(=O)COC(=O)CC,6714002,0,0.3
Desonide,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C,OCC(=O)C12OC(OC1CC1C2(C)CC(O)C2C1CCC1=CC(=O)C=CC21C)(C)C,5311066,0,0.3
Misoprostol,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCCCC(C)(CC=CC1C(CC(=O)C1CCCCCCC(=O)OC)O)O,CCCCC(CC=CC1C(O)CC(=O)C1CCCCCCC(=O)OC)(O)C,5282381,0,0.3
Vonoprazan,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3,CNCc1cc(n(c1)S(=O)(=O)c1cccnc1)c1ccccc1F,15981397,0,0.3
Darunavir,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,CC(CN(S(=O)(=O)c1ccc(cc1)N)CC(C(Cc1ccccc1)NC(=O)OC1COC2C1CCO2)O)C,213039,0,0.3
Prothionamide,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCCC1=NC=CC(=C1)C(=S)N,CCCc1cc(ccn1)C(=S)N,666418,0,0.3
Levofloxacin,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,CN1CCN(CC1)c1c(F)cc2c3c1OCC(n3cc(c2=O)C(=O)O)C,149096,0,0.3
Enoxacin,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,CCn1cc(C(=O)O)c(=O)c2c1nc(N1CCNCC1)c(c2)F,3229,0,0.3
Sparfloxacin,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC1CN(CC(N1)C)C2=C(C(=C3C(=C2F)N(C=C(C3=O)C(=O)O)C4CC4)N)F,CC1NC(C)CN(C1)c1c(F)c(N)c2c(c1F)n(cc(c2=O)C(=O)O)C1CC1,60464,0,0.3
D-cycloserine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,C1C(C(=O)NO1)N,NC1CONC1=O,6234,0,0.3
L-Cycloserine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,C1C(C(=O)NO1)N,NC1CONC1=O,449215,0,0.3
Spiramycin,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)OC4CCC(C(O4)C)N(C)C,O=CCC1CC(C)C(C=CC=CCC(OC(=O)CC(C(C1OC1OC(C)C(C(C1O)N(C)C)OC1CC(C)(O)C(C(O1)C)O)OC)O)C)OC1CCC(C(O1)C)N(C)C,6419898,0,0.3
Cefamandole,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(C4=CC=CC=C4)O)SC2)C(=O)O,OC(C(=O)NC1C(=O)N2C1SCC(=C2C(=O)O)CSc1nnnn1C)c1ccccc1,456255,0,0.3
Benzathine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,C1=CC=C(C=C1)CNCCNCC2=CC=CC=C2,N(Cc1ccccc1)CCNCc1ccccc1,8793,0,0.3
Merbromin,SARS-COV-2,10.1101/2020.04.03.023846,mixed,C1=CC=C2C(=C1)C(=O)OC23C4=CC(=C(C=C4OC5=C(C(=C(C=C35)Br)[O-])[Hg])[O-])Br.O.[Na+].[Na+],O=C1OC2(c3c1cccc3)c1cc(Br)c(cc1Oc1c2cc(Br)c(c1[Hg])[O-])[O-].[Na+].[Na+].O,8505,0,0.3
Ifenprodil tartrate,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)CC3=CC=CC=C3.CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)CC3=CC=CC=C3.C(C(C(=O)O)O)(C(=O)O)O,OC(C(C(=O)O)O)C(=O)O.Oc1ccc(cc1)C(C(N1CCC(CC1)Cc1ccccc1)C)O.Oc1ccc(cc1)C(C(N1CCC(CC1)Cc1ccccc1)C)O,656586,0,0.3
Nylidrin,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC(CCC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O,CC(NC(C(c1ccc(cc1)O)O)C)CCc1ccccc1,4567,0,0.3
Cyclopentolate,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O,CN(CCOC(=O)C(C1(O)CCCC1)c1ccccc1)C,2905,0,0.3
(S)-(-)-Propranolol hydrochloride,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.Cl,OC(COc1cccc2c1cccc2)CNC(C)C.Cl,165193,0,0.3
Ranolazine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,COc1ccccc1OCC(CN1CCN(CC1)CC(=O)Nc1c(C)cccc1C)O,56959,0,0.3
Candesartan,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O,2541,0,0.3
Olmesartan,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(C)(C)O,CCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)C(=O)O)C(O)(C)C,158781,0,0.3
Ambrisentan,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C,COC(C(C(=O)O)Oc1nc(C)cc(n1)C)(c1ccccc1)c1ccccc1,6918493,0,0.3
Fosinopril,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)O)C3CCCCC3,CCC(=O)OC(C(C)C)OP(=O)(CC(=O)N1CC(CC1C(=O)O)C1CCCCC1)CCCCc1ccccc1,55891,0,0.3
Fenoldopam,SARS-COV-2,10.1101/2020.04.03.023846,mixed,C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O,Oc1ccc(cc1)C1CNCCc2c1cc(O)c(c2Cl)O,3341,0,0.3
Meptazinol,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCC1(CCCCN(C1)C)C2=CC(=CC=C2)O,CCC1(CCCCN(C1)C)c1cccc(c1)O,41049,0,0.3
Nalmefene hydrochloride,SARS-COV-2,10.1101/2020.04.03.023846,mixed,C=C1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC6CC6)O.Cl,C=C1CCC2(C34C1Oc1c4c(CC2N(CC3)CC2CC2)ccc1O)O.Cl,5388881,0,0.3
Mirtazapine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,CN1CCN2C(C1)c1ccccc1Cc1c2nccc1,4205,0,0.3
Olanzapine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C,CN1CCN(CC1)C1=Nc2ccccc2Nc2c1cc(s2)C,135398745,0,0.3
Tacrine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,C1CCC2=NC3=CC=CC=C3C(=C2C1)N,Nc1c2CCCCc2nc2c1cccc2,1935,0,0.3
Promazine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31,CN(CCCN1c2ccccc2Sc2c1cccc2)C,4926,0,0.3
Clebopride,SARS-COV-2,10.1101/2020.04.03.023846,mixed,COC1=CC(=C(C=C1C(=O)NC2CCN(CC2)CC3=CC=CC=C3)Cl)N,COc1cc(N)c(cc1C(=O)NC1CCN(CC1)Cc1ccccc1)Cl,2780,0,0.3
Donepezil,SARS-COV-2,10.1101/2020.04.03.023846,mixed,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,COc1cc2c(cc1OC)CC(C2=O)CC1CCN(CC1)Cc1ccccc1,3152,0,0.3
Tolperisone,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2,CC(C(=O)c1ccc(cc1)C)CN1CCCCC1,5511,0,0.3
Idazoxan,SARS-COV-2,10.1101/2020.04.03.023846,mixed,C1CN=C(N1)C2COC3=CC=CC=C3O2,C1CN=C(N1)C1COc2c(O1)cccc2,54459,0,0.3
Ondansetron,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,O=C1C(CCc2c1c1ccccc1n2C)Cn1ccnc1C,4595,0,0.3
Eletriptan,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4,CN1CCCC1Cc1c[nH]c2c1cc(cc2)CCS(=O)(=O)c1ccccc1,77993,0,0.3
Phentermine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC(C)(CC1=CC=CC=C1)N,CC(Cc1ccccc1)(N)C,4771,0,0.3
Buspirone,SARS-COV-2,10.1101/2020.04.03.023846,mixed,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1,2477,0,0.3
Nabumetone,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,COc1ccc2c(c1)ccc(c2)CCC(=O)C,4409,0,0.3
Tolterodine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,Cc1ccc(c(c1)C(c1ccccc1)CCN(C(C)C)C(C)C)O,443879,0,0.3
Benoxinate,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCCCOC1=C(C=CC(=C1)C(=O)OCCN(CC)CC)N,CCCCOc1cc(ccc1N)C(=O)OCCN(CC)CC,4633,0,0.3
Meprylcaine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCCNC(C)(C)COC(=O)C1=CC=CC=C1,CCCNC(COC(=O)c1ccccc1)(C)C,4065,0,0.3
Dyclonine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCCCOC1=CC=C(C=C1)C(=O)CCN2CCCCC2,CCCCOc1ccc(cc1)C(=O)CCN1CCCCC1,3180,0,0.3
Eperisone,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2,CCc1ccc(cc1)C(=O)C(CN1CCCCC1)C,3236,0,0.3
Cisatracurium,SARS-COV-2,10.1101/2020.04.03.023846,mixed,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C,COc1cc2c(cc1OC)CC[N+](C2Cc1ccc(c(c1)OC)OC)(C)CCC(=O)OCCCCCOC(=O)CC[N+]1(C)CCc2c(C1Cc1ccc(c(c1)OC)OC)cc(c(c2)OC)OC,62887,0,0.3
Formoterol,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,3083544,0,0.3
Ambroxol,SARS-COV-2,10.1101/2020.04.03.023846,mixed,C1CC(CCC1NCC2=C(C(=CC(=C2)Br)Br)N)O,OC1CCC(CC1)NCc1cc(Br)cc(c1N)Br,2132,0,0.3
Levalbuterol,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,OCc1cc(ccc1O)C(CNC(C)(C)C)O,123600,0,0.3
Dimenhydrinate,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CN1C2=C(C(=O)N(C1=O)C)NC(=N2)Cl.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,Clc1[nH]c2c(n1)n(C)c(=O)n(c2=O)C.CN(CCOC(c1ccccc1)c1ccccc1)C,10660,0,0.3
Tripelennamine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2,CN(CCN(c1ccccn1)Cc1ccccc1)C,5587,0,0.3
Chloroquine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,2719,0,0.3
Hydroxychloroquine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,OCCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,3652,0,0.3
Artenimol,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)O)C,OC1OC2OC3(C)CCC4C2(C(C1C)CCC4C)OO3,3000518,0,0.3
Dipivefrin,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC(C)(C)C(=O)OC1=C(C=C(C=C1)C(CNC)O)OC(=O)C(C)(C)C,CNCC(c1ccc(c(c1)OC(=O)C(C)(C)C)OC(=O)C(C)(C)C)O,3105,0,0.3
Ethoxzolamide,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCOC1=CC2=C(C=C1)N=C(S2)S(=O)(=O)N,CCOc1ccc2c(c1)sc(n2)S(=O)(=O)N,3295,0,0.3
Oxiglutatione,SARS-COV-2,10.1101/2020.04.03.023846,mixed,C(CC(=O)NC(CSSCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)C(=O)NCC(=O)O)C(C(=O)O)N,O=C(NC(C(=O)NCC(=O)O)CSSCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)CCC(C(=O)O)N,65359,0,0.3
Isotretinoin,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,CC(=CC=CC(=CC(=O)O)C)C=CC1=C(C)CCCC1(C)C,5282379,0,0.3
Anthralin,SARS-COV-2,10.1101/2020.04.03.023846,mixed,C1C2=C(C(=CC=C2)O)C(=O)C3=C1C=CC=C3O,Oc1cccc2c1C(=O)c1c(C2)cccc1O,2202,0,0.3
Ibudilast,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC(C)C1=NN2C=CC=CC2=C1C(=O)C(C)C,CC(C(=O)c1c(nn2c1cccc2)C(C)C)C,3671,0,0.3
Fursultiamine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC1=NC=C(C(=N1)N)CN(C=O)C(=C(CCO)SSCC2CCCO2)C,OCCC(=C(N(Cc1cnc(nc1N)C)C=O)C)SSCC1CCCO1,3002119,0,0.3
Anethole-trithione,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC=CC1=CC=C(C=C1)OC,CC=Cc1ccc(cc1)OC,637563,0,0.3
Zoledronic acid,SARS-COV-2,10.1101/2020.04.03.023846,mixed,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O,OP(=O)(C(P(=O)(O)O)(Cn1cncc1)O)O,68740,0,0.3
Oxyphenisatin,SARS-COV-2,10.1101/2020.04.03.023846,mixed,C1=CC=C2C(=C1)C(C(=O)N2)(C3=CC=C(C=C3)O)C4=CC=C(C=C4)O,Oc1ccc(cc1)C1(c2ccc(cc2)O)C(=O)Nc2c1cccc2,31315,0,0.3
Cyclofenil,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC(=O)OC1=CC=C(C=C1)C(=C2CCCCC2)C3=CC=C(C=C3)OC(=O)C,CC(=O)Oc1ccc(cc1)C(=C1CCCCC1)c1ccc(cc1)OC(=O)C,2898,0,0.3
Lopinavir,SARS-COV-2,10.1101/2020.04.06.026476,experimental,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727,0,0.3
Nelfinavir,SARS-COV-2,10.1101/2020.04.06.026476,experimental,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O,OC(C(NC(=O)c1cccc(c1C)O)CSc1ccccc1)CN1CC2CCCCC2CC1C(=O)NC(C)(C)C,64143,0,0.3
Merimepodib,SARS-COV-2,10.1101/2020.04.07.028589,experimental,COC1=C(C=CC(=C1)NC(=O)NC2=CC=CC(=C2)CNC(=O)OC3CCOC3)C4=CN=CO4,COc1cc(ccc1c1cnco1)NC(=O)Nc1cccc(c1)CNC(=O)OC1COCC1,153241,0,0.3
Ebselen,SARS-COV-2,10.1038/s41586-020-2223-y,experimental,C1=CC=C(C=C1)N2C(=O)C3=CC=CC=C3[Se]2,O=c1c2ccccc2[se]n1c1ccccc1,3194,0,0.3
Disulfiram,SARS-COV-2,10.1038/s41586-020-2223-y,experimental,CCN(CC)C(=S)SSC(=S)N(CC)CC,CCN(C(=S)SSC(=S)N(CC)CC)CC,3117,0,0.3
Tideglusib,SARS-COV-2,10.1038/s41586-020-2223-y,experimental,C1=CC=C(C=C1)CN2C(=O)N(SC2=O)C3=CC=CC4=CC=CC=C43,O=c1sn(c(=O)n1Cc1ccccc1)c1cccc2c1cccc2,11313622,0,0.3
Carmofur,SARS-COV-2,10.1038/s41586-020-2223-y,experimental,CCCCCCNC(=O)N1C=C(C(=O)NC1=O)F,CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O,2577,0,0.3
Shikonin,SARS-COV-2,10.1038/s41586-020-2223-y,experimental,CC(=CCC(C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C,CC(=CCC(C1=CC(=O)c2c(C1=O)c(O)ccc2O)O)C,479503,0,0.3
PX-12,SARS-COV-2,10.1038/s41586-020-2223-y,experimental,CCC(C)SSC1=NC=CN1,CCC(SSc1ncc[nH]1)C,219104,0,0.3
Amantadine,SARS-COV-2,10.1101/2020.04.05.026187,experimental,C1C2CC3CC1CC(C2)(C3)N,NC12CC3CC(C2)CC(C1)C3,2130,0,0.3
Atazanavir,SARS-COV-2,10.1101/2020.04.04.020925,experimental,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,COC(=O)NC(C(C)(C)C)C(=O)NN(Cc1ccc(cc1)c1ccccn1)CC(C(Cc1ccccc1)NC(=O)C(C(C)(C)C)NC(=O)OC)O,148192,0,0.3
Ritonavir,SARS-COV-2,10.1101/2020.04.04.020925,experimental,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622,0,0.3
Spermidine,SARS-COV-2,10.1101/2020.04.15.997254,experimental,C(CCNCCCN)CN,NCCCNCCCCN,1102,0,0.3
MK-2206,SARS-COV-2,10.1101/2020.04.15.997254,experimental,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,O=c1[nH]nc2n1ccc1c2cc(c(n1)c1ccc(cc1)C1(N)CCC1)c1ccccc1,24964624,0,0.3
Niclosamide,SARS-COV-2,10.1101/2020.04.15.997254,experimental,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,Clc1ccc(c(c1)C(=O)Nc1ccc(cc1Cl)[N+](=O)[O-])O,4477,0,0.3
Amodiaquine,SARS-COV-2,10.1101/2020.04.13.039917,experimental,CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O,CCN(Cc1cc(ccc1O)Nc1ccnc2c1ccc(c2)Cl)CC,2165,0,0.3
Toremifene,SARS-COV-2,10.1101/2020.04.13.039917,experimental,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3,ClCCC(=C(c1ccccc1)c1ccc(cc1)OCCN(C)C)c1ccccc1,3005573,0,0.3